<!DOCTYPE html><html lang="en" class="scroll-smooth"><head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Pharmacology Test - Brain And Scalpel</title>
    <link rel="preload" href="assets/background.jpg" as="image">
    <script src="https://cdn.tailwindcss.com"></script>
    <!-- HLS.js for M3U8 support -->
    <script src="https://cdn.jsdelivr.net/npm/hls.js@latest"></script>
    <style>
        
/* Liquid Glass Morphism Universal Theme - Enhanced & Mobile-First */
:root {
  --glass-bg: rgba(0, 0, 0, 0.6);
  --glass-bg-light: rgba(255, 255, 255, 0.1);
  --glass-bg-medium: rgba(255, 255, 255, 0.15);
  --glass-bg-heavy: rgba(255, 255, 255, 0.2);
  --glass-border: rgba(255, 255, 255, 0.2);
  --glass-border-light: rgba(255, 255, 255, 0.1);
  --text-primary: rgba(255, 255, 255, 0.95);
  --text-secondary: rgba(255, 255, 255, 0.7);
  --text-tertiary: rgba(255, 255, 255, 0.5);
  --accent-blue: #60a5fa;
  --accent-purple: #a855f7;
  --accent-green: #34d399;
  --accent-orange: #fb923c;
  --accent-red: #f87171;
  --accent-yellow: #fbbf24;
}

* {
  margin: 0;
  padding: 0;
  box-sizing: border-box;
}

html {
  scroll-behavior: smooth;
}

body {
  margin: 0;
  min-height: 100vh;
  font-family: system-ui, -apple-system, BlinkMacSystemFont, 'Segoe UI', sans-serif;
  position: relative;
  overflow-x: hidden;
  color: var(--text-primary);
  background-color: #000;
}

/* iOS Background Fix */
body::before {
  content: '';
  position: fixed;
  top: 0;
  left: 0;
  height: 100vh;
  width: 100vw;
  z-index: -2;
  background: url("assets/background.jpg") center center / cover no-repeat;
}

body::after {
  content: "";
  position: fixed;
  inset: 0;
  background: rgba(0, 0, 0, 0.4);
  backdrop-filter: blur(10px);
  -webkit-backdrop-filter: blur(10px);
  z-index: -1;
}

/* Glass morphism components */
.glass {
  background: var(--glass-bg);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-light {
  background: var(--glass-bg-light);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid var(--glass-border-light);
  border-radius: 12px;
}

.glass-medium {
  background: var(--glass-bg-medium);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-heavy {
  background: var(--glass-bg-heavy);
  backdrop-filter: blur(25px);
  -webkit-backdrop-filter: blur(25px);
  border: 1px solid var(--glass-border);
  border-radius: 20px;
}

.glass-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.glass-card:hover {
  transform: translateY(-8px);
  background: rgba(255, 255, 255, 0.12);
  border-color: rgba(255, 255, 255, 0.25);
  box-shadow: 0 20px 60px rgba(0, 0, 0, 0.4);
}

.glass-button {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.8), rgba(168, 85, 247, 0.8));
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: white;
  font-weight: 600;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 4px 20px rgba(96, 165, 250, 0.3);
  cursor: pointer;
  border: none;
}

.glass-button:hover {
  transform: translateY(-2px);
  box-shadow: 0 8px 30px rgba(96, 165, 250, 0.4);
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.9), rgba(168, 85, 247, 0.9));
}

.glass-button:disabled {
  opacity: 0.5;
  cursor: not-allowed;
  transform: none;
}

.glass-input {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: var(--text-primary);
  transition: all 0.3s ease;
}

.glass-input:focus {
  outline: none;
  border-color: var(--accent-blue);
  background: rgba(255, 255, 255, 0.12);
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.3);
}

.glass-input::placeholder {
  color: var(--text-tertiary);
}

/* Performance analysis styles */
.performance-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.score-circle {
  position: relative;
  width: 150px;
  height: 150px;
  margin: 0 auto;
}

.score-circle svg {
  transform: rotate(-90deg);
}

.score-circle .circle-bg {
  fill: none;
  stroke: rgba(255, 255, 255, 0.1);
  stroke-width: 8;
}

.score-circle .circle-progress {
  fill: none;
  stroke-width: 8;
  stroke-linecap: round;
  transition: stroke-dasharray 2s cubic-bezier(0.4, 0, 0.2, 1);
}

.score-text {
  position: absolute;
  top: 50%;
  left: 50%;
  transform: translate(-50%, -50%);
  text-align: center;
}

/* Review question styles */
.review-question {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.1);
  border-radius: 16px;
  padding: 20px;
  margin-bottom: 20px;
}

.review-question.correct {
  border-left: 4px solid #22c55e;
}

.review-question.incorrect {
  border-left: 4px solid #ef4444;
}

.review-question.not-attempted {
  border-left: 4px solid #6b7280;
}

/* Gradient backgrounds for accents */
.gradient-blue {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
}

.gradient-purple {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
}

.gradient-green {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
}

.gradient-orange {
  background: linear-gradient(135deg, var(--accent-orange), #f97316);
}

.gradient-red {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
}

.gradient-yellow {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
}

/* Navigation button styles */
.nav-btn-not-attempted {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  color: rgba(255, 255, 255, 0.7);
}

.nav-btn-current {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.4);
}

.nav-btn-correct {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-incorrect {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-bookmarked {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-marked-review {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-answered {
  background: linear-gradient(135deg, #6b7280, #4b5563);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

/* Option button styles - REVISED FOR INLINE FEEDBACK */
.option-button {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.15);
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  position: relative;
  overflow: hidden;
  width: 100%;
  text-align: left;
  padding: 1rem;
  border-radius: 12px;
  color: var(--text-primary);
  cursor: pointer;
  display: flex;
  align-items: center;
  gap: 1rem;
  font-size: 1rem;
}

.option-button:hover {
  background: rgba(255, 255, 255, 0.1);
  border-color: rgba(96, 165, 250, 0.5);
  transform: translateX(8px);
}

.option-button.selected {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.3), rgba(59, 130, 246, 0.3));
  border-color: var(--accent-blue);
  transform: translateX(8px);
}

#optionsContainer.answered .option-button:hover {
    transform: translateX(0); /* Disable hover effect after answering */
}

#optionsContainer.answered .option-button {
    cursor: not-allowed;
    pointer-events: none;
}

#optionsContainer.answered .option-button:not(.correct):not(.incorrect) {
    opacity: 0.5;
}

.option-button.correct {
    background: linear-gradient(135deg, #22c55e, #16a34a);
    border-color: #22c55e;
    color: white;
    transform: translateX(0);
}

.option-button.incorrect {
    background: linear-gradient(135deg, #ef4444, #dc2626);
    border-color: #ef4444;
    color: white;
    transform: translateX(0);
}

.option-letter {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  transition: all 0.3s ease;
  width: 2.5rem;
  height: 2.5rem;
  border-radius: 50%;
  display: flex;
  align-items: center;
  justify-content: center;
  font-weight: bold;
  color: var(--text-primary);
  flex-shrink: 0;
}

.option-button.selected .option-letter {
  background: var(--accent-blue);
  border-color: var(--accent-blue);
  color: white;
}

.option-button.correct .option-letter, .option-button.incorrect .option-letter {
    background: rgba(255, 255, 255, 0.2);
    border-color: rgba(255, 255, 255, 0.3);
}

.option-text {
  flex: 1;
  font-size: 1rem;
  line-height: 1.5;
}

/* Stats bar responsive grid */
.stats-grid {
  display: grid;
  grid-template-columns: repeat(5, 1fr);
  gap: 1rem;
  align-items: center;
  justify-items: center;
}

@media (max-width: 768px) {
  .stats-grid {
    grid-template-columns: repeat(3, 1fr);
    gap: 0.5rem;
  }
 
  .stats-grid > div:nth-child(4),
  .stats-grid > div:nth-child(5) {
    grid-column: span 1;
  }
}

@media (max-width: 480px) {
  .stats-grid {
    grid-template-columns: repeat(2, 1fr);
  }
 
  .stats-grid > div:last-child {
    grid-column: span 2;
    justify-self: center;
  }
}

/* Animations */
@keyframes float {
  0%, 100% { transform: translateY(0px); }
  50% { transform: translateY(-20px); }
}

@keyframes pulse-glow {
  0%, 100% { box-shadow: 0 0 20px rgba(96, 165, 250, 0.3); }
  50% { box-shadow: 0 0 40px rgba(96, 165, 250, 0.6); }
}

@keyframes checkmark {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(180deg); }
  100% { transform: scale(1) rotate(360deg); }
}

@keyframes cross {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(90deg); }
  100% { transform: scale(1) rotate(180deg); }
}

.animate-float {
  animation: float 6s ease-in-out infinite;
}

.animate-pulse-glow {
  animation: pulse-glow 2s ease-in-out infinite;
}

.animate-checkmark {
  animation: checkmark 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

.animate-cross {
  animation: cross 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

/* Custom scrollbar */
::-webkit-scrollbar {
  width: 8px;
}

::-webkit-scrollbar-track {
  background: rgba(255, 255, 255, 0.05);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb {
  background: rgba(255, 255, 255, 0.2);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb:hover {
  background: rgba(255, 255, 255, 0.3);
}

/* --- MOBILE RESPONSIVE STYLES --- */
.quiz-container {
    display: flex;
    flex-direction: column;
    gap: 1.5rem;
}

#mobile-nav-toggle {
    display: none; /* Hidden on desktop */
}

@media (min-width: 1024px) {
    .quiz-container {
        flex-direction: row;
        gap: 2rem;
    }
}

@media (max-width: 1023px) {
    .quiz-sidebar {
        position: fixed;
        top: 0;
        left: 0;
        width: 300px;
        height: 100%;
        z-index: 100;
        transform: translateX(-100%);
        transition: transform 0.3s ease-in-out;
        box-shadow: 10px 0px 30px rgba(0,0,0,0.5);
    }
    .quiz-sidebar.open {
        transform: translateX(0);
    }
    #mobile-nav-toggle {
        display: flex;
        position: fixed;
        bottom: 20px;
        left: 20px;
        z-index: 50;
    }
    .quiz-main-content {
        width: 100%;
    }
}

@media (max-width: 768px) {
    .glass-card, .glass {
        border-radius: 16px;
    }
    h1 { font-size: 2.5rem; }
    #questionText { font-size: 1.125rem; }
    .controls-container {
        flex-direction: column;
        gap: 1rem;
    }
    .controls-container button {
        width: 100%;
    }
}

    </style>
</head>
<body>
    <!-- Mode Selection Modal -->
    <div id="modeModal" class="fixed inset-0 bg-black bg-opacity-70 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-md w-full mx-4 shadow-2xl">
            <h2 class="text-2xl font-bold text-white mb-6 text-center">Choose Study Mode</h2>
            
            <div class="space-y-4">
                <button onclick="selectMode('study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Study Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Interactive learning with immediate feedback</p>
                        </div>
                        <div class="gradient-blue w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 12l2 2 4-4m6 2a9 9 0 11-18 0 9 9 0 0118 0z"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('test')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Test Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Practice test with performance analysis at end</p>
                        </div>
                        <div class="gradient-purple w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 2a1 1 0 000 2h2a1 1 0 100-2H9z"></path>
                                <path fill-rule="evenodd" d="M4 5a2 2 0 012-2v1a1 1 0 001 1h6a1 1 0 001-1V3a2 2 0 012 2v6a2 2 0 01-2 2H6a2 2 0 01-2-2V5zm3 4a1 1 0 000 2h.01a1 1 0 100-2H7zm3 0a1 1 0 000 2h3a1 1 0 100-2h-3z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Study</h3>
                            <p class="text-sm text-white text-opacity-70">Study with time pressure and immediate feedback</p>
                        </div>
                        <div class="gradient-green w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M10 18a8 8 0 100-16 8 8 0 000 16zm1-12a1 1 0 10-2 0v4a1 1 0 00.293.707l2.828 2.829a1 1 0 101.415-1.415L11 9.586V6z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_exam')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Exam</h3>
                            <p class="text-sm text-white text-opacity-70">Real exam simulation with strict timing</p>
                        </div>
                        <div class="gradient-red w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M12.395 2.553a1 1 0 00-1.45-.385c-.345.23-.614.558-.822.88-.214.33-.403.713-.57 1.116-.334.804-.614 1.768-.84 2.734a31.365 31.365 0 00-.613 3.58 2.64 2.64 0 01-.945-1.067c-.328-.68-.398-1.534-.398-2.654A1 1 0 005.05 6.05 6.981 6.981 0 003 11a7 7 0 1011.95-4.95c-.592-.591-.98-.985-1.348-1.467-.363-.476-.724-1.063-1.207-2.03z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
            </div>
        </div>
    </div>

    <!-- Performance Analysis Modal -->
    <div id="performanceModal" class="hidden fixed inset-0 bg-black bg-opacity-80 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-4xl w-full mx-4 shadow-2xl max-h-[90vh] overflow-y-auto">
            <div class="flex items-center justify-between mb-8">
                <h2 class="text-3xl font-bold text-white">Performance Analysis</h2>
                <button onclick="closePerformanceModal()" class="glass-light p-2 rounded-lg text-white hover:bg-white hover:bg-opacity-20">
                    <svg class="w-6 h-6" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M4.293 4.293a1 1 0 011.414 0L10 8.586l4.293-4.293a1 1 0 111.414 1.414L11.414 10l4.293 4.293a1 1 0 01-1.414 1.414L10 11.414l-4.293 4.293a1 1 0 01-1.414-1.414L8.586 10 4.293 5.707a1 1 0 010-1.414z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
            
            <!-- Score Overview -->
            <div class="grid grid-cols-1 md:grid-cols-3 gap-6 mb-8">
                <div class="performance-card p-6 text-center">
                    <div class="score-circle mb-4">
                        <svg width="150" height="150" class="mx-auto">
                            <circle class="circle-bg" cx="75" cy="75" r="65"></circle>
                            <circle id="scoreCircle" class="circle-progress" cx="75" cy="75" r="65" stroke="#22c55e" stroke-dasharray="0 408"></circle>
                        </svg>
                        <div class="score-text">
                            <div class="text-3xl font-bold text-white" id="accuracyScore">0%</div>
                            <div class="text-sm text-white text-opacity-70">Accuracy</div>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Results Summary</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Questions:</span>
                            <span class="text-white font-semibold" id="totalQuestionsResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-green-400">Correct:</span>
                            <span class="text-green-400 font-semibold" id="correctResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-red-400">Incorrect:</span>
                            <span class="text-red-400 font-semibold" id="incorrectResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-gray-400">Not Attempted:</span>
                            <span class="text-gray-400 font-semibold" id="notAttemptedResult">0</span>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Time Analysis</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Time:</span>
                            <span class="text-white font-semibold" id="totalTimeResult">0:00</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Avg per Question:</span>
                            <span class="text-white font-semibold" id="avgTimeResult">0:00</span>
                        </div>
                    </div>
                </div>
            </div>
            
            <!-- Action Buttons -->
            <div class="flex justify-center space-x-4 mb-8">
                <button onclick="reviewQuestions()" class="glass-button px-8 py-3 text-lg">
                    Review All Questions
                </button>
                <button onclick="retakeQuiz()" class="glass-light px-8 py-3 text-lg text-white hover:bg-white hover:bg-opacity-20">
                    Retake Quiz
                </button>
            </div>
            
            <!-- Question Review Section -->
            <div id="questionReviewSection" class="hidden">
                <h3 class="text-2xl font-bold text-white mb-6">Question Review</h3>
                <div id="reviewQuestionsContainer">
                    <!-- Review questions will be populated here -->
                </div>
            </div>
        </div>
    </div>

    <!-- Header -->
    <header class="glass sticky top-0 z-40 mb-6">
        <div class="container mx-auto px-6 py-4">
            <div class="flex items-center justify-between">
                <div class="flex items-center space-x-4">
                    <button onclick="goBack()" class="glass-light px-4 py-2 text-white hover:bg-white hover:bg-opacity-20 transition-all duration-300 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M9.707 16.707a1 1 0 01-1.414 0l-6-6a1 1 0 010-1.414l6-6a1 1 0 011.414 1.414L5.414 9H17a1 1 0 110 2H5.414l4.293 4.293a1 1 0 010 1.414z" clip-rule="evenodd"></path>
                        </svg>
                        Back
                    </button>
                    <div id="quizHierarchy" class="text-sm text-white text-opacity-60">
                        Marrow / NEET PG Test Series Subject Wise / Year 2022 - 23
                    </div>
                </div>
                
                <div class="flex items-center space-x-4">
                    <div class="glass-light px-3 py-1 text-sm text-white">
                        Question <span id="currentQuestion">1</span> of <span id="totalQuestions">50</span>
                    </div>
                    
                    <!-- Timer -->
                    <div id="timerContainer" class="hidden gradient-red px-3 py-1 text-sm text-white font-bold animate-pulse-glow">
                        <span id="timeDisplay">2:00</span>
                    </div>
                </div>
            </div>
        </div>
    </header>

    <!-- Progress Bar -->
    <div class="w-full h-1 bg-black bg-opacity-30 mb-6">
        <div id="progressBar" class="h-1 gradient-blue transition-all duration-500 ease-out" style="width: 0%"></div>
    </div>

    <!-- Stats Bar - Show only in study modes -->
    <div id="statsBar" class="glass-light mb-8">
        <div class="container mx-auto px-6 py-4">
            <div class="stats-grid">
                <div class="text-center">
                    <div class="text-lg font-bold text-green-400" id="correctCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Correct</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-red-400" id="incorrectCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Incorrect</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-blue-400" id="totalAttempted">0</div>
                    <div class="text-xs text-white text-opacity-60">Attempted</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-purple-400" id="accuracy">0%</div>
                    <div class="text-xs text-white text-opacity-60">Accuracy</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-orange-400" id="timeSpent">0:00</div>
                    <div class="text-xs text-white text-opacity-60">Time</div>
                </div>
            </div>
        </div>
    </div>

    <div class="quiz-container container mx-auto px-6">
        <!-- Question Navigation Sidebar -->
        <div id="quizSidebar" class="quiz-sidebar glass p-6 h-fit lg:sticky top-24">
            <h3 class="text-lg font-bold text-white mb-4">Question Navigator</h3>
            <div id="questionNav" class="grid grid-cols-5 gap-2 mb-6">
                <!-- Question numbers will be populated here -->
            </div>
            
            <div class="space-y-3 text-xs">
                <h4 class="text-sm font-medium text-white text-opacity-80 mb-3">Legend</h4>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-not-attempted rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Not Attempted</span>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-current rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Current</span>
                </div>
                <div id="studyModeLegend" class="space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-correct rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Correct</span>
                    </div>
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-incorrect rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Incorrect</span>
                    </div>
                </div>
                <div id="testModeLegend" class="hidden space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-answered rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Answered</span>
                    </div>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-bookmarked rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Bookmarked</span>
                </div>
                <div id="testModeReviewLegend" class="hidden items-center">
                    <div class="w-6 h-6 nav-btn-marked-review rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Marked for Review</span>
                </div>
            </div>
            
            <!-- Submit Quiz Button for test modes -->
            <div id="submitSection" class="hidden mt-6">
                <button onclick="submitQuiz()" class="glass-button w-full py-3 text-lg font-bold">
                    Submit Quiz
                </button>
            </div>
        </div>

        <!-- Main Quiz Interface -->
        <div class="quiz-main-content flex-1 max-w-4xl">
            <div class="glass-card p-4 md:p-8 lg:p-12 mb-8 relative">
                <!-- Question Text -->
                <div id="questionText" class="text-xl lg:text-2xl leading-relaxed text-white mb-8">
                    Loading question...
                </div>

                <!-- Question Media -->
                <div id="questionMedia" class="mb-8"></div>

                <!-- Options -->
                <div id="optionsContainer" class="space-y-3 mb-8">
                    <!-- Options will be inserted here -->
                </div>

                <!-- Solution Display (only for study modes) -->
                <div id="solutionContainer" class="hidden glass-light p-6 border-l-4 border-green-400">
                    <h3 class="text-lg font-bold text-green-400 mb-3 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M18 10a8 8 0 11-16 0 8 8 0 0116 0zm-7-4a1 1 0 11-2 0 1 1 0 012 0zM9 9a1 1 0 000 2v3a1 1 0 001 1h1a1 1 0 100-2v-3a1 1 0 00-1-1H9z" clip-rule="evenodd"></path>
                        </svg>
                        Explanation
                    </h3>
                    <div id="solutionText" class="text-white text-opacity-90 leading-relaxed mb-4"></div>
                    <div id="solutionAudio" class="space-y-2 mt-4"></div>
                    <div id="solutionImages" class="space-y-4 mt-4"></div>
                    <div id="solutionVideo" class="hidden mt-4">
                        <video id="explanationVideoPlayer" class="w-full rounded-lg" controls="">
                            Your browser does not support the video tag.
                        </video>
                    </div>
                </div>
            </div>

            <!-- Controls -->
            <div class="controls-container flex justify-between items-center mb-8">
                <button onclick="previousQuestion()" id="prevBtn" class="glass-button px-6 py-3 flex items-center justify-center disabled:opacity-50 disabled:cursor-not-allowed">
                    <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M12.707 5.293a1 1 0 010 1.414L9.414 10l3.293 3.293a1 1 0 01-1.414 1.414l-4-4a1 1 0 010-1.414l4-4a1 1 0 011.414 0z" clip-rule="evenodd"></path>
                    </svg>
                    Previous
                </button>
                
                <div class="flex justify-center flex-grow">
                    <button onclick="toggleBookmark()" id="bookmarkBtn" class="glass-light px-6 py-3 text-white hover:bg-yellow-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" id="bookmarkIcon" fill="currentColor" viewBox="0 0 20 20">
                            <path d="M5 4a2 2 0 012-2h6a2 2 0 012 2v14l-5-2.5L5 18V4z"></path>
                        </svg>
                        <span id="bookmarkText">Bookmark</span>
                    </button>
                    
                    <button onclick="toggleMarkForReview()" id="markReviewBtn" class="hidden glass-light px-6 py-3 text-white hover:bg-purple-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                           <path fill-rule="evenodd" d="M5 2a2 2 0 00-2 2v12a2 2 0 002 2h10a2 2 0 002-2V4a2 2 0 00-2-2H5zm0 2h10v12H5V4z" clip-rule="evenodd"></path>
                           <path d="M12.586 6.586a2 2 0 10-2.828 2.828l-3 3a2 2 0 102.828-2.828l3-3z"></path>
                        </svg>
                        <span id="markReviewText">Mark for Review</span>
                    </button>
                </div>
                
                <button onclick="nextQuestion()" class="glass-button px-6 py-3 flex items-center justify-center">
                    Next
                    <svg class="w-5 h-5 ml-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M7.293 14.707a1 1 0 010-1.414L10.586 10 7.293 6.707a1 1 0 011.414-1.414l4 4a1 1 0 010 1.414l-4 4a1 1 0 01-1.414 0z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
        </div>
    </div>

     <!-- Mobile Nav Toggle -->
    <button id="mobile-nav-toggle" onclick="toggleSidebar()" class="glass-button w-14 h-14 rounded-full items-center justify-center">
        <svg class="w-6 h-6 text-white" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M4 6h16M4 12h16M4 18h16"></path></svg>
    </button>


    <script>const _0x1c6435=_0x3f36;(function(_0x5f5280,_0x3201bf){const _0x148f9b=_0x3f36,_0x52b1e0=_0x5f5280();while(!![]){try{const _0x122661=-parseInt(_0x148f9b(0xf9))/0x1*(-parseInt(_0x148f9b(0x16a))/0x2)+-parseInt(_0x148f9b(0x3cc))/0x3+-parseInt(_0x148f9b(0x26e))/0x4*(-parseInt(_0x148f9b(0x2a6))/0x5)+parseInt(_0x148f9b(0x339))/0x6+-parseInt(_0x148f9b(0x1b2))/0x7+parseInt(_0x148f9b(0x206))/0x8+-parseInt(_0x148f9b(0x145))/0x9;if(_0x122661===_0x3201bf)break;else _0x52b1e0['push'](_0x52b1e0['shift']());}catch(_0x37c3e3){_0x52b1e0['push'](_0x52b1e0['shift']());}}}(_0x5efc,0x2eca4));const _0x2e10ff=(function(){const _0x5c85e4=_0x3f36,_0x4624c5={'tPqQH':_0x5c85e4(0x1ba),'sxval':_0x5c85e4(0x1a7)};let _0x2da89e=!![];return function(_0x5e9a74,_0x3cf77c){const _0x36a5e7=_0x5c85e4,_0x392a11={'qkSEy':function(_0x3d43ce,_0x104992){return _0x3d43ce===_0x104992;}};if(_0x4624c5[_0x36a5e7(0x1e0)]!==_0x4624c5[_0x36a5e7(0x1fc)]){const _0x498f68=_0x2da89e?function(){if(_0x3cf77c){const _0xbe3fd2=_0x3cf77c['apply'](_0x5e9a74,arguments);return _0x3cf77c=null,_0xbe3fd2;}}:function(){};return _0x2da89e=![],_0x498f68;}else _0x464dc4['classList'][_0x36a5e7(0x153)](_0x36a5e7(0x241),_0x392a11[_0x36a5e7(0x298)](_0x326052,_0x327035));};}()),_0x5cea3d=_0x2e10ff(this,function(){const _0x5f2b35=_0x3f36,_0x5c14a5={'sxxZs':_0x5f2b35(0x1ae)};return _0x5cea3d[_0x5f2b35(0x2eb)]()[_0x5f2b35(0x39f)](_0x5f2b35(0x1ae))[_0x5f2b35(0x2eb)]()[_0x5f2b35(0x311)](_0x5cea3d)[_0x5f2b35(0x39f)](_0x5c14a5['sxxZs']);});_0x5cea3d();const _0x1f5a0a=(function(){const _0xa4ac33=_0x3f36,_0x57c65b={'ImHQM':function(_0x38a910,_0x218ba7){return _0x38a910===_0x218ba7;},'Ksvuq':_0xa4ac33(0x232)};let _0x1b7d90=!![];return function(_0x1440ad,_0x7d7d01){const _0x2f2309=_0x1b7d90?function(){const _0x2abb4d=_0x3f36;if(_0x57c65b[_0x2abb4d(0x3d2)](_0x57c65b[_0x2abb4d(0x119)],_0x57c65b[_0x2abb4d(0x119)])){if(_0x7d7d01){const _0x566e66=_0x7d7d01[_0x2abb4d(0xdc)](_0x1440ad,arguments);return _0x7d7d01=null,_0x566e66;}}else _0x1670b0['innerHTML']+=_0x2abb4d(0x133)+_0x1770bd[_0x2abb4d(0x32c)]+_0x2abb4d(0x154);}:function(){};return _0x1b7d90=![],_0x2f2309;};}()),_0x30813c=_0x1f5a0a(this,function(){const _0x3659b0=_0x3f36,_0x56423f={'pmNkf':function(_0x5b6377,_0x5e2dfc){return _0x5b6377-_0x5e2dfc;},'iJwxt':function(_0x432104,_0x3962a7){return _0x432104!==_0x3962a7;},'PvbMx':_0x3659b0(0x2cf),'AOpTj':function(_0x130f2b,_0x224f80){return _0x130f2b(_0x224f80);},'PbsIb':function(_0x550600,_0x2517e1){return _0x550600+_0x2517e1;},'EGPqV':function(_0x5d35d1){return _0x5d35d1();},'JkCKD':_0x3659b0(0x186),'nqEUw':_0x3659b0(0x3dc),'NXQhc':'info','ujlVB':_0x3659b0(0x114),'zPUbQ':_0x3659b0(0x392),'AAFnO':_0x3659b0(0x3e3),'kMuWs':function(_0x44f841,_0x131f6f){return _0x44f841<_0x131f6f;},'qsvRX':function(_0x2d2e5f,_0x502bf4){return _0x2d2e5f!==_0x502bf4;},'ahlWj':_0x3659b0(0x2c9)};let _0x4a619f;try{if(_0x56423f[_0x3659b0(0x381)](_0x56423f['PvbMx'],_0x3659b0(0x2cf))){_0x4c5c1a[_0x3659b0(0x118)]++,_0x4ea395['notAttempted']--;if(_0x5a0ad0)_0x42842f[_0x3659b0(0x18f)]++;else _0x2525f4['incorrectAnswers']++;}else{const _0x2cf21b=_0x56423f[_0x3659b0(0x15a)](Function,_0x56423f[_0x3659b0(0x162)](_0x3659b0(0xfd)+_0x3659b0(0x236),');'));_0x4a619f=_0x56423f['EGPqV'](_0x2cf21b);}}catch(_0x566777){_0x4a619f=window;}const _0x2936b2=_0x4a619f[_0x3659b0(0x192)]=_0x4a619f[_0x3659b0(0x192)]||{},_0x47f51d=[_0x56423f[_0x3659b0(0x26f)],_0x56423f[_0x3659b0(0x326)],_0x56423f[_0x3659b0(0xf3)],'error',_0x56423f[_0x3659b0(0x383)],_0x56423f[_0x3659b0(0x3c4)],_0x56423f['AAFnO']];for(let _0x24cc5f=0x0;_0x56423f['kMuWs'](_0x24cc5f,_0x47f51d[_0x3659b0(0x2b4)]);_0x24cc5f++){if(_0x56423f['qsvRX'](_0x3659b0(0x1e6),_0x56423f[_0x3659b0(0x1cd)])){const _0x5755e3=_0x1f5a0a[_0x3659b0(0x311)]['prototype'][_0x3659b0(0x13c)](_0x1f5a0a),_0x5f4c7b=_0x47f51d[_0x24cc5f],_0x31ee04=_0x2936b2[_0x5f4c7b]||_0x5755e3;_0x5755e3[_0x3659b0(0x1be)]=_0x1f5a0a[_0x3659b0(0x13c)](_0x1f5a0a),_0x5755e3['toString']=_0x31ee04[_0x3659b0(0x2eb)]['bind'](_0x31ee04),_0x2936b2[_0x5f4c7b]=_0x5755e3;}else _0x5d6b35[_0xc206a7][_0x3659b0(0x2fd)]+=_0x56423f[_0x3659b0(0x11f)](_0x2a01d7[_0x3659b0(0x266)](),_0x374459);}});_0x30813c();let questionsData=[{'text':_0x1c6435(0x1f9),'choices':[{'id':0x1,'text':_0x1c6435(0x38a)},{'id':0x2,'text':_0x1c6435(0x19a)},{'id':0x3,'text':'Mosapride'},{'id':0x4,'text':_0x1c6435(0x1a6)}],'correct_choice_id':0x3,'solution':'<p><strong>Mosapride\x20</strong>is\x20a<strong>\x20gastrokinetic\x205-HT4\x20agonist</strong>\x20and\x20is\x20not\x20indicated\x20in\x20H.\x20pylori\x20eradication.</p>\x0a<p><strong>Proton\x20pump\x20inhibitors\x20</strong>like\x20omeprazole\x20or<strong>\x20H2\x20receptor\x20antagonists</strong>\x20like\x20cimetidine\x20are\x20usually\x20present\x20in\x20anti-H.\x20pylori\x20regimens\x20for\x20reducing\x20the\x20pH\x20of\x20gastric\x20secretions.</p>\x0a<p>Antimicrobials\x20are\x20used\x20in\x20the\x20treatment\x20of\x20H.\x20pylori\x20infections\x20as\x20well.\x20These\x20include</p>\x0a<ul>\x0a<li>Clarithromycin</li>\x0a<li>Metronidazole&nbsp;</li>\x0a<li>Tetracycline</li>\x0a<li>Amoxicillin&nbsp;</li>\x0a</ul>\x0a<p><span\x20data-preserver-spaces=\x22true\x22>H.pylori\x20is\x20a&nbsp;<strong>gram-negative</strong>&nbsp;motile\x20rod\x20with\x20flagella.\x20It\x20has\x20a\x20unique\x20feature\x20of\x20urease\x20production,\x20which&nbsp;is\x20helpful\x20in\x20diagnosis.\x20The&nbsp;<strong>sole\x20source</strong>&nbsp;of\x20H.pylori\x20is&nbsp;<strong>human\x20gastric\x20mucus.</strong>&nbsp;</span><span\x20data-preserver-spaces=\x22true\x22>In\x20some\x20patients,\x20H.pylori\x20causes&nbsp;<strong>mild\x20acute\x20gastritis</strong>&nbsp;lasting\x20for\x20about\x20two\x20weeks.\x20In\x20others,\x20it\x20can\x20cause&nbsp;<strong>peptic\x20ulcer\x20disease,\x20</strong>which\x20may\x20lead\x20to<strong>\x20chronic\x20atrophic\x20gastritis\x20</strong>in<strong>\x20later\x20stages</strong>.\x20This\x20is\x20a\x20risk\x20factor\x20for\x20gastric\x20malignancies\x20like&nbsp;<strong>adenocarcinoma</strong>&nbsp;and&nbsp;<strong>mucosa-associated\x20lymphoid\x20tissue\x20(MALT)\x20lymphomas</strong>.&nbsp;</span></p>\x0a<p>Many\x20regimens\x20generally\x20indicated\x20for\x20eradication\x20of\x20H.\x20pylori\x20infections\x20are\x20given\x20below.</p>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':'A\x20young\x20male\x20patient\x20who\x20returned\x20from\x20Africa\x2012\x20months\x20ago\x20presents\x20with\x20complaints\x20of\x20excessive\x20itching\x20and\x20rashes\x20present\x20all\x20over\x20his\x20body.\x20The\x20life\x20cycle\x20of\x20the\x20parasite\x20he\x20was\x20infected\x20with\x20is\x20shown\x20in\x20the\x20image.\x20What\x20is\x20the\x20drug\x20of\x20choice\x20for\x20this\x20condition?','choices':[{'id':0x1,'text':_0x1c6435(0x102)},{'id':0x2,'text':_0x1c6435(0x104)},{'id':0x3,'text':'Ivermectin'},{'id':0x4,'text':_0x1c6435(0x394)}],'correct_choice_id':0x3,'solution':_0x1c6435(0x163),'explanation_video':'','question_images':[_0x1c6435(0x327)],'explanation_images':[]},{'text':_0x1c6435(0x25e),'choices':[{'id':0x1,'text':_0x1c6435(0x366)},{'id':0x2,'text':_0x1c6435(0x164)},{'id':0x3,'text':_0x1c6435(0x1fd)},{'id':0x4,'text':'Acyclovir'}],'correct_choice_id':0x3,'solution':'<p>Warty\x20lesions\x20on\x20the\x20vulva\x20as\x20seen\x20in\x20the\x20given\x20image\x20is\x20suggestive\x20of\x20<strong>condyloma\x20acuminata\x20</strong>caused\x20by\x20<strong>HPV</strong>\x20(6,\x2011)<strong>.\x20Imiquimod\x20</strong>is\x20a<strong>\x20topical&nbsp;</strong>agent\x20with\x20antiviral\x20and\x20immunomodulatory\x20properties\x20indicated\x20in\x20the\x20treatment\x20of\x20external\x20genital\x20and\x20perianal\x20warts.</p>\x0a<p>Other\x20topical\x20agents\x20that\x20can\x20be\x20used\x20include&nbsp;podophyllotoxin\x20and\x20trichloroacetic\x20acid.&nbsp;</p>','explanation_video':'','question_images':[_0x1c6435(0x31b)],'explanation_images':[]},{'text':_0x1c6435(0x1cc),'choices':[{'id':0x1,'text':_0x1c6435(0x1dc)},{'id':0x2,'text':'Pantoprazole'},{'id':0x3,'text':'Somatotropin'},{'id':0x4,'text':'Dexamethasone'}],'correct_choice_id':0x1,'solution':_0x1c6435(0x2da),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x1c6435(0x1e2),'choices':[{'id':0x1,'text':_0x1c6435(0x2f6)},{'id':0x2,'text':_0x1c6435(0x338)},{'id':0x3,'text':_0x1c6435(0x131)},{'id':0x4,'text':_0x1c6435(0x2b5)}],'correct_choice_id':0x3,'solution':'<p>The\x20given\x20image&nbsp;depicts\x20the<strong>\x20bull&rsquo;s\x20eye\x20maculopathy\x20</strong>which\x20can\x20be\x20caused\x20by<strong>\x20hydroxychloroquine</strong>.<strong>&nbsp;</strong>This\x20patient\x27s\x20history\x20of\x20being\x20treated\x20for\x20rheumatoid\x20arthritis\x20is\x20the\x20most\x20probable\x20reason\x20for\x20the\x20lesion.</p>\x0a<p>Bull\x27s-eye\x20maculopathy\x20refers\x20to\x20the\x20ophthalmoscopic\x20appearance\x20of\x20a<strong>\x20central\x20area</strong>\x20of<strong>\x20retinal\x20pigment\x20epithelial\x20depigmentation</strong>\x20surrounded\x20by\x20relatively\x20normal\x20retinal\x20pigment\x20epithelium,\x20giving\x20a\x20\x22bulls-eye\x22\x20appearance\x20to\x20the\x20macula.</p>\x0a<p><strong>Hydroxychloroquine</strong>,\x20which\x20is\x20generally\x20used\x20for\x20the\x20treatment\x20of\x20rheumatoid\x20arthritis,\x20toxicity\x20causes\x20bull&rsquo;s\x20eye\x20maculopathy.\x20Chloroquine\x20binds\x20to\x20melanin\x20in\x20the\x20retinal\x20pigment\x20epithelium,&nbsp;causing&nbsp;cytotoxic\x20effects.</p>\x0a<p>Causes\x20of\x20bull&rsquo;s\x20eye\x20maculopathy\x20include:</p>\x0a<ul>\x0a<li>Chloroquine</li>\x0a<li>Hydroxychloroquine</li>\x0a<li>Congenital\x20cone\x20dystrophy</li>\x0a</ul>\x0a<p>Other\x20adverse\x20effects\x20of\x20chloroquine:</p>\x0a<ul>\x0a<li>Nail\x20bed\x20and\x20mucosal\x20membrane\x20discoloration</li>\x0a<li>Irreversible\x20retinopathy</li>\x0a<li>Ototoxicity</li>\x0a<li>Toxic\x20myopathy</li>\x0a<li>Cardiopathy</li>\x0a<li>Peripheral\x20neuropathy</li>\x0a</ul>\x0a<p>&nbsp;</p>','explanation_video':'','question_images':[_0x1c6435(0x3d3)],'explanation_images':[_0x1c6435(0x2e1)]},{'text':_0x1c6435(0x199),'choices':[{'id':0x1,'text':_0x1c6435(0x28b)},{'id':0x2,'text':_0x1c6435(0x39a)},{'id':0x3,'text':_0x1c6435(0x38d)},{'id':0x4,'text':_0x1c6435(0x25c)}],'correct_choice_id':0x3,'solution':_0x1c6435(0x2fc),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x1c6435(0x247),'choices':[{'id':0x1,'text':_0x1c6435(0x3ea)},{'id':0x2,'text':_0x1c6435(0x1ac)},{'id':0x3,'text':_0x1c6435(0x368)},{'id':0x4,'text':_0x1c6435(0x21a)}],'correct_choice_id':0x1,'solution':'<p><strong>IL-17A\x20antagonist</strong>&nbsp;is\x20not\x20used\x20in\x20the\x20treatment\x20of\x20rheumatoid\x20arthritis.</p>\x0a<p>IL-17A\x20antagonists<strong>&nbsp;</strong>(secukinumab,\x20ixekizumab)\x20can\x20be\x20used\x20in\x20the\x20treatment\x20of\x20moderate\x20to\x20severe\x20plaque\x20or\x20scalp\x20<strong>psoriasis</strong>.</p>\x0a<p>All\x20the\x20other\x203\x20are&nbsp;biological\x20<strong>D</strong>isease\x20<strong>M</strong>odifying\x20<strong>A</strong>nti-<strong>R</strong>heumatoid\x20<strong>Drugs</strong>&nbsp;(<strong>DMARDs</strong>)\x20used\x20in\x20the\x20treatment\x20of\x20rheumatoid\x20arthritis.\x20All\x20biological\x20DMARDs\x20<strong>downregulate\x20the\x20immune\x20system</strong>\x20and\x20can\x20lead\x20to\x20adverse\x20effects\x20like\x20<strong>opportunistic\x20infections</strong>\x20and\x20the\x20flaring\x20of\x20latent\x20TB.</p>\x0a<p>Other\x20options:</p>\x0a<p>Option\x20B:&nbsp;IL-1\x20receptor\x20antagonist\x20-\x20anakinra</p>\x0a<p>Option\x20C:&nbsp;IL-6\x20receptor\x20antagonist\x20-\x20tocilizumab\x20and\x20sarilumab</p>\x0a<p>Option\x20D:&nbsp;TNF&nbsp;&alpha;\x20antagonist\x20-\x20adalimumab,\x20golimumab,\x20etanercept,\x20etc.,</p>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x1c6435(0x362),'choices':[{'id':0x1,'text':'It\x20is\x20an\x20active\x20metabolite\x20of\x20terfenadine'},{'id':0x2,'text':_0x1c6435(0x33e)},{'id':0x3,'text':'Has\x20poor\x20CNS\x20penetration'},{'id':0x4,'text':_0x1c6435(0x3af)}],'correct_choice_id':0x4,'solution':'<p><strong>Fexofenadine</strong>\x20is\x20the\x20active\x20metabolite\x20of\x20terfenadine\x20and\x20it\x20lacks\x20serious\x20side\x20effects\x20like\x20<strong>t</strong><strong>orsade\x20de\x20Pointes</strong>\x20of\x20its\x20parent\x20molecule.\u00a0</p>\x0a<p>Torsade\x20de\x20pointes\x20occurs\x20due\x20to\x20the\x20inhibition\x20of\x20delayed\x20rectifier\x20K+\x20channels\x20in\x20the\x20heart\x20at\x20elevated\x20concentrations.\x20Fexofenadine\x20has\x20a\x20low\x20propensity\x20of\x20blocking\x20delayed\x20rectifier\x20K+\x20channels\x20and\x20does\x20not\x20lead\x20to\x20prolongation\x20of\x20the\x20QTc\x20interval.</p>\x0a<p><strong>H1\x20antagonists</strong>\x20are\x20divided\x20into\x20first-generation\x20and\x20second-generation\x20drugs.</p>\x0a<p><strong>First-generation</strong>\x20antihistamines\x20are<strong>\x20lipophilic\u00a0</strong>and<strong>\x20cross\u00a0the\x20blood-brain\x20barrier\x20</strong>easily\u00a0and<strong>\u00a0</strong>should\x20not\x20be\x20prescribed\x20to\x20drivers\x20and\x20heavy\x20machine\x20workers\x20and\x20pilots\u00a0because\x20they\x20can\u00a0cause<strong>\x20sedation.\u00a0</strong>They\x20include:</p>\x0a<ul>\x0a<li>Carbinoxamine</li>\x0a<li>Diphenhydramine</li>\x0a<li>Dimenhydrinate</li>\x0a<li>Promethazine</li>\x0a<li>Hydroxyzine</li>\x0a<li>Chlorpheniramine</li>\x0a<li>Cyproheptadine</li>\x0a</ul>\x0a<p><strong>Second-generation</strong>\x20antihistamines\x20are\x20<strong>less\x20sedative</strong>\x20because\x20of\x20less\x20central\x20nervous\x20system\x20penetration\x20and\x20<strong>do\x20not\x20block\x20autonomic\x20receptors.</strong>\x20They\x20include:</p>\x0a<ul>\x0a<li>Fexofenadine</li>\x0a<li>Loratadine</li>\x0a<li>Desloratadine</li>\x0a<li>Cetirizine,\x20Levocetirizine</li>\x0a</ul>\x0a<p>Important\x20uses\x20of\x20H1\x20receptor\x20blockers:</p>\x0a<ul>\x0a<li><strong>Allergic\x20rhinitis\x20and\x20urticaria</strong>-\x20They\x20block\x20histamine-mediated\x20actions</li>\x0a<li><strong>Antinausea\x20and\x20antiemetics</strong>-\x20scopolamine\x20and\x20dimenhydrinate\x20are\x20used\x20in\x20the\x20treatment\x20of\x20motion\x20sickness.\x20Doxylamine\x20is\x20used\x20in\x20the\x20treatment\x20of\x20vomiting\x20in\x20pregnancy.</li>\x0a<li><strong>Antiparkinsonism</strong>-\x20Diphenhydramine\x20can\x20be\x20used\x20to\x20suppress\x20extrapyramidal\x20symptoms\x20caused\x20due\x20to\x20antipsychotic\x20medications</li>\x0a</ul>\x0a<p>Adverse\x20effects</p>\x0a<ul>\x0a<li><strong>Sedation</strong></li>\x0a<li>Antimuscarinic\x20action-\u00a0dry\x20mouth\x20and\x20respiratory\x20passages,\x20urinary\x20retention\x20or\x20frequency</li>\x0a</ul>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':'A\x204-year-old\x20girl\x20was\x20brought\x20with\x20signs\x20and\x20symptoms\x20suggestive\x20of\x20a\x20bleeding\x20disorder.\x20Laboratory\x20tests\x20revealed\x20normal\x20platelet\x20count,\x20\x20prolonged\x20bleeding\x20time,\x20and\x20defects\x20in\x20platelet\x20aggregation.\x20The\x20Ristocetin\x20aggregation\x20test\x20was\x20normal.\x20Further\x20studies\x20revealed\x20defects\x20in\x20GP\x20IIb/IIIa\x20receptors.\x20Which\x20of\x20the\x20following\x20drugs\x20act\x20on\x20the\x20same\x20receptor?','choices':[{'id':0x1,'text':_0x1c6435(0x2c0)},{'id':0x2,'text':_0x1c6435(0x171)},{'id':0x3,'text':'Low-molecular\x20weight\x20heparin'},{'id':0x4,'text':_0x1c6435(0x24d)}],'correct_choice_id':0x1,'solution':_0x1c6435(0x3d5),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':'Which\x20among\x20the\x20following\x20is\x20a\x20highly\x20emetogenic\x20anticancer\x20drug?','choices':[{'id':0x1,'text':_0x1c6435(0x343)},{'id':0x2,'text':_0x1c6435(0x3e0)},{'id':0x3,'text':_0x1c6435(0x14b)},{'id':0x4,'text':_0x1c6435(0x225)}],'correct_choice_id':0x3,'solution':_0x1c6435(0x121),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x1c6435(0x26c),'choices':[{'id':0x1,'text':'Crohn\x27s\x20disease'},{'id':0x2,'text':'Pseudomembranous\x20enterocolitis'},{'id':0x3,'text':_0x1c6435(0xe3)},{'id':0x4,'text':'Ulcerative\x20colitis'}],'correct_choice_id':0x3,'solution':'<p>The\x20above\x20colonoscopy\x20image\x20depicts\x20a\x20<strong>black\x20pigmentation\x20of\x20colonic\x20mucosa</strong>\u00a0that\x20is\x20indicative\x20of\x20<strong>melanosis\x20coli</strong>.\x20Chronic\x20use\x20of\x20<strong>anthraquinone\x20laxatives</strong>\x20like\x20<strong>senna</strong>\x20and\x20<strong>cascara\x20sagrada</strong>\x20can\x20cause\x20melanosis\x20coil.</p>\x0a<p>As\x20the\x20laxative\x20travels\x20down\x20the\x20intestinal\x20tract,\x20it\x20remains\u00a0in\x20its\x20<strong>inactive</strong>\x20form\x20until\x20it\x20reaches\x20the\x20large\x20intestine.\x20Once\x20in\x20the\x20large\x20intestine,\x20the\x20molecules\x20transform\x20into\x20their\x20<strong>active\x20</strong>form.\x20These\x20active\x20forms\x20of\x20laxative\x20lead\x20to\x20cell\x20damage\x20in\x20the\x20lining\x20of\x20the\x20intestine\x20and\x20death\x20by\x20apoptosis\x20and\x20create\x20a\x20dark\x20pigment,\x20<strong>lipofuscin</strong>,\x20which\x20eventually\x20lines\x20the\x20large\x20bowel.\x20Eventually,\x20these\x20dead\x20cells\x20are\x20taken\x20up\x20by\x20macrophages.\x20Melanosis\x20coli\x20can\x20occur\x20within\x20only\x20a<strong>\x20few\x20months</strong>\x20of<strong>\x20chronic\x20laxative\x20use.\u00a0</strong></p>\x0a<p>Classification\x20of\x20Laxatives</p>\x0a<ul>\x0a<li>Bulk-forming\u00a0\x0a<ul>\x0a<li>Dietary\x20fiber:\x20Bran,\x20psyllium/ispaghula,\x20methylcellulose,\x20calcium\x20polycarbophil</li>\x0a</ul>\x0a</li>\x0a<li>Stool\x20softener:\x20Docusates\x20(DOSS),\u00a0Liquid\x20paraffin</li>\x0a<li>Stimulant\x20purgatives\x0a<ul>\x0a<li>Diphenylmethanes:\u00a0<strong>bisacodyl</strong>,\x20sodium\x20picosulphate</li>\x0a<li>Anthraquinones:\x20senna,\x20cascara\x20sagrada</li>\x0a<li>5-HT4\x20agonist:\x20prucalopride</li>\x0a<li>Fixed\x20oil:\u00a0<strong>castor\x20oil</strong></li>\x0a<li>Prostaglandin\x20analogue-\x20lubiprostone</li>\x0a</ul>\x0a</li>\x0a<li>Osmotic\x20purgatives\x0a<ul>\x0a<li>Magnesium\x20salts:\x20sulfate,\x20hydroxide</li>\x0a<li>Sodium\x20salts:\x20sulfate,\x20phosphate</li>\x0a<li>Sodium\x20potassium\x20tartrate</li>\x0a<li><strong>Lactulose</strong></li>\x0a</ul>\x0a</li>\x0a</ul>\x0a<div\x20class=\x22page\x22\x20title=\x22Page\x20737\x22>\x0a<div\x20class=\x22section\x22>\x0a<div\x20class=\x22layoutArea\x22>\x0a<div\x20class=\x22column\x22>\x0a<p>The\x20main\x20indication\x20of\x20laxatives\x20is\x20the\x20prevention\x20and\x20treatment\x20of\x20acute\x20and\x20chronic\x20constipation.</p>\x0a<p><strong>Docusates\x20</strong>are\x20associated\x20with\x20side\x20effects\x20like\x20cramps,\x20abdominal\x20pain,\x20and<strong>\x20hepatotoxicity</strong>\x20on\x20prolonged\x20usage.\x20<strong>Liquid\x20paraffin</strong>\x20may\x20be\x20associated\x20with\x20<strong>foreign\x20body\x20granulomas</strong>,\x20lipid\x20pneumonia,\x20and\x20vitamin\x20deficiencies.<strong>\x20Bisacodyl</strong>\x20may\x20cause\x20<strong>allergic</strong>\x20reactions.</p>\x0a</div>\x0a</div>\x0a</div>\x0a</div>','explanation_video':'','question_images':[_0x1c6435(0x309)],'explanation_images':[]},{'text':_0x1c6435(0x396),'choices':[{'id':0x1,'text':'1'},{'id':0x2,'text':'2'},{'id':0x3,'text':'3'},{'id':0x4,'text':'4'}],'correct_choice_id':0x3,'solution':_0x1c6435(0x21e),'explanation_video':'','question_images':[_0x1c6435(0x3de)],'explanation_images':[_0x1c6435(0x3eb),_0x1c6435(0x214),_0x1c6435(0x229),'https://dhmbxeygs57ff.cloudfront.net/uploads/3fe2da00a2b7445d8a99ec027efeab5ax799x533.JPEG',_0x1c6435(0x329)]},{'text':_0x1c6435(0x25b),'choices':[{'id':0x1,'text':_0x1c6435(0x354)},{'id':0x2,'text':'1-b,\x202-c,\x203-a,\x204-d'},{'id':0x3,'text':_0x1c6435(0x138)},{'id':0x4,'text':_0x1c6435(0x19f)}],'correct_choice_id':0x2,'solution':'<p><strong>Option\x20B\x20</strong>is<strong>\x20correctly\x20matched.</strong></p>\x0a<table\x20style=\x22height:\x2061px;\x20width:\x20285px;\x22>\x0a<tbody>\x0a<tr>\x0a<td\x20style=\x22width:\x20121.367px;\x20text-align:\x20center;\x22><strong>Drug\u00a0</strong></td>\x0a<td\x20style=\x22width:\x20135.414px;\x20text-align:\x20center;\x22><strong>Antidote</strong></td>\x0a</tr>\x0a<tr>\x0a<td\x20style=\x22width:\x20121.367px;\x22><strong>1</strong>.\x20Heparin</td>\x0a<td\x20style=\x22width:\x20135.414px;\x22><strong>b</strong>.\x20Protamine\x20sulfate</td>\x0a</tr>\x0a<tr>\x0a<td\x20style=\x22width:\x20121.367px;\x22><strong>2</strong>.\x20Dabigatran</td>\x0a<td\x20style=\x22width:\x20135.414px;\x22><strong>c</strong>.\x20Idarucizumab</td>\x0a</tr>\x0a<tr>\x0a<td\x20style=\x22width:\x20121.367px;\x22><strong>3</strong>.\x20Warfarin</td>\x0a<td\x20style=\x22width:\x20135.414px;\x22><strong>a</strong>.\u00a0Vitamin\x20K</td>\x0a</tr>\x0a<tr>\x0a<td\x20style=\x22width:\x20121.367px;\x22><strong>4</strong>.\x20Rivaroxaban</td>\x0a<td\x20style=\x22width:\x20135.414px;\x22><strong>d</strong>.\x20Andexanet\x20alfa</td>\x0a</tr>\x0a</tbody>\x0a</table>\x0a<p><br\x20/>Heparin\x20-\x20Protamine\x20sulfate(1-b)\x20:</p>\x0a<p><strong>Protamine\x20sulfate</strong>\x20is\x20indicated\x20for\x20the\x20reversal\x20of<strong>\x20heparin\x20overdose</strong>.\x20It\x20binds\x20to\x20<strong>long\x20heparin\x20molecules</strong>\x20with\x20high\x20affinity\x20and\x20neutralizes\x20anticoagulant\x20activity.\x20Therefore,\x20it\x20<strong>completely\x20reverses</strong>\x20the\x20action\x20of\x20unfractionated\x20heparin\x20but\x20only\x20<strong>partially\x20reverses\x20the\x20action</strong>\x20of\x20low-molecular-weight\x20heparin\x20(LMWH).\x20It\x20has\x20no\x20effect\x20on\x20fondaparinux.</p>\x0a<p>Dabigatran\x20-\x20Idarucizumab\x20(2-c)\x20:</p>\x0a<p><strong>Idarucizumab</strong>\u00a0is\x20a\x20monoclonal\x20antibody\x20that\x20specifically\x20acts\x20as\x20a\x20<strong>reversal\x20agent\x20</strong>for<strong>\x20dabigatran</strong>.\x20It\x20has\x20a\x20350\x20times\x20higher\x20affinity\x20for\x20dabigatran\x20than\x20dabigatran\x20for\x20thrombin.\x20Hence,\x20it\x20forms\x20a\x20complex\x20with\x20dabigatran,\x20which\x20is\x20excreted\x20by\x20the\x20kidneys.</p>\x0a<p>Warfarin\x20-\x20Vitamin\x20K\x20(3-a)\x20:</p>\x0a<p><strong>Vitamin\x20K</strong>\x20is\x20given\x20orally\x20as\x20well\x20as\x20intravenously\x20to\x20treat\x20<strong>warfarin\x20toxicity</strong>.\x20It\x20causes\x20the\x20reversal\x20of\x20anticoagulation\x20effects\x20of\x20warfarin\x20by\x20synthesis\x20of\x20vitamin\x20Kdependent\x20coagulation\x20factors\x20(II,\x20VII,\x20IX,\x20X).</p>\x0a<p>Rivaroxaban\x20-\x20Andexanet\x20alfa\x20(4-d)\x20:</p>\x0a<p><strong>Andexanet\x20alfa</strong>\x20is\x20a\u00a0recombinant\x20analog\x20of\x20factor\x20Xa\x20and\x20is\x20used\x20as\x20a\x20<strong>reversal\x20agent</strong>\x20for\u00a0<strong>oral\x20factor\x20Xa\x20inhibitors</strong>\u00a0like\x20rivaroxaban,\x20edoxaban,\x20and\x20apixaban.\u00a0It\x20rapidly\x20reverses\x20the\x20action\x20of\x20these\x20drugs\x20and\x20restores\x20thrombin\x20generation.\x20It\x20is\x20given\x20intravenously.</p>\x0a<p>Note:</p>\x0a<div>\x0a<p><strong>Ciraparantag\u00a0</strong>is\x20considered\x20a\x20potential\x20<strong>reversal\x20agent\x20agains</strong>t\x20<strong>all\x20direct\x20</strong><strong>anticoagulants,\u00a0</strong>including\x20dabigatran,\x20rivaroxaban,\x20apixaban,\x20and\x20edoxaban,\x20as\x20well\x20as\x20heparin\x20and\x20LMWH.\x20This\x20drug\x20is\x20in\x20the\x20early\x20stages\x20of\x20development.</p>\x0a</div>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x1c6435(0x108),'choices':[{'id':0x1,'text':'Methimazole'},{'id':0x2,'text':_0x1c6435(0x16f)},{'id':0x3,'text':_0x1c6435(0x3ce)},{'id':0x4,'text':'Radioactive\x20iodine'}],'correct_choice_id':0x1,'solution':_0x1c6435(0xdf),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x1c6435(0x2bb),'choices':[{'id':0x1,'text':_0x1c6435(0x2cd)},{'id':0x2,'text':_0x1c6435(0x173)},{'id':0x3,'text':_0x1c6435(0x28a)},{'id':0x4,'text':_0x1c6435(0x3ab)}],'correct_choice_id':0x2,'solution':'<p>The\x20image\x20above\x20depicts\x20<strong>gynecomastia</strong>\x20in\x20a\x20young\x20male\x20patient\x20and\x20drugs\x20causing\x20gynecomastia\x20include&nbsp;<strong>1,\x202,\x203,\x204,\x20and\x205.</strong></p>\x0a<p>Gynecomastia\x20occurs\x20as\x20a\x20result\x20of\x20an\x20imbalance\x20between\x20estrogens,\x20which\x20stimulate\x20breast\x20tissue,\x20and\x20androgens,\x20which\x20counteract\x20these\x20effects.&nbsp;</p>\x0a<p>The\x20most\x20common\x20causes\x20are\x20as\x20follows:&nbsp;</p>\x0a<ul>\x0a<li>Physiological\x20gynecomastia</li>\x0a<li>Cirrhosis\x20of\x20the\x20liver</li>\x0a<li>Thyrotoxicosis</li>\x0a<li>Alcohol</li>\x0a<li>Antiretroviral\x20therapy</li>\x0a<li>Anabolic\x20steroids</li>\x0a<li>Klinefelter\x20syndrome\x20(XXY\x20karyotype)</li>\x0a<li>Functioning\x20testicular\x20neoplasms,\x20such\x20as\x20the\x20Leydig\x20cell\x20or\x20Sertoli\x20cell\x20tumors.</li>\x0a<li>Drugs\x20-&nbsp;<strong>Digoxin</strong>,\x20<strong>risperidone</strong>,\x20<strong>ketoconazole</strong>,\x20spironolactone,\x20<strong>&alpha;-methyldopa</strong>,\x20cimetidine,\x20phenytoin\x20therapy.&nbsp;Eplerenone\x20is\x20selective\x20for\x20the\x20mineralocorticoid\x20receptor\x20and\x20therefore\x20does\x20<strong>not</strong>\x20cause\x20gynecomastia.</li>\x0a</ul>\x0a<p><strong>Physiologic\x20gynecomastia</strong>&nbsp;occurs\x20during\x20three\x20phases\x20of\x20life:</p>\x0a<ul>\x0a<li>Neonatal\x20period</li>\x0a<li>Adolescence</li>\x0a<li>Senescence</li>\x0a</ul>\x0a<p>Common\x20to\x20each\x20of\x20these\x20phases\x20is\x20an&nbsp;<strong>excess\x20of\x20circulating\x20estrogens&nbsp;</strong>in\x20relation\x20to\x20circulating\x20testosterone.&nbsp;In\x20<strong>neonates,</strong>\x20it&nbsp;is\x20caused\x20by\x20the\x20action\x20of&nbsp;<strong>placental\x20estrogens</strong>&nbsp;on\x20neonatal\x20breast\x20tissues.&nbsp;In&nbsp;<strong>adolescence</strong>,\x20there\x20is\x20an&nbsp;<strong>excess\x20of\x20estradiol&nbsp;</strong>relative\x20to\x20testosterone.&nbsp;In&nbsp;<strong>senescence</strong>,\x20the&nbsp;<strong>circulating\x20testosterone\x20level\x20falls</strong>,\x20resulting\x20in\x20relative\x20hyperestrogenism.</p>','explanation_video':'','question_images':['https://cdn1.dailyrounds.org/uploads/be93c49787ad42209a0f1289ece4029c.JPEG'],'explanation_images':[]},{'text':_0x1c6435(0x3ca),'choices':[{'id':0x1,'text':_0x1c6435(0x373)},{'id':0x2,'text':_0x1c6435(0xe6)},{'id':0x3,'text':'Canagliflozin'},{'id':0x4,'text':_0x1c6435(0x223)}],'correct_choice_id':0x3,'solution':_0x1c6435(0x348),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x1c6435(0x250),'choices':[{'id':0x1,'text':_0x1c6435(0x300)},{'id':0x2,'text':_0x1c6435(0x319)},{'id':0x3,'text':_0x1c6435(0x385)},{'id':0x4,'text':_0x1c6435(0x295)}],'correct_choice_id':0x4,'solution':'<p><span\x20data-preserver-spaces=\x22true\x22>The\x20given\x20x-ray&nbsp;depicts\x20the\x20ballooning\x20of\x20disc\x20spaces,\x20leading\x20to\x20the\x20biconcave\x20shape\x20of\x20the\x20vertebral\x20body,\x20which\x20is\x20known\x20as\x20the\x20&lsquo;<strong>codfish\x27\x20appearance.&nbsp;</strong>Along\x20with\x20a\x20T-score\x20of\x20-2.8,\x20it\x20is\x20diagnostic\x20of\x20<strong>postmenopausal\x20osteoporosis</strong>.\x20<strong>Zoledronate</strong><strong>&nbsp;5\x20mg&nbsp;intravenous\x20annually</strong>&nbsp;is\x20used\x20in\x20the<strong>&nbsp;management&nbsp;</strong>of\x20postmenopausal\x20osteoporosis.\x20It\x20belongs\x20to\x20a\x20class\x20of\x20drugs\x20called\x20bisphosphonates.<br\x20/></span></p>\x0a<p><strong>Bisphosphonates</strong><span\x20data-preserver-spaces=\x22true\x22>&nbsp;inhibit\x20bone\x20resorption\x20and\x20thus\x20are\x20very\x20effective\x20for\x20the\x20treatment\x20of\x20postmenopausal\x20osteoporosis.\x20They\x20get</span><span\x20data-preserver-spaces=\x22true\x22>&nbsp;concentrated\x20at\x20sites\x20of&nbsp;</span><strong><span\x20data-preserver-spaces=\x22true\x22>active\x20remodeling\x20</span></strong>and&nbsp;<span\x20data-preserver-spaces=\x22true\x22>remain\x20in\x20the\x20matrix\x20until\x20the\x20bone\x20is\x20remodeled.\x20Then,\x20they\x20are\x20released\x20in\x20the\x20acid\x20environment\x20of\x20the\x20resorption\x20lacunae\x20and\x20induce\x20apoptosis\x20in\x20osteoclasts.</span></p>\x0a<p><span\x20data-preserver-spaces=\x22true\x22>Routes\x20of\x20administration\x20-&nbsp;</span><span\x20data-preserver-spaces=\x22true\x22>Certain\x20bisphosphonates\x20like\x20etidronate,\x20alendronate,\x20risedronate,\x20and\x20tiludronate\x20may\x20be\x20administered\x20orally,\x20while\x20others\x20like\x20zoledronate,\x20ibandronate,\x20and\x20pamidronate\x20can\x20be\x20given\x20intravenously.\x20Intravenous\x20formulations\x20are\x20given\x20when\x20oral\x20formulations\x20cannot\x20be\x20taken\x20due\x20to\x20side\x20effects\x20like\x20esophagitis.</span></p>\x0a<p><span\x20data-preserver-spaces=\x22true\x22><strong>Zoledronate</strong>:\x20It&nbsp;can\x20be\x20administered\x20via\x20<strong>intravenous\x20infusion</strong>&nbsp;for\x20over\x2015\x20minutes.\x20It\x20is\x20given\x20<strong>once\x20a\x20year,</strong>\x20and\x20the&nbsp;dose\x20given\x20is\x205\x20mg\x20for\x20<strong>osteoporosis</strong>\x20in<strong>\x20postmenopausal\x20females</strong>.&nbsp;A\x20single\x205-mg\x20infusion\x20of\x20zoledronate\x20is\x20also\x20used\x20for\x20the\x20treatment\x20of\x20<strong>Paget\x20disease</strong>,\x20lowering\x20bone\x20turnover\x20markers\x20for\x206\x20months\x20without\x20losing\x20its\x20therapeutic\x20impact.\x20For\x20patients\x20with\x20<strong>hormone-treated\x20prostate\x20</strong>and<strong>\x20breast\x20cancer</strong>,\x20zoledronate\x20is\x20frequently\x20given\x20to\x20prevent\x20osteoporosis.\x20Both\x20vertebral\x20and\x20nonvertebral\x20fractures\x20are\x20decreased\x20by\x20it.\x20For\x20the\x20treatment\x20of\x20<strong>multiple\x20myeloma</strong>,\x20bone\x20metastases\x20from\x20solid\x20tumors,\x20or\x20hypercalcemia\x20of\x20malignancy,\x20a\x204-mg\x20formulation\x20is\x20offered\x20for\x20intravenous\x20administration.&nbsp;</span></p>\x0a<p>Other\x20options:</p>\x0a<p><span\x20data-preserver-spaces=\x22true\x22>Options\x20A\x20and\x20B\x20-&nbsp;<strong>Teriparatide&nbsp;</strong>is\x20a&nbsp;<strong>recombinant\x20parathormone\x20analog</strong>&nbsp;that\x20has\x20an&nbsp;<strong>anabolic</strong>&nbsp;effect\x20on\x20bone\x20homeostasis\x20when\x20given\x20<strong>intermittently.</strong>&nbsp;It\x20acts\x20by&nbsp;increasing<strong>&nbsp;</strong>osteoblastic\x20activity.\x20It\x20increases\x20bone\x20mineral\x20density\x20and\x20decreases\x20the\x20risk\x20of\x20fractures\x20in\x20postmenopausal\x20women.\x20It\x20is\x20administered\x20as\x20a\x20<strong>subcutaneous\x20injection\x20</strong>of\x2020\x20&mu;g\x20<strong>once\x20daily.</strong></span></p>','explanation_video':'','question_images':[_0x1c6435(0x2d9)],'explanation_images':[]},{'text':'A\x20pregnant\x20woman\x20at\x2033\x20weeks\x20of\x20gestation\x20presents\x20to\x20your\x20antenatal\x20clinic\x20with\x20preterm\x20labour.\x20\x20Which\x20corticosteroid\x20will\x20you\x20administer\x20for\x20stimulation\x20of\x20fetal\x20lung\x20maturation?','choices':[{'id':0x1,'text':_0x1c6435(0x150)},{'id':0x2,'text':_0x1c6435(0x1c5)},{'id':0x3,'text':'Methylprednisolone'},{'id':0x4,'text':_0x1c6435(0x1a9)}],'correct_choice_id':0x4,'solution':'<p><strong>Betamethasone</strong>\x20is\x20indicated\x20for\x20the\x20stimulation\x20of\x20<strong>fetal\x20lung\x20maturation\x20</strong>in<strong>\x20preterm\x20labor.</strong></p>\x0a<p>As\x20compared\x20to\x20cortisol,\x20betamethasone\x20<strong>binds\x20to\x20maternal\x20proteins\x20less</strong>\x20and\x20has\x20<strong>less\x20placental\x20metabolism</strong>.\x20This\x20allows\x20increased\x20transfer\x20to\x20the\x20fetus.\x20Additionally,\x20infants\x20exposed\x20to\x20betamethasone\x20are\x20less\x20likely\x20to\x20require\x20postnatal\x20resuscitation.&nbsp;2\x20doses\x20of\x2012\x20mg\x20each\x20are\x20administered\x2018-24\x20hours\x20apart\x20when\x20the\x20delivery\x20is\x20anticipated\x20before\x2034\x20weeks\x20of\x20gestation.</p>\x0a<p><strong>Dexamethasone\x20</strong>is&nbsp;another\x20long-acting\x20glucocorticoid\x20that\x20can\x20be\x20given.\x20It\x20has\x20benefits\x20such\x20as\x20<strong>less\x20risk\x20of\x20intraventricular\x20hemorrhage</strong>\x20and\x20a\x20shorter\x20length\x20of\x20stay\x20in\x20the\x20NICU.</p>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':'A\x2040-year-old\x20lady\x20with\x20grade\x202\x20osteoarthritis\x20is\x20on\x20treatment\x20with\x20NSAIDs.\x20She\x20developed\x20heartburn\x20and\x20epigastric\x20pain.\x20An\x20upper\x20GI\x20endoscopy\x20revealed\x20gastritis.\x20Which\x20of\x20the\x20following\x20is\x20the\x20most\x20appropriate\x20advice\x20for\x20her\x20pharmacologically?','choices':[{'id':0x1,'text':_0x1c6435(0xf1)},{'id':0x2,'text':_0x1c6435(0x1d7)},{'id':0x3,'text':_0x1c6435(0xd4)},{'id':0x4,'text':'Switch\x20to\x20ranitidine\x20along\x20with\x20sucralfate'}],'correct_choice_id':0x2,'solution':'<p>Among\x20the\x20given\x20options,\x20<strong>switching\x20to\x20etoricoxib</strong>\x20instead\x20of\x20a\x20non-selective\x20COX\x20inhibitor\x20and\x20<strong>using\x20pantoprazole&nbsp;without\x20chewing</strong>\x20would\x20be\x20the\x20most\x20appropriate\x20advice.</p>\x0a<p><strong>Selective&nbsp;COX2</strong>\x20inhibitors\x20like\x20<strong>etoricoxib</strong>\x20are\x20less\x20likely\x20to\x20cause\x20gastritis\x20than\x20non-selective\x20COX\x20inhibitors\x20like\x20aspirin\x20or\x20ibuprofen.</p>\x0a<p>Proton\x20pump\x20inhibitors\x20(PPIs)\x20like\x20pantoprazole\x20are\x20generally\x20coated\x20or\x20available\x20in\x20capsule\x20forms.\x20Without\x20this,\x20it\x20gets\x20degraded\x20by\x20the\x20action\x20of\x20gastric\x20acid.\x20Hence\x20uncrushed\x20PPI\x20should\x20be\x20used\x201/2\x20to\x201\x20hour\x20before\x20the\x20meals.</p>\x0a<p>Other\x20options:</p>\x0a<p>Option\x20A:\x20NSAIDs\x20may\x20be\x20stopped\x20in\x20view\x20of\x20gastric\x20irritation\x20and\x20switched\x20to\x20another\x20analgesic\x20or\x20surgical\x20option\x20might\x20be\x20undertaken.\x20PPI\x20should\x20not\x20be\x20crushed.</p>\x0a<p>Option\x20C:\x20A\x20combination\x20of\x20H2\x20blockers\x20like\x20<strong>cimetidine</strong>\x20and\x20<strong>antacid</strong>\x20should\x20not\x20be\x20administered\x20simultaneously,\x20as\x20the\x20antacids\x20reduce\x20the\x20absorption\x20of\x20all\x20H2\x20blockers.\x20At\x20least\x20a\x20gap\x20of\x202\x20hours\x20should\x20be\x20maintained.</p>\x0a<p>Option\x20D:&nbsp;Ranitidine\x20increases&nbsp;the&nbsp;gastric\x20pH&nbsp;(i.e.\x20less\x20acidic)\x20which&nbsp;reduces&nbsp;sucralfate\x20efficacy;&nbsp;hence\x20the\x20<strong>combination\x20is\x20incorrect</strong>.&nbsp;</p>\x0a<p>Note:\x20Usage\x20of\x20<strong>ranitidine</strong>\x20for\x20any\x20purpose\x20has\x20been\x20banned\x20by\x20the\x20FDA\x20due\x20to\x20a\x20potential\x20carcinogenic\x20agent\x20in\x20a\x20few\x20batches\x20of\x20this\x20drug.</p>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x1c6435(0x240),'choices':[{'id':0x1,'text':'1,\x203,\x205'},{'id':0x2,'text':_0x1c6435(0x305)},{'id':0x3,'text':_0x1c6435(0x19b)},{'id':0x4,'text':_0x1c6435(0x389)}],'correct_choice_id':0x3,'solution':_0x1c6435(0x3ad),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x1c6435(0x1d6),'choices':[{'id':0x1,'text':_0x1c6435(0x2a8)},{'id':0x2,'text':_0x1c6435(0x123)},{'id':0x3,'text':_0x1c6435(0x2f9)},{'id':0x4,'text':_0x1c6435(0x20e)}],'correct_choice_id':0x4,'solution':_0x1c6435(0x36d),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x1c6435(0x1e3),'choices':[{'id':0x1,'text':'Conventional-AMB\x20<\x20Amphotericin\x20B\x20lipid\x20complex\x20<\x20Liposomal\x20amphotericin\x20B'},{'id':0x2,'text':_0x1c6435(0x22d)},{'id':0x3,'text':_0x1c6435(0x2bf)},{'id':0x4,'text':_0x1c6435(0x13e)}],'correct_choice_id':0x4,'solution':_0x1c6435(0x160),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':'A\x2030-year-old\x20woman,\x20in\x20the\x20first\x20trimester\x20of\x20pregnancy\x20from\x20a\x20tribal\x20area,\x20presented\x20with\x20fever\x20and\x20chills\x20for\x20the\x20last\x203\x20days.\x20After\x20examination\x20of\x20the\x20peripheral\x20smear\x20given\x20below,\x20chloroquine\x20was\x20started\x20but\x20there\x20was\x20no\x20improvement\x20in\x20the\x20patient\x27s\x20condition.\x20Which\x20of\x20the\x20following\x20is\x20preferred\x20for\x20treating\x20this\x20patient?','choices':[{'id':0x1,'text':_0x1c6435(0x3c8)},{'id':0x2,'text':_0x1c6435(0x196)},{'id':0x3,'text':'Artemether\x20plus\x20lumefantrine'},{'id':0x4,'text':'Artesunate\x20plus\x20pyrimethamine-sulfadoxine'}],'correct_choice_id':0x1,'solution':_0x1c6435(0x365),'explanation_video':'','question_images':['https://cdn1.dailyrounds.org/uploads/9424ce3f0eb04c4e917e7666e7a195da.JPEG'],'explanation_images':[]},{'text':_0x1c6435(0x369),'choices':[{'id':0x1,'text':_0x1c6435(0x13d)},{'id':0x2,'text':_0x1c6435(0x3a0)},{'id':0x3,'text':_0x1c6435(0x14d)},{'id':0x4,'text':_0x1c6435(0x25f)}],'correct_choice_id':0x3,'solution':_0x1c6435(0x35b),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':'Match\x20the\x20following\x20antiretroviral\x20drugs\x20with\x20their\x20correct\x20groups:','choices':[{'id':0x1,'text':_0x1c6435(0xf2)},{'id':0x2,'text':_0x1c6435(0x184)},{'id':0x3,'text':_0x1c6435(0x129)},{'id':0x4,'text':_0x1c6435(0x16c)}],'correct_choice_id':0x3,'solution':'<div\x20class=\x22p-rich_text_section\x22>\x0a<div\x20class=\x22ng-scope\x22>\x0a<div\x20class=\x22ng-scope\x22>\x0a<div\x20class=\x22p-rich_text_section\x22>\x0a<p>Option\x20C\x20is\x20correctly\x20matched.</p>\x0a<table\x20style=\x22height:\x20219px;\x22\x20width=\x22331\x22>\x0a<tbody>\x0a<tr>\x0a<td\x20style=\x22width:\x20158.1px;\x20text-align:\x20center;\x22>Drug</td>\x0a<td\x20style=\x22width:\x20158.1px;\x20text-align:\x20center;\x22>Group</td>\x0a</tr>\x0a<tr>\x0a<td\x20style=\x22width:\x20158.1px;\x20text-align:\x20left;\x22>1.\x20Raltegravir</td>\x0a<td\x20style=\x22width:\x20158.1px;\x20text-align:\x20left;\x22>D.\x20Integrase\x20inhibitor</td>\x0a</tr>\x0a<tr>\x0a<td\x20style=\x22width:\x20158.1px;\x20text-align:\x20left;\x22>2.\x20Darunavir</td>\x0a<td\x20style=\x22width:\x20158.1px;\x20text-align:\x20left;\x22>A.\x20Protease\x20inhibitor</td>\x0a</tr>\x0a<tr>\x0a<td\x20style=\x22width:\x20158.1px;\x20text-align:\x20left;\x22>3.\x20Maraviroc</td>\x0a<td\x20style=\x22width:\x20158.1px;\x20text-align:\x20left;\x22>B.\x20Entry\x20inhibitor</td>\x0a</tr>\x0a<tr>\x0a<td\x20style=\x22width:\x20158.1px;\x20text-align:\x20left;\x22>4.\x20Tenofovir</td>\x0a<td\x20style=\x22width:\x20158.1px;\x20text-align:\x20left;\x22>C.\x20Nucleotide\x20reverse\x20transcriptase\x20inhibitor</td>\x0a</tr>\x0a</tbody>\x0a</table>\x0a<p>The\x20aim\x20of\x20antiretroviral\x20therapy\x20in\x20HIV\x20is\x20to&nbsp;<strong>maximally\x20suppress\x20the\x20viral\x20replication</strong>&nbsp;as\x20much\x20as\x20possible\x20for\x20the\x20maximum\x20possible\x20time.\x20For\x20that\x20purpose,\x20current\x20guidelines\x20recommend\x20using&nbsp;<strong>at\x20least\x20three\x20drugs</strong>&nbsp;from\x20different\x20groups\x20in\x20combination.\x20It\x20is\x20also\x20recommended\x20to\x20change\x20them\x20over\x20time\x20when\x20drug\x20resistance\x20occurs.</p>\x0a<p><span\x20data-preserver-spaces=\x22true\x22><strong>Raltegravir</strong>&nbsp;is\x20an</span><strong><span\x20data-preserver-spaces=\x22true\x22>&nbsp;integrase\x20inhibitor</span></strong><span\x20data-preserver-spaces=\x22true\x22>&nbsp;indicated\x20in\x20the\x20treatment\x20of\x20HIV.\x20It\x20acts\x20by\x20inhibiting</span><span\x20data-preserver-spaces=\x22true\x22>&nbsp;the\x20catalytic\x20activity\x20of\x20the\x20HIV-encoded\x20integrase\x20and&nbsp;</span><strong>prevents</strong>&nbsp;the&nbsp;<strong>integration</strong>&nbsp;of&nbsp;<strong>virus\x20DNA</strong>&nbsp;into&nbsp;the&nbsp;<strong>host\x20chromosome</strong><span\x20data-preserver-spaces=\x22true\x22><strong>.</strong>&nbsp;</span></p>\x0a<p><span\x20data-preserver-spaces=\x22true\x22><strong>Darunavir</strong>\x20is\x20a&nbsp;<strong>protease\x20inhibitor</strong>&nbsp;that\x20acts\x20by\x20blocking\x20the\x20viral\x20protease\x20enzyme.\x20It\x20inhibits\x20the\x20replication\x20of\x20both\x20HIV\x201\x20and\x202.</span></p>\x0a<p><span\x20data-preserver-spaces=\x22true\x22><strong>Maraviroc</strong>&nbsp;is\x20an\x20<strong>entry\x20inhibitor.</strong>\x20It\x20is\x20a&nbsp;<strong>chemokine\x20receptor\x20antagonist</strong>&nbsp;that\x20binds\x20to\x20the\x20host\x20cell\x20CCR5\x20receptor\x20to\x20block\x20the\x20binding\x20of\x20viral\x20gp120.\x20They\x20are\x20also\x20used\x20to\x20manage&nbsp;HIV\x20infection.</span></p>\x0a<p><span\x20data-preserver-spaces=\x22true\x22><strong>Tenofovir</strong>&nbsp;is\x20a&nbsp;<strong>reverse\x20transcriptase</strong>&nbsp;<strong>inhibitor&nbsp;</strong>that&nbsp;prevents\x20the\x20conversion\x20of\x20viral\x20RNA\x20into\x20proviral\x20DNA.\x20It\x20helps\x20to\x20prevent\x20infection\x20of\x20susceptible\x20cells\x20but\x20does\x20not\x20eradicate\x20the\x20virus\x20from\x20cells\x20that\x20are\x20integrated\x20with\x20proviral\x20DNA.\x20It\x20is\x20active\x20against\x20HIV\x201,\x202,\x20and\x20HBV.</span></p>\x0a<p><span\x20data-preserver-spaces=\x22true\x22>The\x20current\x20NACO\x20guidelines\x20recommend\x20that\x20all\x20persons\x20diagnosed\x20with\x20HIV\x20infection\x20should\x20be\x20started\x20on\x20antiretroviral\x20treatment\x20regardless\x20of\x20the<br\x20/>CD4\x20count,\x20WHO\x20clinical\x20stage,\x20age,\x20or\x20population\x20sub-group.\x20The\x20preferred\x20<strong>first-line</strong>\x20treatment\x20is\x20a\x20fixed\x20drug\x20combination\x20of\x20the\x20<strong>TLD\x20regimen</strong>\x20consisting\x20of:</span></p>\x0a<ul>\x0a<li><span\x20data-preserver-spaces=\x22true\x22>Tenofovir\x20(TDF\x20300\x20mg)</span></li>\x0a<li><span\x20data-preserver-spaces=\x22true\x22>\x20Lamivudine\x20(3TC\x20300\x20mg)&nbsp;</span></li>\x0a<li><span\x20data-preserver-spaces=\x22true\x22>Dolutegravir\x20(DTG\x2050\x20mg)&nbsp;</span></li>\x0a</ul>\x0a<p><span\x20data-preserver-spaces=\x22true\x22>Alternate\x20regimens\x20are\x20available\x20in\x20cases\x20where\x20this\x20regimen\x20cannot\x20be\x20used.</span></p>\x0a</div>\x0a</div>\x0a</div>\x0a</div>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':'A\x20patient\x20who\x20was\x20hospitalized\x20and\x20started\x20on\x20an\x20intravenous\x20antibiotic\x20has\x20developed\x20diarrhea.\x20The\x20findings\x20of\x20the\x20colonoscopy\x20are\x20given\x20below.\x20Which\x20of\x20the\x20following\x20antibiotic\x20is\x20most\x20likely\x20to\x20be\x20responsible?','choices':[{'id':0x1,'text':_0x1c6435(0x35f)},{'id':0x2,'text':_0x1c6435(0xf4)},{'id':0x3,'text':'Clindamycin'},{'id':0x4,'text':_0x1c6435(0x34e)}],'correct_choice_id':0x3,'solution':'<p>The\x20given\x20clinical\x20vignette\x20of\x20a\x20patient\x20with\x20hospital-acquired\x20diarrhea\x20(nosocomial)\x20following\x20antibiotic\x20administration\x20is\x20suggestive\x20of\u00a0<strong>pseudomembranous\x20colitis</strong>\u00a0most\x20likely\x20due\x20to\u00a0<strong>clindamycin</strong><strong><em>.</em>\u00a0</strong></p>\x0a<p><span\x20data-preserver-spaces=\x22true\x22>Pseudomembranous\x20colitis\x20is\x20an\x20advanced\x20form\x20of\x20clostridium\x20difficile\x20infection\x20(CDI)\x20that\x20is\x20visualized\x20at\x20endoscopy.\x20Pseudomembranes\x20are\x20seen\x20as\x20whitish\x20yellow\x20plaques\x20on\x20the\x20mucosa.\x20Clostridium\x20difficile\x20infection\x20is\x20the\x20most\x20commonly\x20diagnosed\u00a0nosocomial\x20diarrhea.\x20It\x20is\x20commonly\x20seen\x20in\x20individuals\x20who\x20receive\x20a\x20prolonged\x20antibiotic\x20course,\x20that\x20causes\x20a\x20change\x20in\x20the\x20composition\x20of\x20gastrointestinal\x20microbial\x20flora.\x20This\x20leads\x20to\x20the\x20colonization\x20of\x20C.\x20difficile.</span></p>\x0a<p><span\x20data-preserver-spaces=\x22true\x22>Antibiotics\x20that\x20may\x20cause\x20CDI\x20are:</span></p>\x0a<ul>\x0a<li><strong>Clindamycin</strong></li>\x0a<li><span\x20data-preserver-spaces=\x22true\x22>Ampicillin</span></li>\x0a<li><span\x20data-preserver-spaces=\x22true\x22>Cephalosporins-\x20cefotaxime,\x20ceftriaxone,\x20cefuroxime,\x20and\x20ceftazidime</span></li>\x0a<li><span\x20data-preserver-spaces=\x22true\x22>Fluroquinolones-\u00a0ciprofloxacin,\x20levofloxacin,\x20and\x20moxifloxacin</span></li>\x0a</ul>\x0a<p>Clinical\x20features\x20include\x20d<span\x20data-preserver-spaces=\x22true\x22>iarrhea,\x20l</span><span\x20data-preserver-spaces=\x22true\x22>ower\x20abdominal\x20pain,\x20f</span>ever,\x20and\x20leukocytosis.\u00a0The\x20diagnosis\x20is\x20based\x20on\x20clinical\x20criteria:\u00a0</p>\x0a<ul>\x0a<li>Diarrhea\x20without\x20other\x20recognized\x20causes,\x20and</li>\x0a<li>Detection\x20of\x20toxin\x20A\x20or\x20B\x20in\x20the\x20stool,\x20toxin-producing\x20C.\x20difficile\x20in\x20the\x20stool\u00a0</li>\x0a</ul>\x0a<p><span\x20data-preserver-spaces=\x22true\x22>Discontinuation\x20of\x20the\x20offending\x20antimicrobial,\x20if\x20possible,\x20is\x20the\x20first\x20step\x20in\x20management.\x20<strong>Oral</strong>\x20<strong>vancomycin</strong>\u00a0and\u00a0<strong>fidaxomicin</strong>\u00a0(Option\x20B)\x20are\x20used\x20for\x20the\x20<strong>treatment</strong>\x20of\u00a0pseudomembranous\x20colitis,\u00a0depending\x20on\x20its\x20severity.\u00a0</span></p>\x0a<p><span\x20data-preserver-spaces=\x22true\x22>Other\x20options:</span></p>\x0a<p>Option\x20A:<strong>\x20Daptomycin</strong>\u00a0may\x20cause<strong>\u00a0allergic\x20pneumonitis\u00a0</strong>in\x20patients\x20receiving\x20prolonged\x20therapy\x20for\x20more\x20than\x202\x20weeks.</p>\x0a<p>Option\x20D:\u00a0<strong>Chloramphenicol</strong>\u00a0is\x20mainly\x20associated\x20with\x20adverse\x20effects\x20such\x20as\x20bone\x20marrow\x20suppression,\x20and\x20hypersensitivity\x20reactions.\x20When\x20given\x20to\x20infants,\x20it\x20may\x20cause\u00a0<strong>grey\x20baby\x20syndrome.</strong></p>','explanation_video':'','question_images':[_0x1c6435(0x399)],'explanation_images':[]},{'text':_0x1c6435(0x1b8),'choices':[{'id':0x1,'text':'Aminoglycosides'},{'id':0x2,'text':_0x1c6435(0x397)},{'id':0x3,'text':'Chloramphenicol'},{'id':0x4,'text':_0x1c6435(0x1cf)}],'correct_choice_id':0x2,'solution':_0x1c6435(0x2b3),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x1c6435(0x126),'choices':[{'id':0x1,'text':'Buprenorphine'},{'id':0x2,'text':_0x1c6435(0x157)},{'id':0x3,'text':_0x1c6435(0x3dd)},{'id':0x4,'text':_0x1c6435(0x2e4)}],'correct_choice_id':0x3,'solution':_0x1c6435(0x1aa),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x1c6435(0x174),'choices':[{'id':0x1,'text':_0x1c6435(0x33d)},{'id':0x2,'text':'Fever,\x20dystonia,\x20rigidity\x20and\x20normal\x20pupils'},{'id':0x3,'text':_0x1c6435(0x2f1)},{'id':0x4,'text':'Fever,\x20rigidity,\x20normal\x20pupils\x20and\x20reduced\x20bowel\x20sounds'}],'correct_choice_id':0x1,'solution':'<p>In\x20the\x20given\x20clinical\x20scenario,\x20the\x20symptoms\x20of\u00a0<strong>fever</strong>,\x20<strong>rigidity,\x20hyperreflexia,\u00a0</strong>and\x20<strong>dilated\x20</strong>pupils\x20are\x20seen\x20in\x20the\x20patient\x20who\x20is\x20on\x20a\x20<strong>MAO\x20inhibitor\x20+\u00a0\x20SSRI.\x20</strong>It\x20is\x20due\x20to\x20the<strong>\u00a0</strong>development\x20of\u00a0<strong>serotonin\x20syndrome.</strong></p>\x0a<p>Serotonin\x20syndrome\u00a0occurs\x20due\x20to\x20the\x20concurrent\x20administration\x20of\x20an\x20SSRI\x20with\x20an\x20MAO-inhibitor,\x20L-tryptophan,\x20or\x20lithium,\x20raising\x20plasma\x20serotonin\x20concentrations\x20to\x20toxic\x20levels.\x20This\x20serious\x20and\x20possibly\x20fatal\x20syndrome\x20with\x20the\x20symptoms\u00a0</p>\x0a<ul>\x0a<li>diarrhea,\x20diaphoresis,\x20flushing,\x20<strong>mydriasis</strong>,\x20salivation</li>\x0a<li>restlessness</li>\x0a<li>extreme\x20agitation,\x20<strong>hyperreflexia</strong>,\x20and\x20rapid\x20fluctuations\x20in\x20vitals</li>\x0a<li>myoclonus,\x20<strong>hyperthermia</strong>,\x20uncontrollable\x20shivering,\x20<strong>rigidity</strong>;\x20and\x20eventually</li>\x0a<li>delirium,\x20status\x20epilepticus,\x20cardiovascular\x20collapse,\x20and\x20death.\u00a0</li>\x0a</ul>\x0a<p>Treatment\x20involves\u00a0<strong>removing\x20the\x20offending\x20agent\x20</strong>and<strong>\x20supportive\x20care</strong>.\u00a0</p>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x1c6435(0x2ae),'choices':[{'id':0x1,'text':_0x1c6435(0x194)},{'id':0x2,'text':_0x1c6435(0x12e)},{'id':0x3,'text':'To\x20promote\x20the\x20metabolism\x20of\x20levodopa\x20in\x20periphery'},{'id':0x4,'text':_0x1c6435(0x2d8)}],'correct_choice_id':0x4,'solution':_0x1c6435(0x2b6),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':'A\x20psychiatric\x20patient\x20with\x20a\x20history\x20of\x20bipolar\x20disorder\x20is\x20brought\x20by\x20her\x20relatives.\x20They\x20give\x20a\x20history\x20suggestive\x20of\x20an\x20acute\x20manic\x20episode.\x20She\x20is\x20already\x20on\x20lithium\x20therapy\x20and\x20the\x20serum\x20lithium\x20levels\x20are\x20measured\x20to\x20be\x200.2\x20mEq/L.\x20What\x20steady-state\x20concentration\x20will\x20you\x20be\x20aiming\x20to\x20achieve\x20in\x20this\x20scenario?','choices':[{'id':0x1,'text':_0x1c6435(0x22a)},{'id':0x2,'text':'0.8\x20-\x201.2\x20mEq/L'},{'id':0x3,'text':_0x1c6435(0x16e)},{'id':0x4,'text':'0.3\x20-\x200.5\x20mEq/L'}],'correct_choice_id':0x2,'solution':'<p>The\x20given\x20clinical\x20vignette\x20showing\x20increased\x20activity,\x20energy,\x20and\x20euphoria\x20with\x20a\x20decreased\x20need\x20for\x20sleep\x20is\x20indicative\x20of\x20an\x20<strong>acute\x20manic\x20episode</strong>\x20for\x20which\x20a\x20steady-state\x20concentration\x20of\x20<strong>0.8\x20-\x201.2\x20mEq/L</strong>\x20of\x20lithium\x20has\x20to\x20be\x20achieved\x20for\x20adequate\x20treatment.</p>\x0a<p>Lithium\x20is\x20used\x20in\x20the\x20management\x20of\x20bipolar\x20disorder,\x20and\x20mania,\x20and\x20has\x20anti-suicidal\x20properties.\x20It\x20has\x20a\x20narrow\x20therapeutic\x20index,\x20and\x20blood\x20levels\x20in\x20excess\x20of\x20this\x20may\x20cause\x20symptoms\x20of\x20toxicity.\x20Therapeutic\x20drug\x20monitoring\x20is\x20done\x20by\x20measuring\x20lithium\x20levels\x2012\x20hours\x20after\x20the\x20last\x20dose.</p>\x0a<p><strong>Lithium\x20therapy\x20for\x20acute\x20mania</strong>:</p>\x0a<ul>\x0a<li>Three\x20individual\x2010-mg/kg\x20doses\x20of\x20a\x20sustained-release\x20preparation\x20administered\x20at\x202-h\x20intervals.</li>\x0a<li>The\x20sustained-release\x20form\x20is\x20used\x20to\x20minimize\x20GI\x20adverse\x20effects\x20(e.g.,\x20nausea,\x20diarrhea)</li>\x0a<li>Subsequent\x20treatment\x20may\x20then\x20be\x20continued\x20with\x20Li+\x20carbonate.</li>\x0a</ul>\x0a<p><strong>Steady\x20state-concentrations\x20for\x20therapy</strong>\x20:</p>\x0a<ul>\x0a<li>For\x20maintainance\x20therapy\x20in\x20bipolar\x20disorder\x20-\x200.5-0.8\x20mEq/L</li>\x0a<li>For\x20episodes\x20of\x20acute\x20mania\x20-\x200.8-1.2\x20mEq/L</li>\x0a<li>Toxic\x20levels\x20-\x20&gt;1.5\x20mEq/L</li>\x0a</ul>\x0a<p>The\x20blood\x20sample\x20for\x20<strong>serum\x20lithium\x20estimation</strong>\x20is\x20to\x20be\x20<strong>collected\x20after\x20a\x20time\x20interval\x20of\x2010-12\x20hours</strong>&nbsp;from\x20the\x20previous\x20dose\x20of\x20lithium\x20which\x20is\x20used\x20to\x20estimate\x20the\x20steady-state\x20concentration.</p>\x0a<p>Known\x20significant<strong>\x20side\x20effects</strong>\x20of\x20lithium\x20therapy\x20include</p>\x0a<ul>\x0a<li>Polyuria-polydipsia\x20(nephrogenic\x20diabetes\x20insipidus)</li>\x0a<li>Hand\x20tremors</li>\x0a<li>Confusion&nbsp;</li>\x0a<li>ECG\x20changes</li>\x0a<li>Psoriasis</li>\x0a<li>Hypothyroidism</li>\x0a<li>Diarrhea</li>\x0a</ul>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x1c6435(0x1b1),'choices':[{'id':0x1,'text':_0x1c6435(0xf5)},{'id':0x2,'text':'Topiramate'},{'id':0x3,'text':_0x1c6435(0x2ad)},{'id':0x4,'text':_0x1c6435(0x325)}],'correct_choice_id':0x2,'solution':_0x1c6435(0x3d7),'explanation_video':'','question_images':['https://cdn1.dailyrounds.org/uploads/c6d1cf51cf8f4e38adcb74dbf34cb5b3.JPEG'],'explanation_images':[]},{'text':_0x1c6435(0x10f),'choices':[{'id':0x1,'text':_0x1c6435(0x3b5)},{'id':0x2,'text':_0x1c6435(0x189)},{'id':0x3,'text':'Warfarin'},{'id':0x4,'text':_0x1c6435(0x146)}],'correct_choice_id':0x3,'solution':_0x1c6435(0x2f4),'explanation_video':'','question_images':[_0x1c6435(0x17f)],'explanation_images':[_0x1c6435(0x18b)]},{'text':_0x1c6435(0x1e9),'choices':[{'id':0x1,'text':_0x1c6435(0x262)},{'id':0x2,'text':'Diazepam\x20<\x20lorazepam\x20<\x20midazolam\x20<\x20\x20remimazolam'},{'id':0x3,'text':_0x1c6435(0x22e)},{'id':0x4,'text':'Midazolam\x20<\x20diazepam\x20<\x20remimazolam\x20<\x20lorazepam'}],'correct_choice_id':0x1,'solution':'<p><strong>Increasing</strong>\x20order\x20of\x20half-lives\x20of\x20the\x20given\x20benzodiazepines\x20is\x20<strong>remimazolam\x20&lt;\x20midazolam\x20&lt;\x20lorazepam\x20&lt;\x20diazepam</strong>\x20(Option\x20A).&nbsp;</p>\x0a<p>Classification\x20of\x20benzodiazepines:</p>\x0a<ul>\x0a<li><strong>Ultra-short\x20acting</strong>\x0a<ul>\x0a<li>Remimazolam</li>\x0a</ul>\x0a</li>\x0a<li><strong>Short-acting:</strong>\x20<br\x20/>\x0a<ul>\x0a<li>Triazolam</li>\x0a<li>Midazolam</li>\x0a</ul>\x0a</li>\x0a<li><strong>Intermediate-acting:</strong>\x20<br\x20/>\x0a<ul>\x0a<li>Alprazolam</li>\x0a<li>Temazepam</li>\x0a<li>Lorazepam</li>\x0a</ul>\x0a</li>\x0a<li><strong>Long-acting:</strong>\x20<br\x20/>\x0a<ul>\x0a<li>Flurazepam</li>\x0a<li>Diazepam</li>\x0a<li>Quazepam</li>\x0a<li>Chlordiazepoxide</li>\x0a</ul>\x0a</li>\x0a</ul>\x0a<p>Benzodiazepines\x20promote\x20the\x20binding\x20of\x20GABA\x20to\x20the\x20GABA<sub>A&nbsp;</sub>receptor.\x20It\x20produces&nbsp;sedative-hypnotic,\x20muscle-relaxing,\x20anxiolytic,\x20amnesic,\x20and\x20anticonvulsant\x20effects.\x20They\x20are\x20used\x20in\x20the\x20treatment\x20of\x20insomnia,\x20anxiety\x20disorders\x20(generalized\x20anxiety\x20disorder,\x20panic\x20disorder,\x20phobias),\x20seizure\x20disorders,\x20and\x20alcohol\x20withdrawal\x20syndrome.</p>\x0a<p>Adverse\x20effects\x20include&nbsp;light-headedness,\x20motor\x20incoordination,\x20confusion,\x20and\x20anterograde\x20amnesia.&nbsp;Chronic\x20use\x20can\x20lead\x20to\x20drug\x20dependence\x20and\x20abuse.</p>\x0a<p>Note:&nbsp;Remimazolam\x20was\x20approved\x20by\x20FDA\x20in\x202020.</p>\x0a<p>&nbsp;</p>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x1c6435(0x2c4),'choices':[{'id':0x1,'text':_0x1c6435(0x3e6)},{'id':0x2,'text':_0x1c6435(0x310)},{'id':0x3,'text':_0x1c6435(0x2e5)},{'id':0x4,'text':'Blocks\x20Na+-Cl\x20symporter'}],'correct_choice_id':0x1,'solution':'<p>Desmopressin\x20is\x20a\u00a0<strong>V<sub>2</sub>\x20receptor\x20agonist</strong>\x20<strong>of</strong>\x20<strong>vasopressin.</strong>\u00a0It\x20is\x20the\x20<strong>drug\x20of\x20choice</strong>\x20for\x20<strong>central\x20diabetes\x20insipidus.</strong></p>\x0a<p><span\x20data-preserver-spaces=\x22true\x22>Diabetes\x20insipidus\x20can\x20be\x20of\x20two\x20types\x20-\u00a0</span><strong><span\x20data-preserver-spaces=\x22true\x22>central\u00a0</span></strong><span\x20data-preserver-spaces=\x22true\x22>or\u00a0</span><strong><span\x20data-preserver-spaces=\x22true\x22>peripheral\u00a0</span></strong><span\x20data-preserver-spaces=\x22true\x22>(nephrogenic).\x20Central\x20DI\x20occurs\x20due\x20to\x20a\u00a0</span><strong><span\x20data-preserver-spaces=\x22true\x22>deficiency\x20of\x20ADH</span></strong><span\x20data-preserver-spaces=\x22true\x22>.\u00a0</span></p>\x0a<p><span\x20data-preserver-spaces=\x22true\x22>Central\x20diabetes\x20insipidus\x20(DI)\x20is\x20a\x20disorder\x20that\x20occurs\u00a0</span>due\x20to\x20damage\x20to\x20the\u00a0neurohypophysis\u00a0in\x20the\x20posterior\x20pituitary.\x20It\x20can\x20be\x20congenital\x20or\x20acquired<span\x20data-preserver-spaces=\x22true\x22>.\x20It\x20is\x20characterized\x20by\u00a0</span><strong><span\x20data-preserver-spaces=\x22true\x22>decreased\x20ADH</span></strong><span\x20data-preserver-spaces=\x22true\x22>\u00a0leading\x20to\x20large\x20volumes\x20of\u00a0</span><strong><span\x20data-preserver-spaces=\x22true\x22>urine\x20production</span></strong><span\x20data-preserver-spaces=\x22true\x22>.\x20Patients\x20present\x20with\u00a0</span><strong><span\x20data-preserver-spaces=\x22true\x22>excessive\x20thirst,\x20nocturia</span></strong><span\x20data-preserver-spaces=\x22true\x22>,\x20and\u00a0</span><strong><span\x20data-preserver-spaces=\x22true\x22>urinary\x20frequency.</span></strong><span\x20data-preserver-spaces=\x22true\x22>\u00a0</span></p>\x0a<p><span\x20data-preserver-spaces=\x22true\x22>Central\x20DI\x20can\x20be\x20treated\x20with\u00a0<strong>desmopressin</strong>,\x20a\u00a0V<sub>2</sub>\x20receptor\x20agonist\u00a0of\x20vasopressin.\x20It\x20can\x20be\x20given\x20by\x20iv\x20or\x20sc\x20injection,\x20nasal\x20inhalation,\x20or\x20orally.\u00a0<br\x20/></span></p>\x0a<p>Principal\x20cells\x20in\x20the\x20collecting\x20duct\x20have\x20V<sub>2</sub>\x20receptors\x20on\x20their\x20basolateral\x20membrane.\x20When\x20stimulated,\x20they\x20increase\x20the\x20insertion\x20rate\x20of\x20water\x20channels\x20-\x20aquaporin2,\x20into\x20the\x20apical\x20membrane.\x20This\x20increases\x20water\x20permeability.\x20V<sub>2</sub>\x20receptors\x20also\x20increase\x20the\x20permeability\x20of\x20urea\x20and\x20help\x20in\x20the\x20renal\x20conservation\x20of\x20water.</p>\x0a<div\x20class=\x22page\x22\x20title=\x22Page\x20474\x22>\x0a<div\x20class=\x22section\x22>\x0a<div\x20class=\x22layoutArea\x22>\x0a<div\x20class=\x22column\x22>\x0a<p>Activating\x20endothelial\x20V2\x20receptors\x20by\x20desmopressin\x20or\x20vasopressin\x20increases\x20circulating\x20levels\x20of\x20procoagulant\x20factor\x20VIII\x20and\x20the\x20von\x20Willebrand\x20factor.</p>\x0a</div>\x0a</div>\x0a</div>\x0a</div>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x1c6435(0x116),'choices':[{'id':0x1,'text':'Fenofibrate'},{'id':0x2,'text':'Colestipol'},{'id':0x3,'text':_0x1c6435(0x1d3)},{'id':0x4,'text':_0x1c6435(0x211)}],'correct_choice_id':0x1,'solution':_0x1c6435(0x2be),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x1c6435(0x1a0),'choices':[{'id':0x1,'text':'Quinidine'},{'id':0x2,'text':'Sotalol'},{'id':0x3,'text':_0x1c6435(0x34d)},{'id':0x4,'text':_0x1c6435(0x2e3)}],'correct_choice_id':0x4,'solution':'<p>The\x20ECG\x20of\x20this\x20patient\x20shows\u00a0<strong>wide\x20QRS\x20complexes\x20</strong>and\x20an<strong>\u00a0undulating\x20baseline\x20</strong>suggesting\x20the\x20diagnosis\x20of\u00a0<strong>torsades\x20de\x20pointes</strong>.\x20It\x20is\x20associated\x20with\u00a0<strong>prolonged\x20QT\x20interval.\u00a0Lidocaine</strong>\x20does\x20not\x20prolong\x20the\x20QT\x20interval,\x20hence,\x20it\x20is<strong>\x20unlikely</strong>\x20to\x20cause\x20torsades\x20de\x20pointes.\u00a0</p>\x0a<p><strong>Lidocaine</strong>\x20belongs\u00a0to\x20the\x20<strong>class\x20IB</strong>\x20antiarrhythmic\x20agent.\x20It\x20is\x20considered\x20to\x20have\x20the\x20least\x20arrhythmogenic\x20potential\x20among\x20antiarrhythmic.\x20QT\x20interval\x20is\x20usually\x20unaltered\x20or\x20slightly\x20reduced\x20with\x20lidocaine\x20use.</p>\x0a<p>Among\x20the\x20antiarrhythmics,\x20class\x20Ia\x20and\x20class\x20III\x20drugs\x20prolong\x20action\x20potential\x20duration\x20and\x20thus\x20prolong\x20QT\x20interval\x20and\x20are\x20also\x20prone\x20to\x20cause\x20Torsades\x20de\x20pointes.</p>','explanation_video':'','question_images':[_0x1c6435(0x290)],'explanation_images':[_0x1c6435(0x24c)]},{'text':_0x1c6435(0x316),'choices':[{'id':0x1,'text':'1,\x202,\x205'},{'id':0x2,'text':_0x1c6435(0x15c)},{'id':0x3,'text':_0x1c6435(0x122)},{'id':0x4,'text':_0x1c6435(0x318)}],'correct_choice_id':0x2,'solution':_0x1c6435(0xf0),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x1c6435(0x209),'choices':[{'id':0x1,'text':_0x1c6435(0x31f)},{'id':0x2,'text':_0x1c6435(0x335)},{'id':0x3,'text':'Amlodipine'},{'id':0x4,'text':'Hydrochlorthiazide'}],'correct_choice_id':0x3,'solution':'<p>The\x20image\x20shows<strong>\x20pitting\x20pedal\x20edema</strong>\x20in\x20a\x20hypertensive\x20patient.\x20<strong>Calcium\x20channel\x20blockers\x20(CCBs)</strong>\x20like\x20<strong>amlodipine</strong>\x20are\x20most\x20likely\x20to\x20be\x20associated\x20with\x20peripheral\x20edema.</p>\x0a<p>The\x20frequency\x20of\x20CCB-\x20induced\x20peripheral\x20edema\x20is\x20both\x20<strong>drug-specific</strong>\x20(i.e\x20more\x20potent\x20drugs\x20like\x20amlodipine\x20will\x20be\x20associated\x20with\x20higher\x20rates\x20of\x20developing\x20edema)\x20and\x20<strong>dose-dependent</strong>\x20(i.e\x20incidence\x20of\x20edema\x20increases\x20with\x20an\x20increase\x20in\x20drug\x20dosage\x20and\x20chronicity\x20of\x20its\x20usage).\x20It\x20is\x20more\x20common\x20among\x20<strong>females.</strong></p>\x0a<p>CCB-induced\x20peripheral\x20edema\x20occurs\x20due\x20to\x20a\x20disproportionate\x20decrease\x20in\x20the&nbsp;arteriolar\x20resistance\x20than\x20in\x20the\x20venous\x20circulation,\x20resulting\x20in\x20increased&nbsp;hydrostatic\x20pressure\x20in\x20the\x20precapillary\x20circulation.\x20This\x20leads\x20to\x20a\x20fluid\x20shift&nbsp;into\x20the\x20interstitial\x20compartment\x20causing\x20edema.</p>\x0a<p>Treatment:</p>\x0a<ul>\x0a<li>Dose\x20reduction.</li>\x0a<li>Interclass\x20switching\x20of\x20CCB\x20-\x20switch\x20to\x20non-dihydropyridines\x20like\x20verapamil,\x20and\x20diltiazem.</li>\x0a<li>Addition\x20of\x20a\x20venodilator\x20-\x20ACE\x20inhibitor,\x20ARBs,\x20Nitrates.</li>\x0a<li>Others\x20-\x20compression\x20stockings,\x20avoiding\x20prolonged\x20upright\x20position.</li>\x0a<li>Definitive\x20treatment\x20would\x20be\x20discontinuation\x20of\x20the\x20CCB\x20and\x20switching\x20to\x20another\x20class\x20of\x20antihypertensives.</li>\x0a</ul>\x0a<p>Other\x20options:</p>\x0a<p>Option\x20A:\x20Common\x20side\x20effects\x20of\x20<strong>ACE\x20inhibitors</strong>\x20like\x20<strong>enalapril\x20</strong>include\x20hypotension,\x20hyperkalemia,\x20dry\x20cough,\x20rashes,\x20urticaria,\x20dysgeusia,\x20gastrointestinal\x20upset,\x20headache,\x20and\x20dizziness.</p>\x0a<p>Option\x20B:<strong>&nbsp;Telmisartan</strong>,\x20an\x20angiotensin\x20receptor\x20blocker\x20(<strong>ARBs)</strong>,\x20causes\x20adverse\x20effects\x20such\x20as\x20hypotension,\x20hyperkalemia,\x20headache,\x20gastrointestinal\x20upset,\x20and\x20dizziness.</p>\x0a<p>Option\x20D:\x20Adverse\x20effects\x20of\x20<strong>thiazide\x20diuretics</strong>\x20like\x20<strong>hydrochlorothiazide</strong>\x20are\x20hypokalemia,\x20hyponatremia,\x20hyperglycemia,\x20hyperuricemia,\x20hypercalcemia,\x20rashes,&nbsp;headache,\x20gastrointestinal\x20upset,\x20and\x20dizziness.</p>','explanation_video':'','question_images':[_0x1c6435(0x351)],'explanation_images':[]},{'text':'A\x20patient\x20diagnosed\x20with\x20peptic\x20ulcer\x20disease\x20is\x20being\x20treated\x20with\x20sucralfate.\x20Which\x20of\x20the\x20following\x20adverse\x20effects\x20can\x20be\x20seen\x20in\x20the\x20patient?','choices':[{'id':0x1,'text':_0x1c6435(0x23e)},{'id':0x2,'text':_0x1c6435(0x200)},{'id':0x3,'text':'Gastric\x20bezoars'},{'id':0x4,'text':_0x1c6435(0x280)}],'correct_choice_id':0x3,'solution':_0x1c6435(0x19c),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x1c6435(0x36b),'choices':[{'id':0x1,'text':_0x1c6435(0x273)},{'id':0x2,'text':'Hyperosmotic\x20agent'},{'id':0x3,'text':_0x1c6435(0x330)},{'id':0x4,'text':_0x1c6435(0x349)}],'correct_choice_id':0x4,'solution':_0x1c6435(0x179),'explanation_video':'','question_images':['https://cdn1.dailyrounds.org/uploads/4b06ad9765fd4ff49d033ee3f2154e3a.PNG'],'explanation_images':[_0x1c6435(0x29a)]},{'text':_0x1c6435(0x279),'choices':[{'id':0x1,'text':_0x1c6435(0xe1)},{'id':0x2,'text':_0x1c6435(0x333)},{'id':0x3,'text':_0x1c6435(0x336)},{'id':0x4,'text':_0x1c6435(0x3e9)}],'correct_choice_id':0x1,'solution':_0x1c6435(0x3c5),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x1c6435(0x117),'choices':[{'id':0x1,'text':_0x1c6435(0x12f)},{'id':0x2,'text':_0x1c6435(0xe7)},{'id':0x3,'text':_0x1c6435(0x2b7)},{'id':0x4,'text':_0x1c6435(0x2e8)}],'correct_choice_id':0x2,'solution':_0x1c6435(0x258),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x1c6435(0x38b),'choices':[{'id':0x1,'text':_0x1c6435(0x130)},{'id':0x2,'text':_0x1c6435(0x1d2)},{'id':0x3,'text':_0x1c6435(0x386)},{'id':0x4,'text':_0x1c6435(0x3df)}],'correct_choice_id':0x4,'solution':'<p>The\x20time\x20taken\x20to\x20reach\x20steady-state\x20plasma\x20concentration\x20is<strong>\x204-5\x20half-lives.\x20</strong>As\x20the\x20half-life\x20of\x20the\x20given\x20drug\x20is\x208\x20hours,\x20so\x20it\x20will\x20take\x20<strong>32-40\x20hours\x20</strong>to\x20reach\x20a\x20steady\x20state.\x20Hence,\x20<strong>36\x20hours&nbsp;</strong>will\x20be\x20the\x20most\x20appropriate\x20answer.</p>\x0a<p><strong>Steady-state:&nbsp;</strong>The\x20amount\x20of\x20drug\x20administered\x20is\x20equal\x20to\x20the\x20amount\x20of\x20drug\x20eliminated\x20within\x20one\x20dosing\x20interval\x20resulting\x20in\x20a\x20plateau\x20or\x20constant\x20drug\x20plasma\x20concentration,\x20with\x20the\x20plasma\x20concentration\x20fluctuating\x20between\x20a\x20minimum\x20and\x20maximum.</p>\x0a<p>The\x20time\x20taken\x20to\x20reach\x20steady-state\x20plasma\x20concentration\x20is<strong>\x204-5\x20half-lives.\x20</strong></p>\x0a<p>Drugs\x20with\x20a\x20shorter\x20half-life\x20reach\x20a\x20steady\x20state\x20rapidly,\x20whereas\x20drugs\x20with\x20longer\x20half-life\x20take\x20days\x20to\x20weeks\x20to\x20attain\x20a\x20steady\x20state.</p>\x0a<p><strong>Steady-state\x20concentration\x20(Css)\x20=\x20F\x20x\x20Dosing\x20rate/\x20CL</strong></p>\x0a<ul>\x0a<li>where\x20dosing\x20rate\x20is\x20the\x20dose\x20per\x20time\x20interval\x20and\x20is\x20dose/T</li>\x0a<li>F\x20is\x20the\x20fractional\x20bioavailability,\x20CL\x20is\x20clearance.</li>\x0a</ul>\x0a<p>In\x20the\x20case\x20of\x20intravenous\x20infusion,</p>\x0a<p><strong>Steady-state\x20concentration\x20(Css)\x20=\x20Rate\x20of\x20infusion/\x20CL</strong></p>\x0a<p>Pharmacokinetics\x20of\x20repeated\x20drug\x20dosing:</p>\x0a<p>Plasma\x20concentration\x20of\x20the\x20drug\x20will\x20increase,\x20reach\x20a\x20maximum,\x20and\x20decline\x20after\x20the\x20first\x20dose.\x20A\x20second\x20dose\x20will\x20be\x20administered\x20before\x20the\x20first\x20dose\x20is\x20completely\x20eliminated.\x20Consequently,\x20the\x20plasma\x20concentration\x20resulting\x20from\x20the\x20second\x20dose\x20will\x20be\x20higher\x20than\x20from\x20the\x20first\x20dose.</p>\x0a<p>This\x20increase\x20in\x20plasma\x20concentration\x20of\x20the\x20drug\x20will\x20occur\x20continuously\x20on\x20repeated\x20dosing\x20(<strong>drug\x20accumulation</strong>\x20occurs)\x20until\x20a\x20steady\x20state\x20at\x20which\x20drug\x20elimination\x20is\x20equal\x20to\x20drug\x20administration\x20is\x20reached.\x20This\x20is\x20known\x20as\x20the\x20<strong>plateau\x20principle\x20of\x20drug\x20accumulation.</strong></p>\x0a<p>A\x20graph\x20is\x20plotted\x20between\x20plasma\x20drug\x20concentration\x20and\x20time\x20as\x20shown\x20below.\x20The\x20given\x20graph\x20depicts\x20the\x20plateau\x20principle\x20of\x20drug\x20accumulation\x20on\x20repeated\x20oral\x20dosing.</p>','explanation_video':'','question_images':[],'explanation_images':[_0x1c6435(0x22f)]},{'text':_0x1c6435(0x3b3),'choices':[{'id':0x1,'text':_0x1c6435(0x1b4)},{'id':0x2,'text':'Beta\x201'},{'id':0x3,'text':_0x1c6435(0x237)},{'id':0x4,'text':'Alpha\x201'}],'correct_choice_id':0x1,'solution':_0x1c6435(0x255),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':'A\x20patient\x20presents\x20to\x20the\x20emergency\x20department\x20with\x20diarrhea,\x20sweating,\x20excessive\x20lacrimation,\x20and\x20salivation.\x20His\x20pulse\x20rate\x20is\x2055/min\x20and\x20his\x20plasma\x20cholinesterase\x20level\x20was\x2050U/mL.\x20Which\x20of\x20the\x20following\x20can\x20be\x20used\x20to\x20treat\x20this\x20patient?','choices':[{'id':0x1,'text':'Neostigmine'},{'id':0x2,'text':_0x1c6435(0x124)},{'id':0x3,'text':_0x1c6435(0x152)},{'id':0x4,'text':_0x1c6435(0x359)}],'correct_choice_id':0x2,'solution':_0x1c6435(0x315),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':'Which\x20of\x20the\x20following\x20drugs\x20come\x20under\x20Schedule\x20H\x20of\x20the\x20Drugs\x20and\x20Cosmetics\x20Act,\x201945?','choices':[{'id':0x1,'text':_0x1c6435(0x187)},{'id':0x2,'text':_0x1c6435(0xef)},{'id':0x3,'text':'Drugs\x20\x20purchased\x20with\x20the\x20prescription\x20of\x20a\x20qualified\x20doctor'},{'id':0x4,'text':_0x1c6435(0x302)}],'correct_choice_id':0x3,'solution':'<p><strong>Schedule\x20H</strong>\x20includes\x20drugs\x20purchased\x20over\x20the\x20counter\x20with\x20the\x20prescription\x20of\x20a\x20qualified\x20doctor.</p>\x0a<p><strong>The\x20Drugs\x20and\x20Cosmetics\x20Rules</strong>,\x20classify\x20drugs\x20under\x20different\x20schedules\x20based\x20on\x20their\x20potential\x20for\x20abuse,\x20their\x20therapeutic\x20value,\x20and\x20other\x20factors.\x20The\x20rules\x20provide\x20guidelines\x20for\x20the\x20storage,\x20sale,\x20display,\x20and\x20prescription\x20of\x20each\x20schedule.</p>\x0a<p>Other\x20options:</p>\x0a<p>Option\x20A-\x20Biological\x20and\x20special\x20products\x20like\x20insulin,\x20toxin,\x20and\x20antitoxins\x20are\x20included\x20under&nbsp;<strong>Schedule\x20C.</strong></p>\x0a<p>Option\x20B-\x20Bacterial\x20vaccines\x20are\x20included\x20under&nbsp;<strong>Schedule\x20F\x20I.</strong></p>\x0a<p>Option\x20D-\x20Drugs\x20that\x20should\x20be\x20labelled\x20with\x20the\x20words\x20&ldquo;Caution:\x20it\x20is\x20dangerous\x20to\x20take\x20this\x20preparation\x20except\x20under\x20medical\x20supervision&rdquo;\x20are\x20included\x20under&nbsp;<strong>Schedule\x20G.</strong></p>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x1c6435(0x28f),'choices':[{'id':0x1,'text':_0x1c6435(0x21d)},{'id':0x2,'text':_0x1c6435(0x350)},{'id':0x3,'text':_0x1c6435(0x11b)},{'id':0x4,'text':_0x1c6435(0x2fe)}],'correct_choice_id':0x2,'solution':_0x1c6435(0x11d),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x1c6435(0x312),'choices':[{'id':0x1,'text':_0x1c6435(0x398)},{'id':0x2,'text':_0x1c6435(0x2a0)},{'id':0x3,'text':'Agonism'},{'id':0x4,'text':_0x1c6435(0x33b)}],'correct_choice_id':0x1,'solution':_0x1c6435(0x320),'explanation_video':'','question_images':[_0x1c6435(0x18e)],'explanation_images':[]},{'text':_0x1c6435(0x263),'choices':[{'id':0x1,'text':_0x1c6435(0x156)},{'id':0x2,'text':_0x1c6435(0x1cb)},{'id':0x3,'text':_0x1c6435(0x193)},{'id':0x4,'text':_0x1c6435(0x2d1)}],'correct_choice_id':0x3,'solution':_0x1c6435(0x248),'explanation_video':'','question_images':[],'explanation_images':[_0x1c6435(0x28e)]}],quizName=_0x1c6435(0x308);const quizFilename='pharmacology-test-05088d6a.html';let hierarchy=['Marrow','NEET\x20PG\x20Test\x20Series\x20Subject\x20Wise',_0x1c6435(0x201)];if(window[_0x1c6435(0x25d)]['pathname'][_0x1c6435(0xdd)](_0x1c6435(0x15d))){const customData=JSON[_0x1c6435(0x1a4)](localStorage['getItem'](_0x1c6435(0x3cd)));if(customData){const EfFCux=_0x1c6435(0x18c)[_0x1c6435(0x1c3)]('|');let pWQGwe=0x0;while(!![]){switch(EfFCux[pWQGwe++]){case'0':hierarchy=customData[_0x1c6435(0xd6)];continue;case'1':questionsData=customData['questions'];continue;case'2':document[_0x1c6435(0x2a9)](_0x1c6435(0x29f))[_0x1c6435(0x1f1)]=hierarchy[_0x1c6435(0x3a4)](_0x1c6435(0x12b));continue;case'3':document[_0x1c6435(0x2a9)](_0x1c6435(0xfe))[_0x1c6435(0x1f1)]=questionsData[_0x1c6435(0x2b4)];continue;case'4':quizName=customData[_0x1c6435(0x10e)];continue;case'5':document['title']=quizName+_0x1c6435(0x3d9);continue;}break;}}}let currentQuestionIndex=0x0,selectedOption=null,currentMode=_0x1c6435(0x128),timer=null,timeRemaining=0x0,questionStartTime=Date[_0x1c6435(0x266)](),quizStartTime=Date['now'](),isQuizCompleted=![],questionStates=new Array(questionsData[_0x1c6435(0x2b4)])[_0x1c6435(0x259)](null)[_0x1c6435(0x113)](()=>({'status':_0x1c6435(0x28c),'bookmarked':![],'markedForReview':![],'selectedAnswer':null,'timeSpent':0x0})),stats={'correctAnswers':0x0,'incorrectAnswers':0x0,'totalAttempted':0x0,'totalTime':0x0,'notAttempted':questionsData[_0x1c6435(0x2b4)]};function saveProgress(){const _0x22c281=_0x1c6435,_0x11e7ea={'pwxQm':_0x22c281(0x1c1),'RQepu':_0x22c281(0x2ff)};if(isQuizCompleted)return;const _0x166e85=JSON[_0x22c281(0x1a4)](localStorage[_0x22c281(0x1f6)](_0x11e7ea[_0x22c281(0x2ee)]))||{};_0x166e85[quizFilename]={'questionStates':questionStates,'stats':stats,'currentQuestionIndex':currentQuestionIndex,'currentMode':currentMode,'status':_0x11e7ea['RQepu'],'lastSeen':new Date()[_0x22c281(0x32b)]()},localStorage[_0x22c281(0x276)](_0x11e7ea[_0x22c281(0x2ee)],JSON[_0x22c281(0x3a1)](_0x166e85));}function loadProgress(){const _0x53302a=_0x1c6435,_0x186c1c={'TzQPK':'.option-button','oEKwT':function(_0x5872f0,_0xe3cce7){return _0x5872f0(_0xe3cce7);},'wGmZu':_0x53302a(0x1f3),'WRIzg':_0x53302a(0x1c1),'cMVvO':function(_0x4fcc58,_0x12cfc1){return _0x4fcc58===_0x12cfc1;},'VKONi':_0x53302a(0xd3),'xeBtb':_0x53302a(0x2e2),'XjmgZ':_0x53302a(0x370)},_0x4490f9=JSON[_0x53302a(0x1a4)](localStorage[_0x53302a(0x1f6)](_0x186c1c[_0x53302a(0x288)]))||{},_0x19113c=_0x4490f9[quizFilename];if(_0x19113c){if(_0x186c1c[_0x53302a(0x2c1)](_0x53302a(0xd3),_0x186c1c['VKONi'])){const _0x133844=_0x186c1c[_0x53302a(0x235)][_0x53302a(0x1c3)]('|');let _0x208caa=0x0;while(!![]){switch(_0x133844[_0x208caa++]){case'0':stats=_0x19113c[_0x53302a(0x3a2)];continue;case'1':console['log'](_0x186c1c['XjmgZ']);continue;case'2':currentMode=_0x19113c[_0x53302a(0x1e5)];continue;case'3':return!![];case'4':questionStates=_0x19113c[_0x53302a(0x3ed)];continue;case'5':currentQuestionIndex=_0x19113c['currentQuestionIndex'];continue;}break;}}else{const _0xa18422=_0x5ed06e['target'][_0x53302a(0x379)](_0x186c1c[_0x53302a(0x2f3)]);if(_0xa18422){const _0x5a1f02=_0x186c1c[_0x53302a(0x105)](_0x1fbed9,_0xa18422[_0x53302a(0x191)](_0x186c1c['wGmZu']));_0x4f12f0(_0x5a1f02);}}}return![];}function clearProgress(){const _0x2bd6b1=_0x1c6435,_0x353032={'uXUZf':_0x2bd6b1(0x1c1),'vgTzk':_0x2bd6b1(0x36c)},_0x487304=JSON['parse'](localStorage['getItem'](_0x353032[_0x2bd6b1(0x10b)]))||{};_0x487304[quizFilename]&&(delete _0x487304[quizFilename],localStorage['setItem'](_0x353032[_0x2bd6b1(0x10b)],JSON[_0x2bd6b1(0x3a1)](_0x487304)),console[_0x2bd6b1(0x186)](_0x353032[_0x2bd6b1(0x24a)]));}function markQuizAsCompleted(){const _0x465dab=_0x1c6435,_0x419734={'FDZBA':_0x465dab(0x1c1),'ObGVO':_0x465dab(0x23b)},_0x194532=JSON[_0x465dab(0x1a4)](localStorage[_0x465dab(0x1f6)](_0x419734[_0x465dab(0x2b0)]))||{},_0x215b2b=questionsData[_0x465dab(0x2b4)],_0x186751=stats[_0x465dab(0x18f)]||0x0;_0x194532[quizFilename]={'score':_0x186751,'total':_0x215b2b,'status':_0x419734[_0x465dab(0xd8)],'completedOn':new Date()[_0x465dab(0x32b)]()},localStorage[_0x465dab(0x276)](_0x465dab(0x1c1),JSON[_0x465dab(0x3a1)](_0x194532));}const urlParams=new URLSearchParams(window[_0x1c6435(0x25d)][_0x1c6435(0x39f)]),startAt=parseInt(urlParams[_0x1c6435(0xe4)]('startAt')),resume=urlParams[_0x1c6435(0xe4)](_0x1c6435(0x23d))===_0x1c6435(0x313);function goBack(){const _0x117cba=_0x1c6435,_0x107eac={'KoTlh':function(_0x505485){return _0x505485();},'zKNBH':_0x117cba(0x230)};if(!isQuizCompleted)_0x107eac[_0x117cba(0x11c)](saveProgress);window[_0x117cba(0x25d)]['href']=document['referrer']||_0x107eac[_0x117cba(0xf7)];}function selectMode(_0x60efaf){const _0x28bfa8=_0x1c6435,_0x162b62={'KiCxP':_0x28bfa8(0x257),'PyXkp':_0x28bfa8(0x185)};currentMode=_0x60efaf,document[_0x28bfa8(0x2a9)](_0x162b62[_0x28bfa8(0x328)])[_0x28bfa8(0x2ce)][_0x28bfa8(0x139)]=_0x162b62[_0x28bfa8(0x15e)],initializeQuiz();}function initializeQuiz(){const _0x1d0c15=_0x1c6435,_0x11c210={'GfHaX':_0x1d0c15(0x2ec),'euMAe':_0x1d0c15(0x256),'hQYQw':_0x1d0c15(0x242),'oefvX':function(_0x3704b5,_0x3d7346){return _0x3704b5===_0x3d7346;},'xYgnG':_0x1d0c15(0x3c1),'otUKt':'statsBar','fIXjM':'none','NQSxF':'block','cCVsO':_0x1d0c15(0xfa),'xSJII':_0x1d0c15(0x31e),'rReGi':_0x1d0c15(0x3bc),'JBXJs':'timed_study','sjDwR':_0x1d0c15(0x2bc),'zNVST':function(_0x1e7d1f,_0x2dfbfc){return _0x1e7d1f!==_0x2dfbfc;},'yfLeQ':'EClar','JkLHu':_0x1d0c15(0x364),'MMQCi':_0x1d0c15(0x2f5),'cKWnb':function(_0x4efd35,_0xc7f37e){return _0x4efd35>=_0xc7f37e;},'TMeQC':function(_0x4c6936,_0x315e4c){return _0x4c6936<_0x315e4c;},'jqTxc':function(_0x3888bf){return _0x3888bf();},'Qdzah':function(_0x48a630){return _0x48a630();}};quizStartTime=Date[_0x1d0c15(0x266)]();const _0x33f233=document['getElementById'](_0x11c210[_0x1d0c15(0x388)]),_0x16ed59=document[_0x1d0c15(0x2a9)](_0x11c210[_0x1d0c15(0x3b1)]),_0x5f263c=document[_0x1d0c15(0x2a9)](_0x11c210[_0x1d0c15(0x1c9)]),_0x4e17a7=_0x11c210['oefvX'](currentMode,_0x11c210[_0x1d0c15(0x1b5)])||_0x11c210['oefvX'](currentMode,_0x1d0c15(0x2bc));document[_0x1d0c15(0x2a9)](_0x11c210[_0x1d0c15(0x3e1)])['style'][_0x1d0c15(0x139)]=_0x4e17a7?_0x11c210[_0x1d0c15(0x3db)]:_0x11c210['NQSxF'],document[_0x1d0c15(0x2a9)]('studyModeLegend')['style'][_0x1d0c15(0x139)]=_0x4e17a7?_0x11c210['fIXjM']:_0x11c210[_0x1d0c15(0x17a)],document[_0x1d0c15(0x2a9)](_0x11c210[_0x1d0c15(0x14e)])['style'][_0x1d0c15(0x139)]=_0x4e17a7?_0x11c210[_0x1d0c15(0x17a)]:_0x11c210['fIXjM'],document['getElementById'](_0x11c210['xSJII'])[_0x1d0c15(0x2ce)][_0x1d0c15(0x139)]=_0x4e17a7?_0x11c210[_0x1d0c15(0x17a)]:_0x1d0c15(0x185),_0x33f233['style'][_0x1d0c15(0x139)]=_0x4e17a7?_0x1d0c15(0x185):_0x11c210[_0x1d0c15(0x1ec)],_0x16ed59[_0x1d0c15(0x2ce)][_0x1d0c15(0x139)]=_0x4e17a7?_0x11c210[_0x1d0c15(0x1ec)]:_0x11c210[_0x1d0c15(0x3db)],_0x5f263c[_0x1d0c15(0x2ce)][_0x1d0c15(0x139)]=_0x4e17a7?_0x11c210[_0x1d0c15(0x1ec)]:_0x11c210[_0x1d0c15(0x3db)];if(_0x11c210[_0x1d0c15(0x183)](currentMode,_0x11c210[_0x1d0c15(0x144)])||_0x11c210[_0x1d0c15(0x183)](currentMode,_0x11c210[_0x1d0c15(0x294)])){if(_0x11c210[_0x1d0c15(0x2d3)](_0x11c210['yfLeQ'],_0x11c210[_0x1d0c15(0xee)]))document[_0x1d0c15(0x2a9)](_0x11c210[_0x1d0c15(0x3c9)])[_0x1d0c15(0x2f2)][_0x1d0c15(0x31c)]('hidden');else{const _0x321d68=_0x30938a['apply'](_0xda0f41,arguments);return _0xe317e1=null,_0x321d68;}}!isNaN(startAt)&&_0x11c210[_0x1d0c15(0x1bf)](startAt,0x0)&&_0x11c210[_0x1d0c15(0x3e2)](startAt,questionsData[_0x1d0c15(0x2b4)])&&(currentQuestionIndex=startAt),loadBookmarkedQuestions(),_0x11c210['jqTxc'](generateQuestionNav),_0x11c210[_0x1d0c15(0x375)](updateStats),_0x11c210['Qdzah'](displayQuestion);}function generateQuestionNav(){const _0x2d0964=_0x1c6435,_0x3d8d17={'QZjxH':_0x2d0964(0x167),'Piqxz':_0x2d0964(0x36f),'hTtqL':function(_0x1e423f,_0x2c4922){return _0x1e423f+_0x2c4922;}},_0x818d6c=document[_0x2d0964(0x2a9)](_0x3d8d17[_0x2d0964(0x12c)]);_0x818d6c[_0x2d0964(0x1e8)]='';for(let _0x11c560=0x0;_0x11c560<questionsData[_0x2d0964(0x2b4)];_0x11c560++){const _0x136405=document[_0x2d0964(0x2a1)](_0x3d8d17[_0x2d0964(0x2cb)]);_0x136405[_0x2d0964(0x1f1)]=_0x3d8d17['hTtqL'](_0x11c560,0x1),_0x136405[_0x2d0964(0x2f7)]=_0x2d0964(0x38c),_0x136405[_0x2d0964(0x33f)]=()=>jumpToQuestion(_0x11c560),_0x136405['id']=_0x2d0964(0x135)+_0x11c560,_0x818d6c[_0x2d0964(0x1f7)](_0x136405);}updateQuestionNav();}function updateQuestionNav(){const _0x597fc1=_0x1c6435,_0x1d4135={'JNTOd':function(_0x47c3a7,_0x492770){return _0x47c3a7%_0x492770;},'DsFRd':function(_0x2c4ce3,_0x121ecd){return _0x2c4ce3<_0x121ecd;},'zweNT':_0x597fc1(0x317),'ScjOE':_0x597fc1(0x3a8),'cdIus':'nav-btn-marked-review','MFzYz':function(_0x2a64ea,_0x3bb069){return _0x2a64ea===_0x3bb069;},'jvfBT':'study','azXLZ':_0x597fc1(0x24e),'xOYAP':_0x597fc1(0x3a5),'xzgFk':_0x597fc1(0x182),'kMJKe':function(_0x1d61f4,_0x575ffe){return _0x1d61f4===_0x575ffe;},'lhqHD':_0x597fc1(0x2af),'nUEdc':_0x597fc1(0x292),'cbtdQ':_0x597fc1(0x165),'CyjAN':function(_0x5e04fa,_0x2e5a28){return _0x5e04fa!==_0x2e5a28;},'taBhs':'nav-btn-answered'};for(let _0x2e17d6=0x0;_0x1d4135[_0x597fc1(0x1c8)](_0x2e17d6,questionsData[_0x597fc1(0x2b4)]);_0x2e17d6++){const _0x4fbf40=document[_0x597fc1(0x2a9)]('navBtn_'+_0x2e17d6),_0x4665a4=questionStates[_0x2e17d6];let _0x3c499b='';if(_0x2e17d6===currentQuestionIndex)_0x3c499b=_0x1d4135[_0x597fc1(0x30f)];else{if(_0x4665a4['bookmarked'])_0x3c499b=_0x1d4135[_0x597fc1(0x100)];else{if(_0x4665a4[_0x597fc1(0x203)])_0x3c499b=_0x1d4135['cdIus'];else{if(_0x1d4135[_0x597fc1(0x283)](currentMode,_0x1d4135['jvfBT'])||_0x1d4135['MFzYz'](currentMode,_0x1d4135[_0x597fc1(0x188)])){if(_0x1d4135['MFzYz'](_0x4665a4['status'],_0x1d4135[_0x597fc1(0x11e)]))_0x3c499b=_0x1d4135[_0x597fc1(0x1bb)];else{if(_0x1d4135[_0x597fc1(0x30c)](_0x4665a4[_0x597fc1(0x3b6)],_0x1d4135[_0x597fc1(0x127)]))_0x3c499b=_0x597fc1(0x287);else _0x3c499b=_0x1d4135['nUEdc'];}}else{if('aysxq'===_0x1d4135[_0x597fc1(0x39e)]){const _0x16a096=_0x33f986[_0x597fc1(0x26b)](_0xdea22d/0x3c),_0xb5ad0c=_0x1d4135[_0x597fc1(0x32e)](_0xfbb036,0x3c);_0x531648['getElementById']('timeDisplay')['textContent']=_0x16a096+':'+_0xb5ad0c[_0x597fc1(0x2eb)]()[_0x597fc1(0x1c7)](0x2,'0');}else{if(_0x1d4135['CyjAN'](_0x4665a4[_0x597fc1(0x3e8)],null))_0x3c499b=_0x1d4135[_0x597fc1(0x19e)];else _0x3c499b=_0x1d4135[_0x597fc1(0x269)];}}}}}_0x4fbf40[_0x597fc1(0x2f7)]=_0x597fc1(0x2b1)+_0x3c499b;}}function jumpToQuestion(_0x35a81b){const _0xf27f83=_0x1c6435,_0x44a8fb={'IWTVm':function(_0x547854,_0xe96327){return _0x547854>=_0xe96327;},'ufoNS':function(_0x1797ad,_0x5114b0){return _0x1797ad<_0x5114b0;},'oSPly':function(_0x3b3045,_0x2efd90){return _0x3b3045===_0x2efd90;},'vLcqz':_0xf27f83(0x151),'BKpPg':_0xf27f83(0x38f),'BdhoR':function(_0x46b3f5,_0x400cd0){return _0x46b3f5-_0x400cd0;},'ETgGb':function(_0x47c553){return _0x47c553();}};_0x44a8fb[_0xf27f83(0x2c7)](_0x35a81b,0x0)&&_0x44a8fb['ufoNS'](_0x35a81b,questionsData[_0xf27f83(0x2b4)])&&(_0x44a8fb[_0xf27f83(0xe5)](_0x44a8fb[_0xf27f83(0x35d)],_0x44a8fb['BKpPg'])?_0x2b7db6[_0xf27f83(0x1e8)]+=_0xf27f83(0xf8)+_0x2009f4['explanation_audio_hin']+'\x22\x20controls\x20class=\x22w-full\x22></audio></div>':(questionStartTime&&(questionStates[currentQuestionIndex][_0xf27f83(0x2fd)]+=_0x44a8fb[_0xf27f83(0xfb)](Date['now'](),questionStartTime)),currentQuestionIndex=_0x35a81b,_0x44a8fb[_0xf27f83(0x36e)](displayQuestion),saveProgress()));}function updateStats(){const _0x201380=_0x1c6435,_0x56fcd7={'gCzUk':function(_0x45af64,_0x20e757){return _0x45af64===_0x20e757;},'yEQil':_0x201380(0x128),'aVfWt':function(_0x585e88,_0x5d41b7){return _0x585e88===_0x5d41b7;},'yctYj':_0x201380(0x24e),'wExUI':_0x201380(0x2d2),'cEGQy':_0x201380(0x3d8),'mNABP':function(_0x54118c,_0x5a811c){return _0x54118c>_0x5a811c;},'nFGmZ':function(_0x2468bc,_0x1c4f8e){return _0x2468bc*_0x1c4f8e;},'EEIGF':'accuracy','vozzB':function(_0x56febe,_0x1a4fa5){return _0x56febe/_0x1a4fa5;},'ZwMeX':_0x201380(0x2fd),'Msszf':function(_0x1fd415,_0x397a70){return _0x1fd415+_0x397a70;}};if(_0x56fcd7[_0x201380(0x161)](currentMode,_0x56fcd7[_0x201380(0x1bc)])||_0x56fcd7[_0x201380(0x149)](currentMode,_0x56fcd7[_0x201380(0x208)])){document['getElementById'](_0x56fcd7['wExUI'])[_0x201380(0x1f1)]=stats[_0x201380(0x18f)],document[_0x201380(0x2a9)](_0x56fcd7[_0x201380(0x1d4)])[_0x201380(0x1f1)]=stats[_0x201380(0x228)],document[_0x201380(0x2a9)](_0x201380(0x118))['textContent']=stats['totalAttempted'];const _0x176c0f=_0x56fcd7[_0x201380(0x29c)](stats[_0x201380(0x118)],0x0)?Math[_0x201380(0x20a)](_0x56fcd7[_0x201380(0x1db)](stats[_0x201380(0x18f)]/stats[_0x201380(0x118)],0x64)):0x0;document['getElementById'](_0x56fcd7[_0x201380(0x2aa)])[_0x201380(0x1f1)]=_0x176c0f+'%',stats[_0x201380(0x17e)]=questionStates['reduce']((_0xf3055b,_0x1be961)=>_0xf3055b+_0x1be961[_0x201380(0x2fd)],0x0);const _0x12a4fe=Math[_0x201380(0x26b)](_0x56fcd7[_0x201380(0x264)](stats[_0x201380(0x17e)],0x3e8)),_0x572286=Math['floor'](_0x56fcd7[_0x201380(0x264)](_0x12a4fe,0x3c)),_0x2d1a19=_0x12a4fe%0x3c;document[_0x201380(0x2a9)](_0x56fcd7[_0x201380(0x2df)])[_0x201380(0x1f1)]=_0x56fcd7[_0x201380(0x367)](_0x572286+':',_0x2d1a19[_0x201380(0x2eb)]()[_0x201380(0x1c7)](0x2,'0'));}}function setupVideo(_0x182fd4,_0x24b15c){const _0x4227d9=_0x1c6435;if(Hls[_0x4227d9(0x297)]()){const _0x320c93=new Hls();_0x320c93['loadSource'](_0x24b15c),_0x320c93[_0x4227d9(0x37d)](_0x182fd4);}else _0x182fd4['canPlayType'](_0x4227d9(0x176))&&(_0x182fd4[_0x4227d9(0x306)]=_0x24b15c);}function displayQuestion(){const _0x31aacc=_0x1c6435,_0x4b05aa={'TTMap':function(_0x3f712c,_0x48416f){return _0x3f712c+_0x48416f;},'pSbxF':function(_0x57073a,_0x2ae1e7){return _0x57073a===_0x2ae1e7;},'XIYgu':_0x31aacc(0x353),'gzyet':_0x31aacc(0x241),'KUecb':'Option\x20','safPo':function(_0x325d07,_0x5506e1){return _0x325d07+_0x5506e1;},'JYpki':function(_0x2140f0,_0x17a0b4){return _0x2140f0(_0x17a0b4);},'IlPhD':_0x31aacc(0x1f3),'IpYXQ':function(_0x2386fd,_0x1f05a0){return _0x2386fd(_0x1f05a0);},'MVyKe':_0x31aacc(0x115),'AxNUC':_0x31aacc(0x3ba),'oTPsm':function(_0x1724bb,_0x266ab3){return _0x1724bb*_0x266ab3;},'LRKbA':function(_0x4a7a34,_0x1d442b){return _0x4a7a34/_0x1d442b;},'YqlVl':_0x31aacc(0x22b),'BgZah':'currentQuestion','FddWn':function(_0x133013,_0x8e7502){return _0x133013+_0x8e7502;},'UdbDE':function(_0x58b1c3){return _0x58b1c3();},'ALscc':_0x31aacc(0x1b0),'emcVA':function(_0x5b2c6b,_0x292854){return _0x5b2c6b===_0x292854;},'usQeq':'solutionContainer','rsopf':_0x31aacc(0x10c),'WhlDp':'optionsContainer','pfast':_0x31aacc(0xe8),'lEaKb':function(_0xa6de89){return _0xa6de89();},'gfYkF':function(_0x56ea5c,_0x381f5a){return _0x56ea5c===_0x381f5a;},'pqTpe':_0x31aacc(0x2bc),'HOveL':_0x31aacc(0x289)};if(!questionsData||_0x4b05aa['pSbxF'](questionsData['length'],0x0)){document[_0x31aacc(0x2a9)](_0x4b05aa[_0x31aacc(0x3c6)])[_0x31aacc(0x1e8)]=_0x4b05aa[_0x31aacc(0x226)];return;};const _0x54ebd6=questionsData[currentQuestionIndex];questionStartTime=Date[_0x31aacc(0x266)](),selectedOption=questionStates[currentQuestionIndex][_0x31aacc(0x3e8)];const _0x400c81=_0x4b05aa['oTPsm'](_0x4b05aa[_0x31aacc(0xed)](_0x4b05aa[_0x31aacc(0x1b6)](currentQuestionIndex,0x1),questionsData[_0x31aacc(0x2b4)]),0x64);document[_0x31aacc(0x2a9)](_0x4b05aa[_0x31aacc(0x1ad)])[_0x31aacc(0x2ce)]['width']=_0x4b05aa[_0x31aacc(0x2fb)](_0x400c81,'%'),document['getElementById'](_0x4b05aa[_0x31aacc(0x358)])['textContent']=_0x4b05aa[_0x31aacc(0x275)](currentQuestionIndex,0x1),_0x4b05aa[_0x31aacc(0x340)](updateQuestionNav),document[_0x31aacc(0x2a9)](_0x4b05aa['ALscc'])[_0x31aacc(0x20c)]=_0x4b05aa[_0x31aacc(0x361)](currentQuestionIndex,0x0),document[_0x31aacc(0x2a9)](_0x4b05aa[_0x31aacc(0x27c)])['classList'][_0x31aacc(0x19d)](_0x4b05aa[_0x31aacc(0x282)]),document[_0x31aacc(0x2a9)](_0x31aacc(0x115))[_0x31aacc(0x1e8)]=_0x54ebd6['text']||_0x31aacc(0x1a2);let _0x5759a6='';if(_0x54ebd6[_0x31aacc(0x169)])_0x5759a6+='<div\x20class=\x22glass-light\x20p-4\x20mb-4\x22><audio\x20src=\x22'+_0x54ebd6[_0x31aacc(0x169)]+_0x31aacc(0x154);if(_0x54ebd6[_0x31aacc(0x1b9)])_0x5759a6+='<div\x20class=\x22glass-light\x20p-4\x20mb-4\x22><video\x20src=\x22'+_0x54ebd6[_0x31aacc(0x1b9)]+_0x31aacc(0x178);_0x54ebd6[_0x31aacc(0x134)]&&_0x54ebd6[_0x31aacc(0x134)]['forEach'](_0x53a7d3=>{const _0x2e01cd=_0x31aacc;if(_0x53a7d3)_0x5759a6+='<div\x20class=\x22glass-light\x20p-4\x20mb-4\x22><img\x20src=\x22'+_0x53a7d3+_0x2e01cd(0x3cb);});document['getElementById'](_0x31aacc(0x268))[_0x31aacc(0x1e8)]=_0x5759a6;const _0x27f823=document[_0x31aacc(0x2a9)](_0x4b05aa['WhlDp']);_0x27f823[_0x31aacc(0x1e8)]='',_0x27f823[_0x31aacc(0x2f2)][_0x31aacc(0x31c)](_0x31aacc(0x207));_0x54ebd6[_0x31aacc(0x2a3)]&&Array[_0x31aacc(0xdb)](_0x54ebd6[_0x31aacc(0x2a3)])&&(_0x54ebd6['choices']['forEach']((_0x55c6e7,_0x155457)=>{const _0x4a5d0f=_0x31aacc,_0x20f94e=String['fromCharCode'](_0x4b05aa[_0x4a5d0f(0x2fb)](0x41,_0x155457)),_0x5b43dd=_0x4b05aa[_0x4a5d0f(0x347)](selectedOption,_0x155457),_0x4f9c51=document[_0x4a5d0f(0x2a1)](_0x4b05aa[_0x4a5d0f(0x3d0)]);_0x4f9c51['innerHTML']=_0x4a5d0f(0x304)+(_0x5b43dd?_0x4b05aa[_0x4a5d0f(0x218)]:'')+_0x4a5d0f(0x332)+_0x155457+_0x4a5d0f(0x245)+_0x20f94e+'</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22option-text\x22>'+(_0x55c6e7[_0x4a5d0f(0x147)]||_0x4b05aa[_0x4a5d0f(0x2fb)](_0x4b05aa['KUecb'],_0x4b05aa[_0x4a5d0f(0x1b6)](_0x155457,0x1)))+_0x4a5d0f(0x293),_0x27f823[_0x4a5d0f(0x1f7)](_0x4f9c51);}),_0x27f823[_0x31aacc(0x107)](_0x4b05aa[_0x31aacc(0x23a)],function(_0x124252){const _0x1c57cb=_0x31aacc,_0x1b16a1=_0x124252['target'][_0x1c57cb(0x379)](_0x1c57cb(0x39c));if(_0x1b16a1){const _0x259dff=_0x4b05aa[_0x1c57cb(0x2d6)](parseInt,_0x1b16a1[_0x1c57cb(0x191)](_0x4b05aa['IlPhD']));_0x4b05aa[_0x1c57cb(0x16b)](selectOption,_0x259dff);}}));_0x4b05aa['lEaKb'](updateBookmarkButton),_0x4b05aa[_0x31aacc(0x340)](updateMarkReviewButton);if((currentMode==='timed_study'||_0x4b05aa[_0x31aacc(0x31d)](currentMode,_0x4b05aa[_0x31aacc(0x27a)]))&&!isQuizCompleted){if(_0x4b05aa[_0x31aacc(0x2d0)]===_0x31aacc(0x190)){if(_0x3d47dd)_0x3a36b9+='<div\x20class=\x22glass-light\x20p-4\x20mb-4\x22><img\x20src=\x22'+_0x3329dc+_0x31aacc(0x3cb);}else _0x4b05aa[_0x31aacc(0x28d)](startTimer);}}function selectOption(_0x1fdbf7){const _0x56870e=_0x1c6435,_0x109a71={'VsZaw':function(_0x5d2836,_0x46bd4f){return _0x5d2836===_0x46bd4f;},'jRbEJ':_0x56870e(0x217),'BIQXA':_0x56870e(0x207),'yUPYP':function(_0x270f60,_0x2a1235){return _0x270f60-_0x2a1235;},'TAlJb':_0x56870e(0x24e),'NNjag':function(_0x116cec,_0x502906){return _0x116cec!==_0x502906;},'gMDSN':function(_0x1cb171,_0x533ced){return _0x1cb171===_0x533ced;}},_0x3f5b3e=document['getElementById'](_0x109a71[_0x56870e(0x219)]);if(_0x3f5b3e['classList'][_0x56870e(0x267)](_0x109a71[_0x56870e(0x2a5)]))return;questionStartTime&&(questionStates[currentQuestionIndex]['timeSpent']+=_0x109a71[_0x56870e(0x3a3)](Date[_0x56870e(0x266)](),questionStartTime),questionStartTime=Date[_0x56870e(0x266)]()),selectedOption=_0x1fdbf7,questionStates[currentQuestionIndex][_0x56870e(0x3e8)]=_0x1fdbf7,document[_0x56870e(0x3b7)](_0x56870e(0x39c))[_0x56870e(0x3e4)]((_0x128cea,_0x27835a)=>{const _0x113e4b=_0x56870e;_0x128cea['classList']['toggle'](_0x113e4b(0x241),_0x109a71[_0x113e4b(0x3e5)](_0x27835a,_0x1fdbf7));}),_0x109a71['VsZaw'](currentMode,_0x56870e(0x128))||currentMode===_0x109a71[_0x56870e(0x30d)]?_0x109a71[_0x56870e(0x37e)](_0x56870e(0x35e),'AtqJT')?processAnswer():(_0x2ec162[_0x6d5f02][_0x56870e(0x3b6)]===_0x56870e(0x28c)&&(_0x1272d0[_0x1915b2][_0x56870e(0x3b6)]=_0x56870e(0x207),_0x3fc616[_0x56870e(0x118)]++,_0x568a58[_0x56870e(0x1f4)]--),_0x5afc22()):(_0x109a71[_0x56870e(0xf6)](questionStates[currentQuestionIndex]['status'],_0x56870e(0x28c))&&(questionStates[currentQuestionIndex][_0x56870e(0x3b6)]=_0x109a71[_0x56870e(0x2a5)],stats['totalAttempted']++,stats['notAttempted']--),updateQuestionNav()),saveProgress();}function processAnswer(){const _0x3d4ca3=_0x1c6435,_0x4759c6={'CcMTG':function(_0x533f60,_0x398b32){return _0x533f60===_0x398b32;},'fQhvh':function(_0xe6358d,_0x26875e){return _0xe6358d===_0x26875e;},'PpKtd':_0x3d4ca3(0x28c),'Ogclm':_0x3d4ca3(0x2af),'hnuxf':function(_0x2f4632){return _0x2f4632();},'bBhPi':function(_0x44f816,_0x2f1757){return _0x44f816(_0x2f1757);},'yDMXn':function(_0x3c8ea4){return _0x3c8ea4();}},_0x267ac5=questionsData[currentQuestionIndex],_0x4d6f34=_0x267ac5['correct_choice_id'];if(_0x4759c6[_0x3d4ca3(0x2f0)](selectedOption,null))return;const _0x2465f3=_0x267ac5['choices'][selectedOption],_0x2ff4b2=_0x4759c6[_0x3d4ca3(0x132)](_0x2465f3['id'],_0x4d6f34);if(_0x4759c6[_0x3d4ca3(0x132)](questionStates[currentQuestionIndex][_0x3d4ca3(0x3b6)],_0x4759c6[_0x3d4ca3(0x3c2)])){stats[_0x3d4ca3(0x118)]++,stats[_0x3d4ca3(0x1f4)]--;if(_0x2ff4b2)stats['correctAnswers']++;else stats[_0x3d4ca3(0x228)]++;}questionStates[currentQuestionIndex][_0x3d4ca3(0x3b6)]=_0x2ff4b2?_0x3d4ca3(0x3a5):_0x4759c6[_0x3d4ca3(0x1b7)],_0x4759c6[_0x3d4ca3(0x323)](updateStats),_0x4759c6[_0x3d4ca3(0x321)](showInlineFeedback,_0x2ff4b2),_0x4759c6[_0x3d4ca3(0x1ed)](updateQuestionNav);}function showInlineFeedback(_0xc027a5){const _0x1b5a26=_0x1c6435,_0x2a231b={'fvTnH':'selected','MPCIc':function(_0x5d1d48,_0x182e63){return _0x5d1d48===_0x182e63;},'qRCbl':_0x1b5a26(0x3a5),'DkFrj':'incorrect','tOXQG':function(_0x1c2026,_0x973dc2){return _0x1c2026!==_0x973dc2;},'GOGqV':'timed_study','BkhWj':_0x1b5a26(0x217),'FMZms':_0x1b5a26(0x39c),'oRdYi':'answered'};if(_0x2a231b[_0x1b5a26(0x205)](currentMode,'study')&&_0x2a231b['tOXQG'](currentMode,_0x2a231b[_0x1b5a26(0x2e7)]))return;const _0x40d256=document[_0x1b5a26(0x2a9)](_0x2a231b[_0x1b5a26(0x158)]),_0x403a40=_0x40d256[_0x1b5a26(0x3b7)](_0x2a231b['FMZms']),_0x4bab2c=questionsData[currentQuestionIndex],_0x1614c4=_0x4bab2c[_0x1b5a26(0x249)];let _0xc8c129=_0x4bab2c[_0x1b5a26(0x2a3)][_0x1b5a26(0x101)](_0x15e205=>_0x15e205['id']===_0x1614c4);_0x40d256[_0x1b5a26(0x2f2)][_0x1b5a26(0x19d)](_0x2a231b[_0x1b5a26(0x1e4)]),_0x403a40[_0x1b5a26(0x3e4)]((_0x4d0ee4,_0x4bde92)=>{const _0xf16021=_0x1b5a26;_0x4d0ee4[_0xf16021(0x2f2)][_0xf16021(0x31c)](_0x2a231b[_0xf16021(0x110)]);if(_0x2a231b[_0xf16021(0x342)](_0x4bde92,_0xc8c129))_0x4d0ee4[_0xf16021(0x2f2)][_0xf16021(0x19d)](_0x2a231b[_0xf16021(0x2a7)]);else{if(_0x4bde92===selectedOption&&!_0xc027a5)_0x4d0ee4['classList'][_0xf16021(0x19d)](_0x2a231b[_0xf16021(0x106)]);}}),showSolution();}function showSolution(){const _0x49b710=_0x1c6435,_0x25d583={'TPlvW':function(_0x47c68d,_0x325355){return _0x47c68d<_0x325355;},'AgSct':'bookmarkedQuestions','AusJq':function(_0x5dc0df,_0xc35ebf){return _0x5dc0df===_0xc35ebf;},'gajzX':_0x49b710(0x1df),'GQnjt':_0x49b710(0x1a8),'KMYHk':_0x49b710(0x2ab),'IpJMr':function(_0x5c8fd3,_0x2d1094){return _0x5c8fd3+_0x2d1094;},'hPjJy':_0x49b710(0x176),'jRxMr':'solutionText','PkcJF':_0x49b710(0x1bd),'woVKO':_0x49b710(0x27f),'ZzOpN':_0x49b710(0x10c),'dObLx':_0x49b710(0x355),'BoXtp':function(_0x5cfc7d,_0x7aa0d0,_0x559b02){return _0x5cfc7d(_0x7aa0d0,_0x559b02);},'jHZIy':function(_0x574bd5,_0x1fec92){return _0x574bd5!==_0x1fec92;},'jWULK':_0x49b710(0x103),'goFcg':_0x49b710(0x210),'TLxwW':_0x49b710(0x2e6),'ceyQw':_0x49b710(0x1d1)};if(currentMode!==_0x49b710(0x128)&&currentMode!==_0x49b710(0x24e))return;const _0x181a06=questionsData[currentQuestionIndex];document[_0x49b710(0x2a9)](_0x25d583[_0x49b710(0x3c0)])[_0x49b710(0x1e8)]=_0x181a06[_0x49b710(0x30a)]||_0x49b710(0x3b2);const _0x418e79=document['getElementById']('solutionVideo'),_0x403498=document[_0x49b710(0x2a9)](_0x25d583[_0x49b710(0x18d)]),_0x2fcab9=_0x181a06['explanation_video'];if(_0x2fcab9){if(_0x25d583[_0x49b710(0x2c6)](_0x25d583[_0x49b710(0x3d1)],_0x25d583[_0x49b710(0x3d1)])){_0x418e79[_0x49b710(0x2f2)][_0x49b710(0x31c)](_0x25d583[_0x49b710(0x1f8)]);if(_0x2fcab9['includes'](_0x25d583['dObLx']))_0x25d583['BoXtp'](setupVideo,_0x403498,_0x2fcab9);else _0x403498[_0x49b710(0x306)]=_0x2fcab9;}else{const _0x4014c5=_0x1ea05f['parse'](_0x460746['getItem'](_0x25d583[_0x49b710(0x1d5)]))||[];_0x4014c5['forEach'](_0xcec0c9=>{const _0x3235cc=_0x49b710;_0xcec0c9['quizFile']['includes'](_0x18bc9d[_0x3235cc(0x36a)]()['replace'](/ /g,'-'))&&(_0x25d583[_0x3235cc(0x387)](_0xcec0c9[_0x3235cc(0x14c)],_0x618613[_0x3235cc(0x2b4)])&&(_0x5b139b[_0xcec0c9[_0x3235cc(0x14c)]][_0x3235cc(0x23f)]=!![]));});}}else _0x418e79[_0x49b710(0x2f2)][_0x49b710(0x19d)](_0x25d583[_0x49b710(0x1f8)]);const _0x560816=document[_0x49b710(0x2a9)]('solutionAudio');_0x560816[_0x49b710(0x1e8)]='';_0x181a06['explanation_audio_eng']&&(_0x560816[_0x49b710(0x1e8)]+='<div\x20class=\x22mt-2\x22><p\x20class=\x22text-sm\x20text-white\x20text-opacity-70\x20mb-1\x22>English\x20Explanation:</p><audio\x20src=\x22'+_0x181a06[_0x49b710(0x32c)]+_0x49b710(0x154));if(_0x181a06['explanation_audio_hin']){if(_0x25d583[_0x49b710(0xeb)](_0x49b710(0x103),_0x25d583[_0x49b710(0x371)])){const _0x14974f=_0x361014[_0x49b710(0x3e8)]===_0x92d8ca,_0x12dd6c=_0x25d583[_0x49b710(0x2c6)](_0x90ac9b['id'],_0x11a3d6);let _0x2abfe8=_0x25d583[_0x49b710(0x39d)];if(_0x12dd6c)_0x2abfe8=_0x25d583[_0x49b710(0x1f5)];else{if(_0x14974f)_0x2abfe8=_0x25d583[_0x49b710(0x378)];}return _0x49b710(0x384)+_0x2abfe8+_0x49b710(0x1e1)+_0x53b2ae[_0x49b710(0x33a)](_0x25d583['IpJMr'](0x41,_0x5f0b07))+_0x49b710(0x2dc)+_0x37e5d3[_0x49b710(0x147)]+_0x49b710(0x202);}else _0x560816[_0x49b710(0x1e8)]+=_0x49b710(0xf8)+_0x181a06[_0x49b710(0x172)]+'\x22\x20controls\x20class=\x22w-full\x22></audio></div>';}const _0x33582b=document[_0x49b710(0x2a9)](_0x25d583[_0x49b710(0x37b)]);_0x33582b['innerHTML']='';if(_0x181a06[_0x49b710(0x3b8)]){if(_0x49b710(0x1f2)!==_0x25d583[_0x49b710(0x125)])_0x181a06[_0x49b710(0x3b8)][_0x49b710(0x3e4)](_0x1f3e55=>{const _0x5401ea=_0x49b710;if(_0x1f3e55)_0x33582b[_0x5401ea(0x1e8)]+=_0x5401ea(0x277)+_0x1f3e55+'\x22\x20alt=\x22Explanation\x20Image\x22\x20class=\x22w-full\x20rounded-lg\x22></div>';});else{if(_0x1ee759[_0x49b710(0x297)]()){const _0x134a36=new _0x127fb8();_0x134a36[_0x49b710(0x3e7)](_0x21f6a3),_0x134a36[_0x49b710(0x37d)](_0x285910);}else _0x222ff8['canPlayType'](_0x25d583[_0x49b710(0x334)])&&(_0x54afa4['src']=_0x46a198);}}document[_0x49b710(0x2a9)](_0x25d583['ceyQw'])[_0x49b710(0x2f2)][_0x49b710(0x31c)](_0x25d583[_0x49b710(0x1f8)]);}function submitQuiz(){const _0x454371=_0x1c6435,_0x59186b={'ZFevY':function(_0x26c4c3,_0x3fb4bf){return _0x26c4c3===_0x3fb4bf;},'LMGLx':_0x454371(0x35c),'HwTPv':function(_0x36fe59,_0x523f0f){return _0x36fe59===_0x523f0f;},'PwVkS':_0x454371(0x181),'YeSym':_0x454371(0x142),'ndTNK':function(_0x294ef9,_0x1e74f6){return _0x294ef9===_0x1e74f6;},'oEalv':_0x454371(0x3a5),'quvEe':function(_0x2e536e,_0x354c7d){return _0x2e536e(_0x354c7d);},'YjItz':_0x454371(0x357),'LFQaH':function(_0x60cff1,_0x71add0){return _0x60cff1-_0x71add0;},'iUKTk':function(_0x2ae8f4,_0x26b646){return _0x2ae8f4+_0x26b646;},'xtXoc':_0x454371(0x20f),'gKHrN':function(_0x1b5142){return _0x1b5142();},'hBRST':function(_0x1f9399,_0x292632,_0x352cff,_0x362d70,_0x572011){return _0x1f9399(_0x292632,_0x352cff,_0x362d70,_0x572011);},'mGtcn':function(_0x477003,_0xcc17bf){return _0x477003+_0xcc17bf;}};if(timer)_0x59186b['quvEe'](clearInterval,timer);if(!confirm(_0x59186b[_0x454371(0x31a)]))return;isQuizCompleted=!![];let _0x5175f6=0x0,_0x3bf7a9=0x0;const _0x428fbd=_0x59186b[_0x454371(0x1c0)](Date['now'](),quizStartTime);questionsData[_0x454371(0x3e4)]((_0x2d1fdc,_0x25e54d)=>{const _0x4a6589=_0x454371;if(_0x59186b[_0x4a6589(0x243)](_0x4a6589(0x35c),_0x59186b[_0x4a6589(0xd9)])){const _0x46baf5=questionStates[_0x25e54d];_0x46baf5[_0x4a6589(0x3e8)]!==null&&(_0x59186b['HwTPv'](_0x59186b[_0x4a6589(0x25a)],_0x59186b[_0x4a6589(0x2c8)])?_0x15cab0[_0x4a6589(0x306)]=_0x11a106:_0x59186b['ndTNK'](_0x2d1fdc['choices'][_0x46baf5[_0x4a6589(0x3e8)]]['id'],_0x2d1fdc[_0x4a6589(0x249)])?(_0x5175f6++,_0x46baf5[_0x4a6589(0x3b6)]=_0x59186b[_0x4a6589(0x314)]):(_0x3bf7a9++,_0x46baf5[_0x4a6589(0x3b6)]=_0x4a6589(0x2af)));}else{const _0x302b6d=new _0x66d9b1();_0x302b6d['loadSource'](_0x4944f6),_0x302b6d['attachMedia'](_0x57ab95);}});const _0x362ed3=JSON[_0x454371(0x1a4)](localStorage[_0x454371(0x1f6)]('quizPerformanceData'))||[];_0x362ed3['push']({'quizName':quizName,'hierarchy':hierarchy,'timestamp':Date[_0x454371(0x266)](),'totalTime':_0x428fbd,'stats':{'correct':_0x5175f6,'incorrect':_0x3bf7a9,'notAttempted':_0x59186b['LFQaH'](questionsData['length'],_0x59186b[_0x454371(0x274)](_0x5175f6,_0x3bf7a9))}}),localStorage[_0x454371(0x276)](_0x59186b[_0x454371(0x285)],JSON['stringify'](_0x362ed3)),stats['correctAnswers']=_0x5175f6,stats['incorrectAnswers']=_0x3bf7a9,_0x59186b[_0x454371(0x16d)](markQuizAsCompleted),_0x59186b[_0x454371(0x331)](showPerformanceAnalysis,_0x5175f6,_0x3bf7a9,_0x59186b[_0x454371(0x1c0)](questionsData[_0x454371(0x2b4)],_0x59186b[_0x454371(0xea)](_0x5175f6,_0x3bf7a9)),_0x428fbd);}function showPerformanceAnalysis(_0x1e5302,_0x56f062,_0xd53736,_0x384bb6){const _0x412677=_0x1c6435,_0x3e5614={'MTDlB':_0x412677(0x1c6),'LDsLU':function(_0x26e539,_0x6eb738){return _0x26e539+_0x6eb738;},'zlVzV':function(_0x51fab5,_0x5aed6f){return _0x51fab5/_0x5aed6f;},'VIjpA':_0x412677(0x3bf),'jFQHE':function(_0x216fdd,_0x4a6d8b){return _0x216fdd-_0x4a6d8b;},'qbJys':_0x412677(0x20b),'rTqwK':'correctResult','ndoHW':_0x412677(0x324),'JPTlI':_0x412677(0x140),'LWHyY':function(_0x5a8759,_0x14f4d1){return _0x5a8759/_0x14f4d1;},'AgTEK':function(_0x40e678,_0x5a3cca){return _0x40e678%_0x5a3cca;},'VEmVL':_0x412677(0x13b),'CAnbi':function(_0xc68f27,_0x24058b){return _0xc68f27/_0x24058b;},'JDDHP':_0x412677(0x24f),'OIoll':_0x412677(0x10c)},_0x19bf29=document[_0x412677(0x2a9)](_0x3e5614[_0x412677(0x254)]),_0x1ad0cb=_0x3e5614[_0x412677(0x213)](_0x1e5302,_0x56f062)>0x0?Math[_0x412677(0x20a)](_0x3e5614[_0x412677(0x12a)](_0x1e5302,_0x1e5302+_0x56f062)*0x64):0x0,_0x4d79ec=0x2*Math['PI']*0x41,_0x28b55b=document[_0x412677(0x2a9)](_0x3e5614[_0x412677(0x253)]);_0x28b55b['style'][_0x412677(0x198)]=_0x4d79ec+'\x20'+_0x4d79ec,_0x28b55b['style']['strokeDashoffset']=_0x3e5614[_0x412677(0x175)](_0x4d79ec,_0x1ad0cb/0x64*_0x4d79ec),document[_0x412677(0x2a9)](_0x3e5614[_0x412677(0x10d)])[_0x412677(0x1f1)]=_0x1ad0cb+'%',document[_0x412677(0x2a9)](_0x412677(0x212))['textContent']=questionsData[_0x412677(0x2b4)],document['getElementById'](_0x3e5614[_0x412677(0x1d9)])[_0x412677(0x1f1)]=_0x1e5302,document['getElementById'](_0x3e5614[_0x412677(0x2ac)])['textContent']=_0x56f062,document[_0x412677(0x2a9)](_0x3e5614[_0x412677(0x3ae)])[_0x412677(0x1f1)]=_0xd53736;const _0x217387=Math[_0x412677(0x26b)](_0x3e5614[_0x412677(0x17b)](_0x384bb6,0xea60)),_0x47224a=Math[_0x412677(0x26b)](_0x3e5614[_0x412677(0x17b)](_0x3e5614[_0x412677(0x15f)](_0x384bb6,0xea60),0x3e8));document[_0x412677(0x2a9)](_0x3e5614[_0x412677(0x21b)])['textContent']=_0x217387+':'+_0x47224a[_0x412677(0x2eb)]()['padStart'](0x2,'0');const _0x26a53d=_0x3e5614[_0x412677(0x17d)](_0x384bb6,questionsData[_0x412677(0x2b4)]),_0x3bfb1f=Math[_0x412677(0x26b)](_0x3e5614[_0x412677(0x17b)](_0x26a53d,0xea60)),_0x183632=Math['floor'](_0x3e5614[_0x412677(0x17b)](_0x3e5614[_0x412677(0x15f)](_0x26a53d,0xea60),0x3e8));document[_0x412677(0x2a9)](_0x3e5614['JDDHP'])[_0x412677(0x1f1)]=_0x3bfb1f+':'+_0x183632[_0x412677(0x2eb)]()[_0x412677(0x1c7)](0x2,'0'),_0x19bf29['classList']['remove'](_0x3e5614['OIoll']);}function closePerformanceModal(){const _0x57d3c7=_0x1c6435,_0x382e2f={'FhYkg':'performanceModal','MGJlQ':_0x57d3c7(0x10c)};document[_0x57d3c7(0x2a9)](_0x382e2f[_0x57d3c7(0x12d)])['classList'][_0x57d3c7(0x19d)](_0x382e2f[_0x57d3c7(0x1ca)]);}function reviewQuestions(){const _0xe9fb0c=_0x1c6435,_0x2636f7={'UdmLe':function(_0x40c10d,_0x2cb381){return _0x40c10d(_0x2cb381);},'wQsHN':_0xe9fb0c(0x1f3),'TmcfP':'BZDmK','OTkBF':function(_0x2900da,_0xc36dd7){return _0x2900da===_0xc36dd7;},'suOah':'border-gray-600','IONBv':_0xe9fb0c(0x1a8),'qcAfL':function(_0x4c802c,_0x3abffd){return _0x4c802c+_0x3abffd;},'feoUA':function(_0x40a52e,_0x15429c){return _0x40a52e!==_0x15429c;},'bzBNw':_0xe9fb0c(0x216),'ELGJg':_0xe9fb0c(0x17c),'SPABU':_0xe9fb0c(0x2a4),'ELkoh':_0xe9fb0c(0x35a),'YYzrV':function(_0x1998ae,_0x4ebbe2){return _0x1998ae!==_0x4ebbe2;},'weiJI':function(_0x33741d,_0x1c6162){return _0x33741d===_0x1c6162;},'trLFu':_0xe9fb0c(0x3ec),'IsYJz':_0xe9fb0c(0x3a5),'ATGgN':_0xe9fb0c(0x2dd),'IDgOs':_0xe9fb0c(0x2af),'GTJwo':'Incorrect','avKZD':function(_0x3988fb,_0x491421){return _0x3988fb+_0x491421;},'Rfmqx':_0xe9fb0c(0xde),'XKCwV':_0xe9fb0c(0x265),'KGpEL':'No\x20solution\x20available.','KIeWb':'reviewQuestionsContainer','XCLzO':function(_0x1f8848){return _0x1f8848();}};document[_0xe9fb0c(0x2a9)](_0xe9fb0c(0x1ef))[_0xe9fb0c(0x2f2)][_0xe9fb0c(0x31c)](_0xe9fb0c(0x10c));const _0x4170d2=document['getElementById'](_0x2636f7[_0xe9fb0c(0xd7)]);_0x4170d2[_0xe9fb0c(0x1e8)]='',questionsData[_0xe9fb0c(0x3e4)]((_0x5ef68e,_0x7984d8)=>{const _0x15e53f=_0xe9fb0c,_0x1b626a={'sdqPZ':function(_0x13bc4e,_0x1d74ea){const _0x210284=_0x3f36;return _0x2636f7[_0x210284(0x2a2)](_0x13bc4e,_0x1d74ea);},'jbFCy':_0x2636f7[_0x15e53f(0x1ab)],'PZysf':function(_0x1a4076,_0x1144bd){return _0x1a4076(_0x1144bd);},'APhcZ':function(_0x233513,_0x4e3547){return _0x233513-_0x4e3547;},'HZKex':function(_0x3f5665,_0x274c5d){return _0x3f5665!==_0x274c5d;},'NcaPN':_0x2636f7[_0x15e53f(0x3a7)],'UGoTb':function(_0x36a3aa,_0x5cec4c){return _0x2636f7['OTkBF'](_0x36a3aa,_0x5cec4c);},'nEGtr':_0x2636f7[_0x15e53f(0x32d)],'yILyV':_0x2636f7['IONBv'],'JCfWs':'border-red-500','doUNi':function(_0x3f9285,_0x5bfb2c){const _0x1f20c8=_0x15e53f;return _0x2636f7[_0x1f20c8(0x37a)](_0x3f9285,_0x5bfb2c);}};if(_0x2636f7[_0x15e53f(0x23c)](_0x2636f7[_0x15e53f(0x21c)],_0x2636f7[_0x15e53f(0x155)])){const _0xd3d770=questionStates[_0x7984d8],_0x487df7=_0x5ef68e['correct_choice_id'];let _0x57c34a=_0x2636f7['SPABU'],_0x4fbe0e=_0x2636f7[_0x15e53f(0x2bd)];if(_0x2636f7[_0x15e53f(0x301)](_0xd3d770[_0x15e53f(0x3e8)],null)){const _0x4ba46c=_0x5ef68e[_0x15e53f(0x2a3)][_0xd3d770[_0x15e53f(0x3e8)]];if(_0x2636f7[_0x15e53f(0x270)](_0x4ba46c['id'],_0x487df7)){if(_0x2636f7[_0x15e53f(0x2c5)](_0x2636f7[_0x15e53f(0x393)],_0x2636f7[_0x15e53f(0x393)]))_0x57c34a=_0x2636f7[_0x15e53f(0x13f)],_0x4fbe0e=_0x2636f7['ATGgN'];else{const _0x37345f=_0x1b626a[_0x15e53f(0x15b)](_0x1b9071,_0x1bdfb2[_0x15e53f(0x191)](_0x1b626a[_0x15e53f(0x37f)]));_0x1b626a['PZysf'](_0x5b7fc1,_0x37345f);}}else _0x57c34a=_0x2636f7[_0x15e53f(0xda)],_0x4fbe0e=_0x2636f7['GTJwo'];}const _0x43b8c0=document[_0x15e53f(0x2a1)]('div');_0x43b8c0[_0x15e53f(0x2f7)]=_0x15e53f(0x34c)+_0x57c34a;let _0x4572d0=(_0x5ef68e['choices']||[])[_0x15e53f(0x113)]((_0x97de37,_0x5188e0)=>{const _0x6b90d4=_0x15e53f,_0x5b4a82={'itBOG':function(_0x10bf3f,_0x5abdff){const _0x7db9be=_0x3f36;return _0x1b626a[_0x7db9be(0x13a)](_0x10bf3f,_0x5abdff);}};if(_0x1b626a[_0x6b90d4(0x21f)](_0x1b626a[_0x6b90d4(0x204)],_0x1b626a[_0x6b90d4(0x204)]))_0x22820d[_0xc0a750]['timeSpent']+=_0x5b4a82[_0x6b90d4(0x32f)](_0xba632a[_0x6b90d4(0x266)](),_0x4e59ab);else{const _0x3bd598=_0x1b626a[_0x6b90d4(0x391)](_0xd3d770[_0x6b90d4(0x3e8)],_0x5188e0),_0x3f2356=_0x97de37['id']===_0x487df7;let _0x41cfa8=_0x1b626a[_0x6b90d4(0x14a)];if(_0x3f2356)_0x41cfa8=_0x1b626a[_0x6b90d4(0x1c4)];else{if(_0x3bd598)_0x41cfa8=_0x1b626a[_0x6b90d4(0x10a)];}return _0x6b90d4(0x384)+_0x41cfa8+_0x6b90d4(0x1e1)+String[_0x6b90d4(0x33a)](_0x1b626a['doUNi'](0x41,_0x5188e0))+_0x6b90d4(0x2dc)+_0x97de37['text']+_0x6b90d4(0x202);}})[_0x15e53f(0x3a4)]('');const _0x462af5=_0x5ef68e[_0x15e53f(0x239)]?_0x15e53f(0x137)+_0x7984d8+_0x15e53f(0x2cc)+_0x5ef68e[_0x15e53f(0x239)]+_0x15e53f(0x14f):'';let _0x1af8ad='';if(_0x5ef68e[_0x15e53f(0x32c)])_0x1af8ad+=_0x15e53f(0x1de)+_0x5ef68e[_0x15e53f(0x32c)]+_0x15e53f(0x154);if(_0x5ef68e['explanation_audio_hin'])_0x1af8ad+=_0x15e53f(0x3bb)+_0x5ef68e[_0x15e53f(0x172)]+'\x22\x20controls\x20class=\x22w-full\x22></audio></div>';let _0x4058df=(_0x5ef68e[_0x15e53f(0x3b8)]||[])[_0x15e53f(0x113)](_0x5de4b0=>_0x5de4b0?'<div\x20class=\x22mt-4\x22><img\x20src=\x22'+_0x5de4b0+'\x22\x20alt=\x22Explanation\x20Image\x22\x20class=\x22w-full\x20rounded-lg\x22></div>':'')[_0x15e53f(0x3a4)]('');_0x43b8c0[_0x15e53f(0x1e8)]='\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22mb-4\x22>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22flex\x20justify-between\x20items-center\x20mb-3\x22>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<h4\x20class=\x22text-lg\x20font-bold\x20text-white\x22>Question\x20'+_0x2636f7[_0x15e53f(0x1eb)](_0x7984d8,0x1)+_0x15e53f(0x238)+(_0x2636f7['OTkBF'](_0x57c34a,_0x15e53f(0x3a5))?_0x2636f7[_0x15e53f(0x33c)]:_0x2636f7[_0x15e53f(0x270)](_0x57c34a,_0x2636f7[_0x15e53f(0xda)])?_0x2636f7[_0x15e53f(0x222)]:'gray')+_0x15e53f(0x2b9)+_0x4fbe0e+_0x15e53f(0x148)+_0x5ef68e[_0x15e53f(0x147)]+_0x15e53f(0x3be)+_0x4572d0+_0x15e53f(0x3d6)+(_0x5ef68e[_0x15e53f(0x30a)]||_0x2636f7['KGpEL'])+_0x15e53f(0x3bd)+_0x462af5+'\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20'+_0x1af8ad+_0x15e53f(0x180)+_0x4058df+_0x15e53f(0x11a),_0x4170d2[_0x15e53f(0x1f7)](_0x43b8c0);}else{if(_0x670283){const _0x4fb6c6=_0x1609ab[_0x15e53f(0xdc)](_0x3e4765,arguments);return _0x557eb5=null,_0x4fb6c6;}}}),_0x2636f7['XCLzO'](initializeReviewVideos);}function initializeReviewVideos(){const _0x564b84=_0x1c6435,_0x5ec90e={'vtTQf':function(_0x42f7a3){return _0x42f7a3();},'oiWrN':_0x564b84(0x355),'ZPFDv':_0x564b84(0x27d),'cBYEW':function(_0x3b2d5f,_0x500255,_0x45a41d){return _0x3b2d5f(_0x500255,_0x45a41d);},'pSkCd':function(_0x386cbe,_0x3862d9){return _0x386cbe!==_0x3862d9;},'IYIOX':_0x564b84(0x278)};document[_0x564b84(0x3b7)](_0x564b84(0x109))[_0x564b84(0x3e4)](_0x46d9c3=>{const _0x355f30=_0x564b84,_0x1c7f14=_0x46d9c3['dataset'][_0x355f30(0x306)];if(_0x1c7f14&&_0x1c7f14['includes'](_0x5ec90e['oiWrN']))_0x5ec90e['ZPFDv']!==_0x355f30(0xfc)?_0x5ec90e[_0x355f30(0x3b0)](setupVideo,_0x46d9c3,_0x1c7f14):(_0x6ac68f[_0x355f30(0x34b)](),_0x5ec90e['vtTQf'](_0x46c2b0));else{if(_0x1c7f14){if(_0x5ec90e['pSkCd'](_0x5ec90e[_0x355f30(0x284)],_0x355f30(0xd5)))_0x46d9c3[_0x355f30(0x306)]=_0x1c7f14;else{const _0x1c2bcd=_0x21766b[_0x355f30(0x311)]['prototype'][_0x355f30(0x13c)](_0x3783ac),_0x170382=_0x32c3dd[_0x516215],_0x39045c=_0x23f5d8[_0x170382]||_0x1c2bcd;_0x1c2bcd[_0x355f30(0x1be)]=_0x1ffdad[_0x355f30(0x13c)](_0x298918),_0x1c2bcd['toString']=_0x39045c[_0x355f30(0x2eb)]['bind'](_0x39045c),_0x480a35[_0x170382]=_0x1c2bcd;}}}});}function retakeQuiz(){const _0x49a168=_0x1c6435,_0xd23911={'fBJBg':function(_0x45f25d,_0x3d192c){return _0x45f25d(_0x3d192c);},'dZIYW':_0x49a168(0x15d),'tIhxV':'customQuizData','qIiIO':function(_0x4f4739){return _0x4f4739();}};_0xd23911[_0x49a168(0x1af)](confirm,_0x49a168(0x244))&&(window['location'][_0x49a168(0x27e)][_0x49a168(0xdd)](_0xd23911[_0x49a168(0x224)])&&localStorage[_0x49a168(0x360)](_0xd23911[_0x49a168(0x307)]),_0xd23911[_0x49a168(0x120)](clearProgress),location[_0x49a168(0x2e9)]());}function loadBookmarkedQuestions(){const _0xb5343c=_0x1c6435,_0x2d0a60={'IzAGg':function(_0x486226,_0x6505bf){return _0x486226-_0x6505bf;},'JGQLk':function(_0x32f28d,_0xed730){return _0x32f28d<_0xed730;},'ockAX':function(_0x51737b,_0x372f0b){return _0x51737b<_0x372f0b;},'mmqRe':_0xb5343c(0x1fe),'yseSp':_0xb5343c(0x1a3)},_0x250c80=JSON[_0xb5343c(0x1a4)](localStorage['getItem'](_0x2d0a60[_0xb5343c(0x170)]))||[];_0x250c80['forEach'](_0xd44d2e=>{const _0x250e5c=_0xb5343c,_0x4e7b02={'PULso':function(_0x59dd32,_0x285519){const _0x259f75=_0x3f36;return _0x2d0a60[_0x259f75(0xec)](_0x59dd32,_0x285519);},'PVOLD':function(_0x4417b6,_0x2acc76){return _0x4417b6(_0x2acc76);},'xGUIv':'.option-button','ufXDp':function(_0x17aa06,_0x5bc07b){const _0x5a77c3=_0x3f36;return _0x2d0a60[_0x5a77c3(0x376)](_0x17aa06,_0x5bc07b);}};if(_0xd44d2e['quizFile'][_0x250e5c(0x1dd)](quizName[_0x250e5c(0x36a)]()[_0x250e5c(0x2ba)](/ /g,'-'))){if(_0x2d0a60['ockAX'](_0xd44d2e[_0x250e5c(0x14c)],questionsData[_0x250e5c(0x2b4)])){if(_0x2d0a60[_0x250e5c(0x2de)]!==_0x250e5c(0x32a))questionStates[_0xd44d2e[_0x250e5c(0x14c)]][_0x250e5c(0x23f)]=!![];else{const _0x3dabeb=_0x4e7b02[_0x250e5c(0x143)](_0x4e7b02[_0x250e5c(0x2e0)](_0x2a5526,_0x2a8c93[_0x250e5c(0x345)]),0x1),_0x293a54=_0x327b43[_0x250e5c(0x3b7)](_0x4e7b02[_0x250e5c(0x24b)]);if(_0x4e7b02[_0x250e5c(0x233)](_0x3dabeb,_0x293a54[_0x250e5c(0x2b4)]))_0x4e7b02[_0x250e5c(0x2e0)](_0x143512,_0x3dabeb);}}}});}function toggleBookmark(){const _0x3316b7=_0x1c6435,_0x3bc5c1={'yNzHK':'.m3u8','UqaCW':function(_0x1f96a9,_0x585add,_0x5ca93f){return _0x1f96a9(_0x585add,_0x5ca93f);},'EPKeG':'video[data-src]','JGMtc':_0x3316b7(0x1a3),'ggsCN':_0x3316b7(0x372),'VxdLT':function(_0x28db8c){return _0x28db8c();}},_0x453cb1=!questionStates[currentQuestionIndex][_0x3316b7(0x23f)];questionStates[currentQuestionIndex][_0x3316b7(0x23f)]=_0x453cb1;let _0x321269=JSON[_0x3316b7(0x1a4)](localStorage[_0x3316b7(0x1f6)](_0x3bc5c1['JGMtc']))||[];if(_0x453cb1){if(_0x3bc5c1[_0x3316b7(0xff)]!==_0x3316b7(0x372)){const _0x1d896c={'MmiPK':_0x3bc5c1['yNzHK'],'AZejq':function(_0x157604,_0x4d66d7,_0x2b3001){const _0x23edfc=_0x3316b7;return _0x3bc5c1[_0x23edfc(0x260)](_0x157604,_0x4d66d7,_0x2b3001);}};_0x559c27[_0x3316b7(0x3b7)](_0x3bc5c1['EPKeG'])[_0x3316b7(0x3e4)](_0x4ae72c=>{const _0x51ffef=_0x3316b7,_0x2bd4aa=_0x4ae72c[_0x51ffef(0x30b)][_0x51ffef(0x306)];if(_0x2bd4aa&&_0x2bd4aa['includes'](_0x1d896c[_0x51ffef(0x3d4)]))_0x1d896c[_0x51ffef(0x177)](_0x2c90d5,_0x4ae72c,_0x2bd4aa);else _0x2bd4aa&&(_0x4ae72c[_0x51ffef(0x306)]=_0x2bd4aa);});}else{const _0x2df656={'quizName':quizName,'quizFile':window['location']['pathname'][_0x3316b7(0x1c3)]('/')[_0x3316b7(0xe0)](),'questionIndex':currentQuestionIndex,'question':questionsData[currentQuestionIndex],'hierarchy':hierarchy,'timestamp':Date[_0x3316b7(0x266)]()};_0x321269[_0x3316b7(0x1a1)](_0x2df656);}}else _0x321269=_0x321269[_0x3316b7(0x346)](_0x764101=>!(_0x764101['quizFile']['includes'](quizName['toLowerCase']()['replace'](/ /g,'-'))&&_0x764101[_0x3316b7(0x14c)]===currentQuestionIndex));localStorage[_0x3316b7(0x276)]('bookmarkedQuestions',JSON[_0x3316b7(0x3a1)](_0x321269)),_0x3bc5c1[_0x3316b7(0x1ea)](updateBookmarkButton),updateQuestionNav();}function updateBookmarkButton(){const _0x38589f=_0x1c6435,_0x20f1b3={'dAvui':_0x38589f(0x2ec),'pVLlK':'bookmarkText','iUGTj':_0x38589f(0x322),'xtHYV':'Bookmarked'},_0x2fd23b=document[_0x38589f(0x2a9)](_0x20f1b3[_0x38589f(0x382)]),_0xa0a9e4=document[_0x38589f(0x2a9)](_0x20f1b3[_0x38589f(0x3c7)]),_0x1c9dce=questionStates[currentQuestionIndex]['bookmarked'];_0x2fd23b[_0x38589f(0x2f7)]=_0x1c9dce?_0x38589f(0x286):_0x20f1b3['iUGTj'],_0xa0a9e4[_0x38589f(0x1f1)]=_0x1c9dce?_0x20f1b3[_0x38589f(0x1ce)]:_0x38589f(0x1c2);}function toggleMarkForReview(){const _0xa27432=_0x1c6435,_0x4a460d={'megsr':function(_0x5126f0){return _0x5126f0();}};questionStates[currentQuestionIndex][_0xa27432(0x203)]=!questionStates[currentQuestionIndex]['markedForReview'],updateMarkReviewButton(),_0x4a460d[_0xa27432(0x231)](updateQuestionNav);}function updateMarkReviewButton(){const _0x14d6be=_0x1c6435,_0xdf09d0={'ZCCqs':_0x14d6be(0x256),'TrwuF':_0x14d6be(0x2d5),'lkzHD':_0x14d6be(0x395),'llnLj':_0x14d6be(0x1fa)},_0x37da1e=document[_0x14d6be(0x2a9)](_0xdf09d0['ZCCqs']),_0x5c2bcf=document[_0x14d6be(0x2a9)](_0xdf09d0[_0x14d6be(0x261)]),_0x505f56=questionStates[currentQuestionIndex][_0x14d6be(0x203)];_0x37da1e['className']=_0x505f56?_0x14d6be(0xe9):_0x14d6be(0x252),_0x5c2bcf[_0x14d6be(0x1f1)]=_0x505f56?_0xdf09d0['lkzHD']:_0xdf09d0[_0x14d6be(0x1e7)];}function previousQuestion(){const _0x1cfd05=_0x1c6435,_0x48f03a={'GDmRl':_0x1cfd05(0x1c1),'PPswe':_0x1cfd05(0x36c),'MbNSt':function(_0x2e1ebe,_0x2da0a2){return _0x2e1ebe>_0x2da0a2;},'NktQU':_0x1cfd05(0x27b),'qENlJ':_0x1cfd05(0x26d),'ZcNne':function(_0x308e46,_0x4a7207){return _0x308e46===_0x4a7207;},'ubDhb':_0x1cfd05(0x166),'IGXoM':function(_0x1172ed){return _0x1172ed();}};_0x48f03a[_0x1cfd05(0x227)](currentQuestionIndex,0x0)&&(_0x48f03a[_0x1cfd05(0x111)]!==_0x48f03a[_0x1cfd05(0x159)]?(questionStartTime&&(_0x48f03a[_0x1cfd05(0x30e)](_0x1cfd05(0x2c2),_0x48f03a[_0x1cfd05(0x2d7)])?_0x9a87ac():questionStates[currentQuestionIndex][_0x1cfd05(0x2fd)]+=Date[_0x1cfd05(0x266)]()-questionStartTime),currentQuestionIndex--,displayQuestion(),_0x48f03a['IGXoM'](saveProgress)):(delete _0x3e68db[_0x4c7a68],_0x59016e['setItem'](_0x48f03a['GDmRl'],_0x1fc0f['stringify'](_0x50ee1f)),_0x5c89f7['log'](_0x48f03a['PPswe'])));}function nextQuestion(){const _0x36e6dc=_0x1c6435,_0x4515a7={'vLbnH':function(_0x6169c3,_0x32b9e3){return _0x6169c3===_0x32b9e3;},'Vsbol':'correct','DqCSo':_0x36e6dc(0x2dd),'tDwEE':'Incorrect','mluSp':_0x36e6dc(0x1ff),'FOovd':function(_0x477b11,_0x4ee540){return _0x477b11-_0x4ee540;},'ZefwI':function(_0xc4b221,_0x4c1301){return _0xc4b221<_0x4c1301;},'iTdqV':function(_0x4a8cc2,_0xad2fa2){return _0x4a8cc2===_0xad2fa2;},'YRsBe':_0x36e6dc(0x291),'ctiWa':'UmcwH','jAVMt':function(_0x2749bc){return _0x2749bc();},'WGRtU':function(_0x1017a6,_0xbbd8a4){return _0x1017a6===_0xbbd8a4;},'hKzMX':_0x36e6dc(0x221),'uDGEY':_0x36e6dc(0x3c1),'nhozM':function(_0xc1111d,_0x272500){return _0xc1111d===_0x272500;},'rFlIB':_0x36e6dc(0x2bc),'rAyOe':function(_0x3b7325){return _0x3b7325();},'zgVVw':_0x36e6dc(0x3da)};if(questionStartTime){if(_0x4515a7[_0x36e6dc(0x3a6)]===_0x4515a7[_0x36e6dc(0x3a6)])questionStates[currentQuestionIndex][_0x36e6dc(0x2fd)]+=_0x4515a7[_0x36e6dc(0x18a)](Date['now'](),questionStartTime);else{if(_0x15e32a)_0x249236[_0x36e6dc(0x1e8)]+=_0x36e6dc(0x277)+_0x2e90f6+_0x36e6dc(0x29d);}}if(_0x4515a7[_0x36e6dc(0x26a)](currentQuestionIndex,questionsData[_0x36e6dc(0x2b4)]-0x1)){if(_0x4515a7[_0x36e6dc(0x39b)](_0x4515a7['YRsBe'],_0x4515a7[_0x36e6dc(0x352)])){const _0x412e50=_0x1f00d7[_0x36e6dc(0x2a3)][_0x869114[_0x36e6dc(0x3e8)]];_0x4515a7[_0x36e6dc(0x281)](_0x412e50['id'],_0x248c51)?(_0x1d4bf5=_0x4515a7['Vsbol'],_0x5c8851=_0x4515a7['DqCSo']):(_0x312151='incorrect',_0x19675a=_0x4515a7[_0x36e6dc(0x251)]);}else currentQuestionIndex++,displayQuestion(),_0x4515a7[_0x36e6dc(0x2c3)](saveProgress);}else _0x4515a7[_0x36e6dc(0x2f8)](_0x4515a7[_0x36e6dc(0x374)],_0x4515a7[_0x36e6dc(0x374)])?_0x4515a7[_0x36e6dc(0x39b)](currentMode,_0x4515a7[_0x36e6dc(0x220)])||_0x4515a7[_0x36e6dc(0x1da)](currentMode,_0x4515a7['rFlIB'])?confirm('You\x20have\x20reached\x20the\x20end\x20of\x20the\x20quiz.\x20Would\x20you\x20like\x20to\x20submit\x20your\x20answers\x20now?')&&_0x4515a7[_0x36e6dc(0x234)](submitQuiz):confirm(_0x4515a7[_0x36e6dc(0x22c)])&&(currentQuestionIndex=0x0,_0x4515a7['rAyOe'](displayQuestion),_0x4515a7[_0x36e6dc(0x234)](saveProgress)):(_0x238f06=_0x4515a7['Vsbol'],_0x401f60=_0x4515a7[_0x36e6dc(0x356)]);}function startTimer(){const _0x42034e=_0x1c6435,_0x1f3aad={'GRQGJ':_0x42034e(0x10c),'ANzdm':function(_0x584f8f,_0x5a44ef){return _0x584f8f!==_0x5a44ef;},'QGZmC':_0x42034e(0x3a9),'oXCeV':'YYUNn','RCLdp':function(_0x245943,_0x4697a9){return _0x245943<=_0x4697a9;},'KpABA':function(_0x5c1801,_0x3e5cc8){return _0x5c1801(_0x3e5cc8);},'gNsQZ':function(_0x53da17,_0x12762c){return _0x53da17===_0x12762c;},'DhIhq':_0x42034e(0x2bc),'GJIie':function(_0x2bebf0){return _0x2bebf0();},'ukFCQ':function(_0xaca6b0,_0x3d067e){return _0xaca6b0(_0x3d067e);},'IoLLy':function(_0x49d2c5){return _0x49d2c5();},'WkMtm':function(_0x37c304,_0x230aa8,_0x3dc3ca){return _0x37c304(_0x230aa8,_0x3dc3ca);}};if(timer)_0x1f3aad['ukFCQ'](clearInterval,timer);timeRemaining=0x78,_0x1f3aad[_0x42034e(0x341)](updateTimerDisplay),timer=_0x1f3aad[_0x42034e(0x197)](setInterval,()=>{const _0x43276d=_0x42034e,_0x5cd677={'azZQS':_0x1f3aad[_0x43276d(0x2db)]};_0x1f3aad['ANzdm'](_0x1f3aad[_0x43276d(0x2b8)],_0x1f3aad[_0x43276d(0x380)])?(timeRemaining--,updateTimerDisplay(),_0x1f3aad['RCLdp'](timeRemaining,0x0)&&(_0x1f3aad[_0x43276d(0x141)](clearInterval,timer),_0x1f3aad[_0x43276d(0x2d4)](currentMode,_0x1f3aad['DhIhq'])?submitQuiz():_0x1f3aad['GJIie'](nextQuestion))):_0x236469['classList']['add'](_0x5cd677[_0x43276d(0x272)]);},0x3e8);}function _0x3f36(_0x14421e,_0x167a0b){const _0x4d2ec0=_0x5efc();return _0x3f36=function(_0x30813c,_0x1f5a0a){_0x30813c=_0x30813c-0xd3;let _0x85923f=_0x4d2ec0[_0x30813c];return _0x85923f;},_0x3f36(_0x14421e,_0x167a0b);}function updateTimerDisplay(){const _0x5a0d29=_0x1c6435,_0x2b3a85={'YvwNx':function(_0xaaebea,_0x36e84a){return _0xaaebea/_0x36e84a;},'aweyA':'timeDisplay','GOoGT':function(_0x5a8b64,_0x216ddd){return _0x5a8b64+_0x216ddd;}},_0x3f9520=Math['floor'](_0x2b3a85[_0x5a0d29(0x2fa)](timeRemaining,0x3c)),_0x3c3f11=timeRemaining%0x3c;document[_0x5a0d29(0x2a9)](_0x2b3a85[_0x5a0d29(0x2ca)])[_0x5a0d29(0x1f1)]=_0x2b3a85[_0x5a0d29(0x2b2)](_0x3f9520+':',_0x3c3f11[_0x5a0d29(0x2eb)]()[_0x5a0d29(0x1c7)](0x2,'0'));}function toggleSidebar(){const _0x4a7557=_0x1c6435,_0x522763={'mMMZf':_0x4a7557(0x112),'svZjD':_0x4a7557(0x38e)};document[_0x4a7557(0x2a9)](_0x522763['mMMZf'])[_0x4a7557(0x2f2)]['toggle'](_0x522763[_0x4a7557(0x34f)]);}document[_0x1c6435(0x107)]('DOMContentLoaded',()=>{const _0x1f9081=_0x1c6435,_0xd094a7={'vLPiJ':'customQuizData','zpQDD':_0x1f9081(0x29f),'CLFoo':function(_0x53edc9,_0x361415){return _0x53edc9+_0x361415;},'DrbAC':_0x1f9081(0x3d9),'pCfKD':function(_0x2d2f15){return _0x2d2f15();},'RuCzQ':function(_0x37c632,_0x45c8f6){return _0x37c632!==_0x45c8f6;},'QKIdW':_0x1f9081(0x344),'VmtAa':'feGQy','SGOVs':function(_0x3f9393){return _0x3f9393();},'MJmhM':_0x1f9081(0x257),'xUpsy':_0x1f9081(0x3bc)};if(resume){if(_0xd094a7['pCfKD'](loadProgress)){if(_0xd094a7[_0x1f9081(0x1a5)](_0xd094a7[_0x1f9081(0x377)],_0xd094a7['VmtAa']))document['getElementById'](_0x1f9081(0x257))[_0x1f9081(0x2ce)][_0x1f9081(0x139)]=_0x1f9081(0x185),_0xd094a7[_0x1f9081(0x1f0)](initializeQuiz);else{const _0x2b7b04=_0xe042a0[_0x1f9081(0x1a4)](_0x2a4ea3[_0x1f9081(0x1f6)](_0xd094a7[_0x1f9081(0x3aa)]));if(_0x2b7b04){const _0x4ca0a5=_0x1f9081(0x34a)['split']('|');let _0x25da53=0x0;while(!![]){switch(_0x4ca0a5[_0x25da53++]){case'0':_0x26fe50['getElementById'](_0xd094a7[_0x1f9081(0x3ac)])[_0x1f9081(0x1f1)]=_0x3ddd04[_0x1f9081(0x3a4)]('\x20>\x20');continue;case'1':_0x194acc['title']=_0xd094a7[_0x1f9081(0x337)](_0x3109e7,_0xd094a7[_0x1f9081(0x3cf)]);continue;case'2':_0x1447dc['getElementById']('totalQuestions')['textContent']=_0x53f41b[_0x1f9081(0x2b4)];continue;case'3':_0x3f14e7=_0x2b7b04['hierarchy'];continue;case'4':_0x1cdbf4=_0x2b7b04['questions'];continue;case'5':_0xb3f671=_0x2b7b04[_0x1f9081(0x10e)];continue;}break;}}}}else clearProgress(),document[_0x1f9081(0x2a9)](_0xd094a7['MJmhM'])[_0x1f9081(0x2ce)]['display']=_0xd094a7['xUpsy'];}else!window[_0x1f9081(0x25d)][_0x1f9081(0x27e)]['endsWith']('custom_quiz.html')?(clearProgress(),document[_0x1f9081(0x2a9)](_0x1f9081(0x257))['style'][_0x1f9081(0x139)]=_0x1f9081(0x3bc)):_0xd094a7[_0x1f9081(0x1d0)](initializeQuiz);}),document[_0x1c6435(0x107)](_0x1c6435(0x195),function(_0x17b312){const _0x184a0f=_0x1c6435,_0x3c20b1={'PVbaP':function(_0x203468,_0x42f874){return _0x203468!==_0x42f874;},'WVjJr':_0x184a0f(0x257),'UMpDL':_0x184a0f(0x185),'TEqYZ':function(_0x273634,_0x4b6775){return _0x273634===_0x4b6775;},'GbKGU':'performanceModal','HrgJr':_0x184a0f(0x10c),'CEHzu':function(_0x6f7729,_0x139c2b){return _0x6f7729>=_0x139c2b;},'SqBpK':function(_0x18448c,_0x243e88){return _0x18448c-_0x243e88;},'xNJfS':function(_0x371e3e,_0x3b8e37){return _0x371e3e(_0x3b8e37);},'RBaIB':function(_0x319bf5,_0x218b59){return _0x319bf5<_0x218b59;},'JSqvj':function(_0x5bb9b5,_0x572040){return _0x5bb9b5===_0x572040;},'THvpJ':_0x184a0f(0x1fb),'puFZq':function(_0x428791){return _0x428791();},'XIgJO':_0x184a0f(0x3b9),'npiXD':_0x184a0f(0x296),'ytePK':function(_0x4dedfd,_0x209855){return _0x4dedfd===_0x209855;},'ZrAWP':_0x184a0f(0x24e),'sxQYV':function(_0x517c7f){return _0x517c7f();},'jPxSv':function(_0x2403b9,_0x2c10bb){return _0x2403b9===_0x2c10bb;},'qsIZz':function(_0x150ef6,_0x1ca9e0){return _0x150ef6===_0x1ca9e0;},'UtHHf':_0x184a0f(0x3c1),'facEz':function(_0x2a04a6,_0x2ef3c2){return _0x2a04a6!==_0x2ef3c2;},'izjmb':'KKykB','HNWqK':function(_0x3ebf8d){return _0x3ebf8d();},'RcePi':function(_0x4978a1,_0x3b5243){return _0x4978a1===_0x3b5243;},'Byccc':_0x184a0f(0x2bc)};if(_0x3c20b1[_0x184a0f(0x271)](document[_0x184a0f(0x2a9)](_0x3c20b1[_0x184a0f(0x299)])[_0x184a0f(0x2ce)][_0x184a0f(0x139)],_0x3c20b1[_0x184a0f(0x1d8)]))return;if(_0x3c20b1[_0x184a0f(0x20d)](document[_0x184a0f(0x2a9)](_0x3c20b1['GbKGU'])['classList']['contains'](_0x3c20b1[_0x184a0f(0x2ed)]),![]))return;if(_0x3c20b1['CEHzu'](_0x17b312[_0x184a0f(0x345)],'1')&&_0x17b312['key']<='4'){const _0x3162f9=_0x3c20b1['SqBpK'](_0x3c20b1[_0x184a0f(0x136)](parseInt,_0x17b312['key']),0x1),_0x2ee193=document[_0x184a0f(0x3b7)](_0x184a0f(0x39c));if(_0x3c20b1['RBaIB'](_0x3162f9,_0x2ee193[_0x184a0f(0x2b4)]))selectOption(_0x3162f9);}else{if(_0x3c20b1[_0x184a0f(0x29b)](_0x17b312['key'],_0x3c20b1[_0x184a0f(0x1b3)]))_0x3c20b1['puFZq'](previousQuestion);else{if(_0x3c20b1[_0x184a0f(0x29b)](_0x17b312[_0x184a0f(0x345)],_0x3c20b1[_0x184a0f(0x29e)])||_0x17b312['key']==='\x20')_0x3c20b1[_0x184a0f(0x3c3)]===_0x184a0f(0x246)?_0x5cb0ce='nav-btn-marked-review':(_0x17b312[_0x184a0f(0x34b)](),nextQuestion());else{if(_0x17b312['key'][_0x184a0f(0x36a)]()==='b'&&(currentMode===_0x184a0f(0x128)||_0x3c20b1[_0x184a0f(0x390)](currentMode,_0x3c20b1['ZrAWP'])))_0x3c20b1[_0x184a0f(0x215)](toggleBookmark);else{if(_0x3c20b1[_0x184a0f(0xe2)](_0x17b312[_0x184a0f(0x345)][_0x184a0f(0x36a)](),'m')&&(_0x3c20b1[_0x184a0f(0x363)](currentMode,_0x3c20b1[_0x184a0f(0x1ee)])||_0x3c20b1[_0x184a0f(0x20d)](currentMode,'timed_exam'))){if(_0x3c20b1[_0x184a0f(0x2ea)](_0x184a0f(0x168),_0x3c20b1[_0x184a0f(0x303)]))_0x3c20b1[_0x184a0f(0x2ef)](toggleMarkForReview);else{if(!_0x4b7537)_0xa768e5();_0x1a485b['location'][_0x184a0f(0x3b4)]=_0x5903f6['referrer']||'index.html';}}else _0x3c20b1['RcePi'](_0x17b312[_0x184a0f(0x345)][_0x184a0f(0x36a)](),'s')&&(currentMode===_0x3c20b1[_0x184a0f(0x1ee)]||currentMode===_0x3c20b1[_0x184a0f(0x37c)])&&_0x3c20b1[_0x184a0f(0x2ef)](submitQuiz);}}}}});function _0x5efc(){const _0x4963d2=['submitSection','Enalapril','<p>Drug\x20B\x20has\x20a\x20<strong>competitive\x20antagonistic</strong>\x20effect\x20on\x20drug\x20A.</p>\x0a<p>In\x20<strong>competitive\x20antagonism</strong>,\x20DRC\x20shows\x20a\x20<strong>parallel\x20rightward\x20shift</strong>.\x20Competitive\u00a0antagonism\x20occurs\x20when\x20the\x20agonist\x20and\x20antagonist\x20compete\x20for\x20the\x20same\x20binding\x20site\x20on\x20the\x20receptor.\x20The\x20response\x20curve\x20for\x20the\x20agonist\x20shifts\x20to\x20the\x20right\x20in\x20a\x20concentration-related\x20manner\x20by\x20the\x20antagonist.</p>\x0a<p>In\u00a0<strong>non-competitive\x20antagonism</strong>,\x20there\x20is<strong>\x20flattening\x20</strong>of\x20the\x20agonist\x20DRC.<strong>\u00a0</strong>Non-competitive\x20antagonism\u00a0effects\x20occur\x20when\x20the\x20agonist\x20and\x20antagonist\x20bind\x20to\x20different\x20sites\x20on\x20the\x20receptor.\x20(\x20allosteric\x20site)\x20and\x20inhibits\x20the\x20response.\x20The\x20response\x20curve\u00a0progressively\x20shifts\x20in\x20a\u00a0<strong>right\x20and\x20downward\x20direction\x20</strong>until\x20it\x20reaches\x20a\x20limiting\x20value\x20when\x20the\x20allosteric\x20site\x20is\x20fully\x20occupied.</p>\x0a<p>In\x20<strong>competitive\x20agonism</strong>,\x20the\x20curve\x20shifts\x20to\x20the\x20<strong>left</strong>.</p>\x0a<p>In\x20<strong>partial\x20agonism</strong>,\x20the\u00a0partial\x20agonist\x20which\x20has\x20an\x20affinity\x20for\x20the\x20same\x20receptor,\x20also\x20competes\x20with\x20and\u00a0antagonizes\x20a\x20full\x20agonist,\x20while\x20producing\x20a\x20submaximal\x20response.\u00a0</p>','bBhPi','glass-light\x20px-6\x20py-3\x20text-white\x20hover:bg-yellow-500\x20hover:bg-opacity-20\x20transition-all\x20duration-300\x20flex\x20items-center','hnuxf','incorrectResult','Oxcarbazepine','nqEUw','https://cdn1.dailyrounds.org/uploads/0e9691ef46534bde90bf857a9fe1f601.GIF','KiCxP','https://dhmbxeygs57ff.cloudfront.net/uploads/2687fee5df024653908a0728befd85afx1024x683.JPEG','ugDAq','toISOString','explanation_audio_eng','suOah','JNTOd','itBOG','Decreased\x20trabecular\x20outflow','hBRST','\x22\x20data-option-index=\x22','Reduced\x20cardiac\x20contractility','hPjJy','Telmisartan','Increased\x20left\x20ventricular\x20end\x20diastolic\x20volume','CLFoo','Captopril','1270044Apxfms','fromCharCode','Partial\x20agonism','Rfmqx','Fever,\x20rigidity,\x20dilated\x20pupils,\x20and\x20hyperreflexia','It\x20is\x20a\x20second-generation\x20H1\x20receptor\x20antagonists','onclick','UdbDE','IoLLy','MPCIc','Paclitaxel','UkxqP','key','filter','pSbxF','<p>The\x20most\x20suitable\x20drug\x20to\x20reduce\x20this\x20patient\x27s\x20blood\x20glucose\x20level\x20is\x20<strong>canagliflozin</strong>.</p>\x0a<p><strong>Canagliflozin</strong>\x20is\x20a\x20sodium-glucose\x20transporter\x202\x20(<strong>SGLT-2</strong>)\x20inhibitor.\x20Other\x20SGLT-2\x20inhibitors\x20include\x20dapagliflozin\x20and\x20empagliflozin.\x20They\x20act\x20by&nbsp;inhibiting\x20the&nbsp;SGLT-2\x20transporter\x20which\x20is\x20present\x20on\x20the\x20proximal\x20segment\x20of\x20the\x20renal\x20tubule\x20and\x20responsible\x20for\x20the\x20reabsorption\x20of\x2080-90%\x20of\x20filtered\x20glucose.&nbsp;It&nbsp;inhibits\x20glucose\x20reabsorption\x20resulting\x20in\x20glycosuria\x20and\x20a\x20change\x20in\x20the\x20renal\x20threshold.\x20This\x20results\x20in\x20a\x20decrease\x20in\x20blood\x20glucose\x20levels.&nbsp;</p>\x0a<p>The\x20common\x20side\x20effects\x20include&nbsp;<strong>urinary\x20tract\x20infections</strong>&nbsp;and<strong>&nbsp;genital\x20mycotic\x20infections</strong>&nbsp;due\x20to\x20the\x20high\x20glucose\x20content\x20of\x20the\x20urine.\x20There\x20is\x20a\x20risk\x20of\x20the\x20development\x20of&nbsp;<strong>euglycemic\x20diabetic\x20ketoacidosis</strong>.\x20It\x20increases\x20the\x20risk\x20of\x20fractures\x20and\x20lower\x20limb\x20amputations\x20due\x20to\x20the\x20creation\x20of\x20an\x20imbalance\x20with\x20the\x20minerals\x20and\x20circulating\x20parathormone\x20and\x20vitamin\x20D.&nbsp;</p>\x0a<p>Other\x20options:</p>\x0a<p>Option\x20A:<strong>\x20Liraglutide</strong>\x20(GLP-1\x20agonist)\x20cannot\x20be\x20used\x20as\x20it\x20is\x20can\x20be\x20given\x20only\x20parenterally\x20and\x20the\x20patient\x20insists\x20on\x20taking\x20medications\x20via\x20the\x20non-parenteral\x20route.</p>\x0a<p>Option&nbsp;B:<strong>\x20Sitagliptin</strong>\x20cannot\x20be\x20given\x20since\x20the\x20drug\x20increases\x20the\x20risk\x20of\x20fatal\x20and\x20non-fatal\x20pancreatitis.\x20The\x20patient\x20is\x20already\x20suffering\x20from\x20pancreatitis.</p>\x0a<p>Option\x20D:<strong>\x20Pioglitazone</strong>\x20is\x20associated\x20with\x20bladder\x20cancer.\x20The\x20patient\x20has\x20a\x20family\x20history\x20of\x20bladder\x20cancer.</p>','Increased\x20uveoscleral\x20outflow','4|5|3|1|2|0','preventDefault','review-question\x20','Procainamide','Chloramphenicol','svZjD','30.5\x20mg','https://cdn1.dailyrounds.org/uploads/8a4bcdecc8194bae9ef8a680f6175771.JPEG','ctiWa','div','1-b,\x202-d,\x203-a,\x204-c','.m3u8','DqCSo','Are\x20you\x20sure\x20you\x20want\x20to\x20submit\x20the\x20quiz?','BgZah','Benztropine','Not\x20Attempted','<p>The\x20given\x20clinical\x20vignette\x20shows\x20a\x20patient\x20undergoing\x20chemotherapy.\x20A\x20drug\x20not\x20effective\x20in\x20controlling\x20this\x20patient\x27s\x20emesis\x20is\x20a\x20<strong>histamine\x20H1\x20antagonist.</strong></p>\x0a<p>Classification\x20of\x20anti-emetic\x20agents:</p>\x0a<table\x20style=\x22width:\x20746.417px;\x22>\x0a<tbody>\x0a<tr>\x0a<td\x20style=\x22width:\x20215px;\x20text-align:\x20center;\x22><strong>Mechanism\x20of\x20action</strong></td>\x0a<td\x20style=\x22width:\x20314px;\x20text-align:\x20center;\x22><strong>Use</strong></td>\x0a<td\x20style=\x22width:\x20192.417px;\x20text-align:\x20center;\x22><strong>Example</strong></td>\x0a</tr>\x0a<tr>\x0a<td\x20style=\x22width:\x20215px;\x22>Centrally\x20acting\x20dopamine\x20receptor\x20antagonists</td>\x0a<td\x20style=\x22width:\x20314px;\x22>Chemotherapy-induced\x20nausea\x20and\x20vomiting</td>\x0a<td\x20style=\x22width:\x20192.417px;\x22>Metoclopramide<br\x20/>Promethazine</td>\x0a</tr>\x0a<tr>\x0a<td\x20style=\x22width:\x20215px;\x22><strong>5HT3\x20receptor\x20antagonists</strong></td>\x0a<td\x20style=\x22width:\x20314px;\x22>Chemotherapy-induced\x20nausea\x20and\x20vomiting</td>\x0a<td\x20style=\x22width:\x20192.417px;\x22>Ondansetron</td>\x0a</tr>\x0a<tr>\x0a<td\x20style=\x22width:\x20215px;\x22><strong>Cannabinoid\x20receptor\x20agonists</strong></td>\x0a<td\x20style=\x22width:\x20314px;\x22>Chemotherapy-induced\x20nausea\x20and\x20vomiting</td>\x0a<td\x20style=\x22width:\x20192.417px;\x22>Dronabinol\x20nabilone</td>\x0a</tr>\x0a<tr>\x0a<td\x20style=\x22width:\x20215px;\x22><strong>Neurokinin\x20receptor\x20antagonists</strong></td>\x0a<td\x20style=\x22width:\x20314px;\x22>Cytotoxic\x20drug-induced\x20emesis\x20(delayed\x20vomiting)</td>\x0a<td\x20style=\x22width:\x20192.417px;\x22>Aprepitant</td>\x0a</tr>\x0a<tr>\x0a<td\x20style=\x22width:\x20215px;\x22>Muscarinic\x20receptor\x20antagonists</td>\x0a<td\x20style=\x22width:\x20314px;\x22>Vestibular\x20emesis\x20(Motion\x20sickness)</td>\x0a<td\x20style=\x22width:\x20192.417px;\x22>Hyoscine</td>\x0a</tr>\x0a<tr>\x0a<td\x20style=\x22width:\x20215px;\x22>Histamine\x20H1\x20antagonist</td>\x0a<td\x20style=\x22width:\x20314px;\x22>Vestibular\x20emesis\x20(Motion\x20sickness)</td>\x0a<td\x20style=\x22width:\x20192.417px;\x22>Cyclizine</td>\x0a</tr>\x0a</tbody>\x0a</table>\x0a<p>&nbsp;</p>\x0a<ul>\x0a<li>5HT3\x20antagonist\x20+\x20dexamethasone\x20+\x20NK1\x20antagonist\x20are\x20used\x20in\x20early\x20stages,\x20dexamethasone+aprepitant\x20are\x20used\x20in&nbsp;delayed\x20emesis\x20in\x20case\x20of\x20cancer\x20chemotherapy</li>\x0a<li>Dronabinol\x20is\x20a\x20useful\x20agent\x20in\x20patients\x20receiving\x20cancer\x20chemotherapy\x20when\x20other\x20antiemetic\x20medications\x20are\x20not\x20effective.</li>\x0a</ul>','DFDrU','vLcqz','zbdgP','Daptomycin','removeItem','emcVA','A\x20patient\x20has\x20profuse\x20rhinorrhea\x20and\x20sneezing.\x20He\x20was\x20prescribed\x20fexofenadine.\x20Which\x20of\x20the\x20following\x20is\x20false\x20regarding\x20this\x20drug?','qsIZz','ZffAc','<p><strong>Quinine\x20plus\x20clindamycin</strong>\x20is\x20<strong>preferred</strong>\x20for\x20the\x20treatment\x20of\x20<strong>chloroquine-resistant\x20falciparum\x20malaria</strong>\x20in\x20the\x20<strong>1st\x20trimester\x20of\x20pregnancy</strong>.</p>\x0a<p>The\x20given\x20clinical\x20vignette\x20is\x20suggestive\x20of\x20a\x20<strong>chloroquine-resistant</strong>\u00a0<strong>malarial\x20infection</strong>.\x20The\x20image\x20given\x20shows\x20ring\x20forms/\x20early\x20trophozoites\x20in\x20erythrocytes,\x20which\x20are\x20binucleate\x20(double\x20chromatin)\x20and\x20resemble\x20stereo\x20headphones\x20in\x20appearance,\x20characteristic\x20of\x20malaria\x20caused\x20by<strong><em>\x20P.\x20falciparum</em>.</strong>\u00a0</p>\x0a<p>Worldwide\x20most\x20infections\x20with\u00a0<em>P</em>.\x20f<em>alciparum</em>\x20malaria\x20are\x20resistant\x20to\x20chloroquine.\x20In<strong>\u00a0</strong>the<strong>\x201st\x20trimester,\x20</strong>pregnant\x20women\x20diagnosed\x20with<strong>\x20uncomplicated\x20malaria\x20</strong>caused\x20by\x20<strong>chloroquine-resistant\u00a0<em>P.\x20falciparum</em>\u00a0</strong>infection,\x20the\x20drug\x20of\x20choice\x20is\x20a\u00a0<strong>combination\x20of\x20quinine\x20and\x20clindamycin</strong><strong>.\x20</strong>Artemisinin-based\x20combination\x20therapy\x20can\x20be\x20used\x20as\x20an\x20alternative\x20for\x20patients\x20that\x20are\x20unable\x20to\x20tolerate\x20oral\x20quinine.</p>\x0a<p>In<strong>\u00a0the\x20second\x20and\x20third\x20trimesters</strong>,\u00a0they<strong>\u00a0</strong>can\x20be\x20treated\x20with\x20artemisinin\x20combination\x20therapy<strong>\u00a0</strong>such\x20as:</p>\x0a<ul>\x0a<li>Artemether-lumefantrine</li>\x0a<li>Artesunate-amodiaquine</li>\x0a<li>Artesunate-mefloquine</li>\x0a<li>Dihydroartemisinin-piperaquine</li>\x0a<li>Artesunate\x20+\x20clindamycin</li>\x0a</ul>\x0a<p>During\x20pregnancy,\x20<strong><em>P.\x20vivax</em>\x20malaria</strong>\x20is\x20treated\x20with\x20<strong>chloroquine</strong>\x20as\x20it\x20is\x20safe\x20in\x20pregnancy\x20and\x20children.\u00a0In\x20chloroquine-resistant\x20vivax\x20cases,<strong>\x20clindamycin,\x20quinine,\x20chloroquine,\x20</strong>and<strong>\x20proguanil\u00a0</strong>can\x20be\x20used.</p>\x0a<p>Other\x20options:</p>\x0a<p>Option\x20B:\x20Doxycycline\x20is\x20useful\x20in\x20the\x20treatment\x20of\x20malaria\x20but\x20<strong>not\x20used\x20in\x20pregnancy</strong>.</p>\x0a<p>Options\x20C:\x20Artemether\x20plus\x20lumefantrine\x20is\x20not\x20the\x20drug\x20of\x20choice\x20in\x20the\x201st\x20trimester\x20of\x20pregnancy.\x20ACT\x20may\x20be\x20given\x20in\x20the\x20first\x20trimester\x20only\x20if\x20oral\x20quinine\x20is\x20not\x20tolerated\x20or\x20not\x20available.</p>\x0a<p>Option\x20D:\x20ACT\x20with\x20sulfadoxine-pyrimethamine\x20is\x20avoided\x20in\x20the\x20first\x20trimester.</p>\x0a<p>\u00a0</p>','Docosanol','Msszf','IL-6\x20receptor\x20antagonist','A\x2044-year-old\x20female\x20patient\x20with\x20breast\x20cancer\x20comes\x20for\x20her\x20second\x20round\x20of\x20chemotherapy.\x20She\x20reveals\x20that\x20she\x20had\x20severe\x20vomiting\x20during\x20and\x20after\x20her\x20first\x20round\x20of\x20chemotherapy.\x20A\x20drug\x20with\x20which\x20of\x20the\x20following\x20mechanisms\x20of\x20action\x20is\x20not\x20effective\x20in\x20controlling\x20this\x20patient\x27s\x20emesis?','toLowerCase','A\x20patient\x20was\x20started\x20on\x20a\x20drug\x20for\x20the\x20treatment\x20of\x20glaucoma.\x20He\x20came\x20to\x20the\x20ophthalmological\x20outpatient\x20department\x20with\x20a\x20change\x20in\x20the\x20appearance\x20of\x20his\x20eyes,\x20as\x20shown\x20in\x20the\x20given\x20image.\x20Identify\x20the\x20mechanism\x20of\x20action\x20of\x20the\x20drug\x20he\x20was\x20taking.','Previous\x20progress\x20cleared.','<p>Besides\x20its\x20anti-tubercular\x20action,\x20rifampicin\x20also\x20has\x20certain\x20<strong>non-tubercular\x20uses</strong>\x20which\x20include:</p>\x0a<ul>\x0a<li><strong>Prophylaxis</strong>\x20of\x20meningococcal\x20and<em>\x20H.\x20influenzae</em>\x20meningitis</li>\x0a<li>Treatment\x20of<strong>\x20MRSA</strong>,\x20<strong>diphtheroid</strong>,\x20and\x20<strong>legionella</strong>\x20infections&nbsp;</li>\x0a<li>Eradication\x20of\x20<strong>staphylococcal\x20nasal\x20carrier\x20state</strong>\x20in\x20patients\x20with\x20chronic\x20furunculosis</li>\x0a<li>A\x20combination\x20of\x20doxycycline\x20and\x20rifampicin\x20is\x20used\x20as\x20the\x20first-line\x20therapy\x20for<strong>\x20brucellosis</strong></li>\x0a<li>A\x20part\x20of\x20the\x20WHO\x20regimen\x20for\x20standard\x20therapy\x20of&nbsp;both\x20paucibacillary\x20and\x20multibacillary&nbsp;<strong>leprosy</strong></li>\x0a</ul>\x0a<p>Rifampicin\x20is\x20not\x20used\x20in\x20the\x20treatment\x20of\x20Nocardia\x20species.\x20<strong>Cotrimoxazole&nbsp;</strong>is\x20considered\x20the\x20drug\x20of\x20choice\x20for\x20pleuropulmonary\x20nocardiosis.</p>','ETgGb','button','Progress\x20loaded.','jWULK','QuirX','Liraglutide','hKzMX','jqTxc','JGQLk','QKIdW','KMYHk','closest','qcAfL','goFcg','Byccc','attachMedia','NNjag','jbFCy','oXCeV','iJwxt','dAvui','ujlVB','<div\x20class=\x22p-3\x20rounded-lg\x20border\x20','Zoledronate\x20\x205\x20mg\x20monthly','30\x20hours','TPlvW','GfHaX','3,\x204,\x205','Metronidazole','A\x20drug\x20having\x20a\x20half-life\x20of\x208\x20hours\x20is\x20administered\x20orally\x20thrice\x20daily.\x20How\x20much\x20time\x20will\x20be\x20taken\x20for\x20the\x20plasma\x20concentration\x20to\x20reach\x20a\x20steady\x20state?','w-8\x20h-8\x20text-sm\x20font-medium\x20rounded\x20transition-all\x20duration-200','Pegloticase','open','SquMO','ytePK','UGoTb','table','trLFu','Fluconazole','Marked','A\x202-year-old\x20child\x20diagnosed\x20with\x20bronchial\x20asthma\x20requires\x20bronchodilator\x20therapy.\x20Which\x20of\x20the\x20following\x20device\x20will\x20you\x20prescribe\x20for\x20this\x20child,\x20to\x20avoid\x20oropharyngeal\x20adverse\x20effects?','Tetracyclines','Competitive\x20antagonism','https://cdn1.dailyrounds.org/uploads/50b92ea18dc94db5bf372c7eee96fe74.JPEG','Febuxostat','iTdqV','.option-button','gajzX','cbtdQ','search','Cannabinoid\x20receptor\x20agonists','stringify','stats','yUPYP','join','correct','mluSp','TmcfP','nav-btn-bookmarked','XuUjF','vLPiJ','1,\x205,\x20and\x206\x20only','zpQDD','<p>The\x20mechanism\x20of\x20action\x20of\x20dapsone\x20includes:</p>\x0a<ol>\x0a<li>Inhibition\x20of\x20dihydropteroate\x20synthase</li>\x0a<li>Inhibition\x20of\x20neutrophil\x20myeloperoxidase</li>\x0a<li>Inhibition\x20of\x20neutrophil\x20migration</li>\x0a</ol>\x0a<p>Dapsone\x20is\x20a\x20<strong>structural\x20analogue\x20of\x20PABA</strong>\x20and&nbsp;<strong>competitively\x20inhibits\x20dihydropteroate\x20synthase</strong>\x20in\x20the\x20folate\x20pathway.</p>\x0a<p>The\x20anti-inflammatory\x20effects\x20of\x20dapsone\x20occur\x20due\x20to\x20the<strong>\x20inhibition\x20of:</strong></p>\x0a<ol>\x0a<li>Tissue\x20damage\x20by\x20neutrophils</li>\x0a<li>Neutrophil\x20myeloperoxidase\x20activity\x20and\x20respiratory\x20burst</li>\x0a<li>Migration\x20of\x20neutrophils\x20to\x20inflammatory\x20lesions</li>\x0a</ol>\x0a<p>Dapsone\x20may\x20also\x20act\x20as\x20a\x20neutrophil-free-radical\x20scavenger.</p>\x0a<p>Dapsone\x20is\x20used\x20in\x20the\x20treatment\x20of\x20leprosy,\x20malaria,&nbsp;P.\x20jiroveci\x20infection,\x20and\x20toxoplasma\x20prophylaxis.\x20Its\x20anti-inflammatory\x20property\x20is\x20the\x20basis\x20for\x20the\x20treatment\x20of\x20pemphigoid,\x20dermatitis\x20herpetiformis,\x20linear\x20IgA\x20bullous\x20disease,\x20etc.</p>\x0a<p>Adverse\x20effects\x20include\x20hemolysis\x20at\x20doses\x20of\x20200-300mg\x20and\x20methemoglobinemia.</p>\x0a<p>Note:\x20Dapsone\x20does\x20<strong>not\x20cause\x20inhibition\x20of\x20DHFR\x20or\x20thymidylate\x20synthase.&nbsp;Methotrexate</strong>\x20and\x20pemetrexed\x20are\x20<strong>dihydrofolate\x20reductase\x20inhibitors</strong>.\x20<strong>5-Fluorouracil</strong>\x20(5FU)\x20and\x20capecitabine\x20are\x20<strong>thymidylate\x20synthase\x20inhibitors</strong>.</p>','JPTlI','Causes\x20Torsade\x20de\x20Pointes','cBYEW','euMAe','No\x20solution\x20provided','A\x2020-year-old\x20male\x20patient\x20presents\x20to\x20the\x20emergency\x20department\x20with\x20complaints\x20of\x20breathing\x20difficulty,\x20facial\x20swelling,\x20and\x20palpitations\x20following\x20a\x20bee\x20sting.\x20He\x20was\x20immediately\x20given\x20an\x20intramuscular\x20injection\x20of\x20a\x20drug\x20in\x201:1000\x20dilution.\x20The\x20drug\x20acts\x20on\x20which\x20of\x20the\x20following\x20receptor\x20to\x20improve\x20the\x20patient\x27s\x20breathing\x20difficulty?','href','Alcohol','status','querySelectorAll','explanation_images','ArrowRight','No\x20questions\x20available\x20for\x20this\x20quiz.','<div\x20class=\x22mt-2\x22><p\x20class=\x22text-sm\x20text-white\x20text-opacity-70\x20mb-1\x22>Hinglish:</p><audio\x20src=\x22','flex','</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20','</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22space-y-2\x20mb-4\x22>','scoreCircle','jRxMr','test','PpKtd','npiXD','zPUbQ','<p>The\x20mechanism\x20of\x20action\x20of\x20nitrates\x20in\x20prinzmetal\x20angina\x20is\x20<strong>endothelium-independent\x20coronary\x20vasodilatation</strong>.</p>\x0a<p><strong>Prinzmetal\x20angina\x20</strong>occurs\x20due\x20to\x20<strong>vasospasm</strong>\x20of\x20the\x20coronary\x20arteries.\x20<strong>Nitrates</strong>\x20relax\x20the\x20smooth\x20muscles\x20of\x20epicardial\x20coronary\x20arteries\x20and\x20<strong>relieve\x20coronary\x20artery\x20spasm.</strong></p>\x0a<p>In\x20the\x20case\x20of\x20<strong>stable\x20angina</strong>,\x20the\x20primary\x20mechanism\x20of\x20action\x20of\x20<strong>nitrates</strong>\x20is&nbsp;<strong>preferential\x20dilatation\x20of\x20veins</strong>\x20(by\x20increasing\x20cGMP).\x20Venous\x20dilatation\x20leads\x20to\x20a\x20<strong>decrease</strong>\x20in\x20the\x20venous\x20return\x20to\x20the\x20heart\x20(<strong>preload</strong>).\x20This\x20decreases\x20the\x20ventricular\x20end-diastolic\x20volume\x20and\x20thereby\x20a\x20<strong>decrease</strong>\x20in\x20<strong>myocardial\x20oxygen\x20consumption</strong>.\x20The\x20diastolic\x20perfusion\x20pressure\x20(aortic\x20blood\x20pressure\x20in\x20diastole\x20-\x20left\x20ventricular\x20pressure\x20in\x20diastole)\x20is\x20increased.</p>','MVyKe','pVLlK','Quinine\x20plus\x20clindamycin','MMQCi','A\x20morbidly\x20obese,\x20diabetic\x20woman\x20did\x20not\x20respond\x20well\x20to\x20metformin\x20therapy.\x20She\x20has\x20a\x20history\x20of\x20pancreatitis\x20and\x20a\x20family\x20history\x20of\x20bladder\x20cancer.\x20The\x20patient\x20does\x20not\x20want\x20to\x20take\x20injections.\x20Which\x20of\x20the\x20following\x20would\x20be\x20suitable\x20to\x20reduce\x20her\x20glucose\x20levels?','\x22\x20alt=\x22Question\x20Image\x22\x20class=\x22w-full\x20rounded-lg\x22></div>','982977bHGaSx','customQuizData','Propylthiouracil','DrbAC','XIYgu','woVKO','ImHQM','https://cdn1.dailyrounds.org/uploads/baa9f999670e44d6882ef99c0a239fb3.PNG','MmiPK','<p>The\x20given\x20clinical\x20complex\x20describes\x20a\x20case\x20of\x20<strong>Glanzmann\x27s\x20thrombasthenia</strong>\x20caused\x20due\x20to\x20deficiency\x20of\x20the\x20<strong>glycoprotein\x20IIb-IIIa\x20receptor</strong>.\x20<strong>Abciximab</strong>\x20is\x20an\x20anti-platelet\x20drug\x20that\x20functions\x20by\x20blocking\x20this\x20receptor.&nbsp;</p>\x0a<p\x20class=\x22p1\x22>Other\x20drugs\x20that\x20act\x20by\x20<strong>blocking\x20Gp\x20IIb/IIIa\x20receptors\x20</strong>are<strong>&nbsp;tirofiban\x20</strong>and\x20<strong>eptifibatide.&nbsp;</strong></p>\x0a<p\x20class=\x22p1\x22>They\x20are\x20mainly\x20used\x20during\x20<strong>percutaneous\x20coronary\x20intervention\x20</strong>for\x20acute\x20coronary\x20syndrome.\x20They\x20carry\x20a\x20<strong>high\x20risk\x20of\x20bleeding</strong>\x20and\x20can\x20cause\x20<strong>thrombocytopenia</strong>.</p>\x0a<p>Note:</p>\x0a<p>Deficiency\x20of\x20the\x20same\x20receptor,&nbsp;Glycoprotein\x20IIb-IIIa,\x20leads\x20to\x20a\x20condition\x20called\x20immune\x20thrombocytopenic\x20purpura.\x20In<strong>&nbsp;immune\x20thrombocytopenic\x20purpura\x20(ITP)</strong>,\x20antibodies\x20are\x20formed\x20in\x20the\x20spleen\x20against\x20the\x20cell-surface\x20antigens\x20GpIIb/IIIa\x20or\x20GpIb/IX,\x20causing\x20increased\x20<strong>peripheral\x20destruction\x20of\x20platelets.</strong></p>\x0a<p>Other\x20options:</p>\x0a<p>Option\x20B:\x20<strong>Clopidogrel</strong>&nbsp;&nbsp;is\x20an&nbsp;<strong>irreversible</strong>&nbsp;inhibitor\x20of\x20the\x20<strong>ADP\x20(P2Y<sub>12</sub>)\x20receptor</strong>\x20of\x20platelets.</p>\x0a<p>Option\x20C:&nbsp;<strong>Low-molecular-weight\x20heparin</strong>\x20is\x20an\x20anticoagulant\x20that\x20acts\x20by\x20<strong>inhibiting\x20factors\x20Xa\x20and&nbsp;IIa.</strong></p>\x0a<p>Option\x20D:\x20<strong>Rivaroxaban</strong>\x20is\x20a&nbsp;direct\x20oral\x20<strong>factor\x20Xa\x20inhibitor</strong>\x20that\x20inhibits\x20the\x20free\x20and\x20clot-associated\x20factor\x20Xa\x20resulting\x20in\x20reduced\x20thrombin\x20generation.</p>\x0a<p>&nbsp;</p>','</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22bg-green-900\x20bg-opacity-20\x20p-4\x20rounded-lg\x20border\x20border-green-700\x22>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<h5\x20class=\x22text-green-400\x20font-bold\x20mb-2\x22>Explanation:</h5>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22text-white\x20text-opacity-90\x22>','<p>The\x20clinical\x20vignette\x20showing\u00a0acute<strong>\u00a0</strong>symptoms\x20of\u00a0<strong>right\x20flank\x20pain\x20</strong>radiating\x20to\x20the\x20groin\u00a0along\x20with\x20bilateral\x20stones\x20in\x20the\x20abdominal\x20x-ray\x20makes\x20<strong>renal\x20calculi</strong>\x20a\x20likely\x20diagnosis,\x20which\x20is\x20commonly\x20associated\x20with\x20the\x20antiepileptic\x20drug\x20<strong>Topiramate</strong>.</p>\x0a<p>Acute\x20renal\x20colic\x20presents\x20with\x20sudden\x20onset\x20of\x20severe\x20pain\u00a0originating\x20in\x20the\x20flank\x20and\x20radiating\x20inferiorly\x20and\x20anteriorly.\x20At\x20least\x20half\x20the\x20patients\x20will\x20also\x20present\x20with\u00a0nausea\x20and\x20vomiting.\x20Patients\x20with\x20renal\x20calculi\x20may\x20report\x20infection\x20or\x20hematuria.</p>\x0a<p>Topiramate\x20is\x20an\x20anti-epileptic\x20that\x20can\x20be\x20used\x20as\x20initial\x20mono-drug\x20therapy\x20for\u00a0</p>\x0a<ul>\x0a<li>Focal\x20seizures</li>\x0a<li>GTCS</li>\x0a<li>Lennox-Gastaut\x20syndrome\x20in\x20patients\u00a0\x202\x20years\u00a0</li>\x0a</ul>\x0a<p>Mechanism\x20of\x20action:\x20Topiramate\x20acts\x20by</p>\x0a<ul>\x0a<li>Reducing\x20<strong>voltage-gated\x20Na+\x20currents</strong>\u00a0</li>\x0a<li>Activating\x20a\x20hyperpolarizing\x20K+\x20current</li>\x0a<li>Enhancing\x20postsynaptic\x20GABA<sub>A</sub>\x20receptor\x20currents</li>\x0a<li>Limiting\x20the\x20activation\x20of\x20glutamate\x20receptors.\u00a0</li>\x0a</ul>\x0a<p>The\u00a0drug\x20is\x20also\x20a\x20<strong>weak\x20inhibitor</strong>\x20of\x20<strong>renal\x20carbonic\x20anhydrase\u00a0</strong>and\x20can\x20lead\x20to\x20metabolic\x20acidosis.\x20Metabolic\x20acidosis\x20causes\x20hypocitraturia\x20and\x20hypercalciuria\x20that\x20increase\x20urinary\x20saturation\x20and\x20predispose\x20to\x20the\x20formation\x20of\x20<strong>renal\x20calculi</strong>.</p>\x0a<p>Other\x20options\x20:</p>\x0a<p>Option\x20A:\x20Ezogabine\x20causes\x20urinary\x20retention\x20and\x20blue\x20pigmentation\x20of\x20the\x20skin.</p>\x0a<p>Option\x20C:\x20Vigabatrin\x20causes\x20bilateral\x20vision\x20loss\x20and\x20a\u00a0contraction\x20of\x20the\x20visual\x20field.</p>\x0a<p>Option\x20D:\x20Oxcarbazepine\x20causes\x20side\x20effects\x20similar\x20to\x20carbamazepine\x20which\x20include\x20hyponatremia\x20and\u00a0Stevens-Johnson\x20syndrome.</p>','incorrectCount','\x20-\x20Brain\x20And\x20Scalpel','You\x20have\x20completed\x20all\x20questions.\x20Would\x20you\x20like\x20to\x20review\x20from\x20the\x20beginning?','fIXjM','warn','Disulfiram','https://cdn1.dailyrounds.org/uploads/9d49df501d8440d3bbffd6ee3c455cc4.JPEG','36\x20hours','Vincristine','otUKt','TMeQC','trace','forEach','VsZaw','V2\x20receptor\x20agonist\x20of\x20vasopressin','loadSource','selectedAnswer','Decreased\x20diastolic\x20perfusion\x20pressure','IL-17A\x20antagonist','https://dhmbxeygs57ff.cloudfront.net/uploads/dcf1afee41f64b98a0129246c3cb0a72x720x404.JPEG','QIwrD','questionStates','PeKmg','Use\x20a\x20combination\x20of\x20antacid\x20and\x20cimetidine\x20for\x20rapid\x20healing','ohOIm','hierarchy','KIeWb','ObGVO','LMGLx','IDgOs','isArray','apply','endsWith','green','<p>In\x20the\x20given\x20clinical\x20scenario,\x20the\x20most\x20likely\x20diagnosis\x20is\x20<strong>thyrotoxicosis</strong>.\x20As\x20she\x20is\x20in\x20her<strong>\x20third\x20trimester</strong>,\x20the\x20drug\x20of\x20choice\x20for\x20the\x20treatment\x20of\x20thyrotoxicosis\x20is\x20<strong>methimazole.</strong></p>\x0a<p>Treatment\x20of\x20thyrotoxicosis\x20in\x20pregnancy\x20has\x20been\x20summarized\x20in\x20the\x20table\x20below.</p>\x0a<table\x20style=\x22border-collapse:\x20collapse;\x20width:\x2038.5561%;\x22\x20border=\x221\x22>\x0a<tbody>\x0a<tr>\x0a<td\x20style=\x22width:\x2050.0766%;\x20text-align:\x20center;\x22>Trimester</td>\x0a<td\x20style=\x22width:\x2049.9234%;\x20text-align:\x20center;\x22>Treatment\x20options</td>\x0a</tr>\x0a<tr>\x0a<td\x20style=\x22width:\x2050.0766%;\x22>First\x20trimester</td>\x0a<td\x20style=\x22width:\x2049.9234%;\x22>\x0a<p>Propylthiouracil</p>\x0a</td>\x0a</tr>\x0a<tr>\x0a<td\x20style=\x22width:\x2050.0766%;\x22>Second\x20trimester</td>\x0a<td\x20style=\x22width:\x2049.9234%;\x22>Methimazole\x20(preferred)<br\x20/>Subtotal\x20thyroidectomy</td>\x0a</tr>\x0a<tr>\x0a<td\x20style=\x22width:\x2050.0766%;\x22><strong>Third\x20trimester</strong></td>\x0a<td\x20style=\x22width:\x2049.9234%;\x22><strong>Methimazole</strong></td>\x0a</tr>\x0a</tbody>\x0a</table>\x0a<p><strong>Thyrotoxicosis</strong>\x20during\x20pregnancy\x20is\x20usually\x20controlled\x20by\x20thioamide\x20drugs.\x20<strong>Propylthiouracil</strong>\x20was\x20preferred\x20previously\x20because\x20it\x20partially\x20inhibits\x20the\x20conversion\x20of\x20T4\x20to\x20T3\x20and\x20crosses\x20the\x20placenta\x20less\x20readily\x20than\x20methimazole.\x20However,\x20since\x20it\x20has\x20a\x20<strong>higher\x20risk\x20</strong>of\x20causing\x20<strong>propylthiouracil-associated\x20liver\x20failure\x20in\x20pregnancy</strong>,\x20<strong>methimazole</strong>\x20is\x20prescribed\x20according\x20to\x20guidelines\x20in<strong>\u00a0</strong>the<strong>\x20</strong>second\x20trimester<strong>\x20and\x20third\x20trimesters</strong>.\u00a0Methimazole\x20is\x20usually\x20avoided\x20in\x20the\x20first\x20trimester\x20due\x20to\x20<strong>methimazole-associated\x20embryopathy.</strong>\u00a0</p>\x0a<p>Other\x20options:</p>\x0a<p>Option\x20B:\x20<strong>Subtotal\x20thyroidectomy</strong>\x20is\x20done\x20once\x20the\x20hyperthyroidism\x20is\x20medically\x20controlled.\x20It\x20is\x20usually\x20avoided\x20during\x20pregnancy,\x20however,\x20may\x20be\x20done\x20in\x20some\x20cases\x20in\x20the\x20second\x20trimester\x20where\x20it\x20can\x27t\x20be\x20controlled\x20via\x20medication.</p>\x0a<p>Option\x20D:\x20<strong>Radioactive\x20iodine</strong>\x20is\x20<strong>contraindicated</strong>\x20in\x20pregnant\x20women\x20as\x20it\x20may\x20cause\x20<strong>fetal\x20thyroid\x20gland\x20destruction</strong>.</p>','pop','Endothelium\x20independent\x20coronary\x20vasodilation','jPxSv','Melanosis\x20coli','get','oSPly','Sitagliptin','A-2,\x20B-1,\x20C-4,\x20D-3','click','gradient-purple\x20px-6\x20py-3\x20text-white\x20transition-all\x20duration-300\x20flex\x20items-center','mGtcn','jHZIy','IzAGg','LRKbA','JkLHu','Bacterial\x20vaccines','<p><strong>Spironolactone,\x20triamterene,</strong>\x20and\x20<strong>amiloride</strong>\x20(1,\x203,\x20and\x204)\x20should\x20not\x20be\x20prescribed\x20to\x20patients\x20taking\x20ramipril.\x20Ramipril\x20is\x20an\x20<strong>ACE\x20inhibitor,\x20</strong>and\x20if\x20it\x20is\x20taken\x20along\x20with\x20<strong>potassium-sparing\x20diuretics,</strong>\u00a0it\x20may\x20lead\x20to\x20<strong>hyperkalemia.\u00a0</strong></p>\x0a<p>K<sup>+</sup>\u00a0sparing\x20diuretics\x20work\x20by\x202\x20mechanisms:</p>\x0a<ul>\x0a<li><strong>Blocking</strong>\u00a0the\u00a0<strong>ENaC</strong>\u00a0(epithelial\x20sodium\x20channel)\x20in\x20the\x20late\x20distal\x20tubules.\x0a<ul>\x0a<li>Triamterene</li>\x0a<li>Amiloride</li>\x0a</ul>\x0a</li>\x0a<li><strong>Aldosterone</strong>\u00a0receptor\u00a0<strong>antagonist</strong>\x0a<ul>\x0a<li>Spironolactone</li>\x0a<li>Eplerenone</li>\x0a<li>Canrenone</li>\x0a</ul>\x0a</li>\x0a</ul>\x0a<p>Thiazides\x20and\x20loop\x20diuretics\x20may\x20lead\x20to\x20loss\x20of\x20potassium\x20and\x20cause\x20hypokalemia.\x20Metolazone\x20and\x20chlorthalidone\x20are\x20thiazides\x20and\u00a0can\x20be\x20given\x20along\x20with\x20ACE\x20inhibitors.</p>','Stop\x20NSAIDs\x20and\x20chew\x20capsule\x20pantoprazole\x20for\x20rapid\x20action','1-D,\x202-B,\x203-A,\x204-C','NXQhc','Fidaxomicin','Ezogabine','gMDSN','zKNBH','<div\x20class=\x22mt-2\x22><p\x20class=\x22text-sm\x20text-white\x20text-opacity-70\x20mb-1\x22>Hinglish\x20Explanation:</p><audio\x20src=\x22','4SJzwaE','testModeLegend','BdhoR','XXhTa','return\x20(function()\x20','totalQuestions','ggsCN','ScjOE','findIndex','Praziquantel','Lkybw','Mebendazole','oEKwT','DkFrj','addEventListener','A\x20pregnant\x20female\x20at\x2036\x20weeks\x20gestation,\x20presents\x20with\x20palpitations,\x20protrusion\x20of\x20the\x20eyeball,\x20and\x20heat\x20intolerance.\x20On\x20blood\x20investigations,\x20it\x20was\x20found\x20that\x20she\x20had\x20increased\x20T3\x20and\x20T4\x20levels\x20and\x20decreased\x20TSH\x20levels.\x20\x20Which\x20of\x20the\x20following\x20should\x20be\x20the\x20next\x20step\x20in\x20the\x20management\x20of\x20this\x20patient?','video[data-src]','JCfWs','uXUZf','hidden','qbJys','name','A\x2028-year-old\x20woman\x20gave\x20birth\x20to\x20a\x20child\x20with\x20the\x20features\x20shown\x20in\x20the\x20given\x20image.\x20On\x20examination,\x20the\x20child\x20had\x20brittle\x20bones,\x20and\x20x-ray\x20scans\x20revealed\x20stippled\x20epiphyses.\x20Which\x20of\x20the\x20following\x20drugs\x20is\x20most\x20likely\x20to\x20be\x20implicated\x20in\x20causing\x20this\x20teratogenic\x20condition?','fvTnH','NktQU','quizSidebar','map','exception','questionText','A\x20young\x20patient\x20was\x20found\x20to\x20have\x20triglyceride\x20levels\x20of\x20600\x20mg/\x20dL.\x20His\x20LDL\x20levels\x20are\x20slightly\x20lower\x20than\x20normal\x20and\x20HDL\x20levels\x20are\x20reduced.\x20His\x20mother\x20too\x20has\x20elevated\x20triglycerides\x20with\x20reduced\x20levels\x20of\x20LDL\x20and\x20HDL\x20cholesterol.\x20The\x20patient\x20appears\x20healthy,\x20has\x20a\x20normal\x20BMI,\x20and\x20has\x20no\x20history\x20of\x20coronary\x20heart\x20disease\x20in\x20his\x20family.\x20Which\x20of\x20the\x20following\x20drugs\x20will\x20be\x20beneficial\x20for\x20this\x20patient?','Match\x20the\x20following\x20beta-blockers\x20with\x20their\x20receptor\x20selectivity\x20and\x20additional\x20actions.','totalAttempted','Ksvuq','\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20</div>','12.5\x20mg','KoTlh','<p>30.5\x20mg\x20of\x20the\x20drug\x20will\x20remain\x20after\x206\x20hours.</p>\x0a<p>In\x20<strong>first\x20order\x20kinetics,\u00a0</strong>a<strong>\x20constant\x20fraction</strong>\x20of\x20the\x20drug\x20is<strong>\x20excreted\x20in\x20</strong>a<strong>\x20given\x20time.</strong>\u00a0</p>\x0a<p>75\x20mg\x20of\x20200\x20mg\x20is\x20excreted\x20in\x2090\x20minutes</p>\x0a<p>75/200\x20=\x2037.5/100\x20=\u00a0<strong>0.375</strong>\u00a0is\x20eliminated\u00a0</p>\x0a<p>After\x2090\x20minutes;\x20200\x20mg-75\x20mg\x20=\x20125\x20mg\x20remains\u00a0</p>\x0a<p>The\x20next\x2090\x20minutes\x20(after\x20180\x20minutes)\x20=\x20125\x20x\x200.375\u00a0=\x2046.875\x20mg\x20is\x20eliminated,\x20and\x20125-46.875\x20=\x2078.125\x20mg\x20remains\u00a0</p>\x0a<p>The\x20next\x2090\x20minutes\x20(after\x20270\x20minutes)\x20=\x2078.125\x20x\x200.375\u00a0=\x2029.297\x20mg\x20is\x20eliminated,\x20and\x2078.125-29.297\x20=\x2048.828\x20remains\u00a0</p>\x0a<p>The\x20next\x2090\x20minutes\x20(after\x20360\x20minutes)\x20=\x2048.828\x20x\x200.375\u00a0=\x2018.310\x20mg\x20is\x20eliminated,\x2048.828-18.310\x20=\u00a0<strong>30.518\x20mg\x20remains\x20after\x206\x20hours.\u00a0</strong></p>\x0a<p>A\x20simpler\x20way\x20to\x20calculate\u00a0</p>\x0a<p>3/8\x20fraction\x20is\x20excreted\x20in\x2090\x20minutes\u00a0\x205/8\x20remains\x20after\x2090\x20minutes.</p>\x0a<p>6\x20hours\x20(360\x20min)\x20is\x204\x20times\x20of\x2090\x20minutes.</p>\x0a<p>So\x20200\x20x\x20(5/8)(5/8)(5/8)(5/8)\x20=\x20<strong>30.518\x20mg\x20remains\x20after\x20360\x20minutes\u00a0</strong></p>','xOYAP','pmNkf','qIiIO','<p><strong>Cisplatin</strong>\x20is\x20a\x20highly\x20emetogenic\x20anticancer\x20drug.&nbsp;Cisplatin\x20causes\x20marked\x20nausea\x20and\x20vomiting\x20in\x20almost\x20all\x20cases\x20and\x20is\x20usually\x20administered\x20along\x20with\x20anti-emetic\x20regimens.</p>\x0a<p>This\x20can\x20usually\x20be\x20controlled\x20with\x205HT3\x20receptor\x20antagonists,\x20neurokinin\x20(NK1)\x20receptor\x20antagonists\x20(e.g.,\x20aprepitant),\x20and\x20high-dose\x20corticosteroids.</p>','2,\x204','2\x20and\x204\x20only','Atropine','TLxwW','An\x2018-year-old\x20boy\x20visits\x20his\x20doctor\x20to\x20discuss\x20his\x20opioid\x20addiction.\x202\x20years\x20ago\x20he\x20tried\x20to\x20cut\x20down\x20on\x20his\x20opioid\x20consumption\x20but\x20developed\x20excessive\x20sweating,\x20lacrimation,\x20and\x20yawning.\x20He\x20wants\x20to\x20quit\x20now\x20with\x20the\x20help\x20of\x20medications.\x20Which\x20of\x20the\x20following\x20will\x20not\x20be\x20useful\x20in\x20this\x20patient?','lhqHD','study','1-D,\x202-A,\x203-B,\x204-C','zlVzV','\x20>\x20','QZjxH','FhYkg','To\x20inhibit\x20the\x20metabolism\x20of\x20levodopa\x20in\x20brain','A-2,\x20B-3,\x20C-4,\x20D-1','16\x20hours','Hydroxychloroquine','fQhvh','<div\x20class=\x22mt-2\x22><p\x20class=\x22text-sm\x20text-white\x20text-opacity-70\x20mb-1\x22>English\x20Explanation:</p><audio\x20src=\x22','question_images','navBtn_','xNJfS','<div\x20class=\x22mt-4\x22><video\x20id=\x22review-video-','1-b,\x202-a,\x203-c,\x204-d','display','APhcZ','totalTimeResult','bind','5HT3\x20receptor\x20antagonists','Liposomal\x20amphotericin\x20B\x20<\x20Amphotericin\x20B\x20lipid\x20complex\x20<\x20Conventional-AMB','IsYJz','notAttemptedResult','KpABA','RovLR','PULso','JBXJs','392013fnwtjg','Lithium','text','</span>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22text-white\x20mb-4\x22>','aVfWt','nEGtr','Cisplatin','questionIndex','H1\x20receptor\x20antagonists','cCVsO','\x22\x20class=\x22w-full\x20rounded-lg\x22\x20controls></video></div>','Hydrocortisone','HNOQS','Epinephrine','toggle','\x22\x20controls\x20class=\x22w-full\x22></audio></div>','ELGJg','2,\x203,\x204,\x205','Methadone','BkhWj','qENlJ','AOpTj','sdqPZ','1,\x203,\x204','custom_quiz.html','PyXkp','AgTEK','<p>The\x20correct\x20order\x20of\x20nephrotoxicity\x20with\x20amphotericin\x20B\x20formulations\x20is\x20<strong>liposomal\x20amphotericin\x20B\x20&lt;\x20amphotericin\x20B\x20lipid\x20complex\x20&lt;\x20conventional-amphotericin\x20B.</strong></p>\x0a<p>Nephrotoxicity\x20with&nbsp;amphotericin\x20B:</p>\x0a<p>All\x20<strong>lipid\x20formulations\x20of\x20amphotericin\x20B</strong>\x20are\x20<strong>less\x20nephrotoxic</strong>\x20than\x20conventional\x20amphotericin\x20B.&nbsp;Liposomal\x20amphotericin\x20B\x20is\x20less\x20nephrotoxic\x20than\x20amphotericin\x20B\x20lipid\x20complex,\x20especially\x20in\x20patients\x20with\x20a\x20higher\x20risk\x20of\x20nephrotoxicity.\x20Azotemia\x20is\x20seen\x20in\x2080%\x20of\x20cases\x20with\x20C-AMB.\x20Renal\x20tubular\x20acidosis\x20and\x20renal\x20wasting\x20of\x20potassium\x20and\x20magnesium\x20are\x20seen.\x20Nephrotoxicity\x20can\x20be\x20<strong>reduced\x20by\x20saline\x20loading.&nbsp;</strong></p>\x0a<p>Other\x20adverse\x20effects:</p>\x0a<p><strong>Infusion-related\x20reactions</strong>\x20-\x20It\x20is\x20most\x20prominent\x20with\x20amphotericin\x20B&nbsp;colloidal\x20dispersion.\x20Fever\x20and\x20chills\x20following\x20IV\x20injection\x20is\x20a\x20major\x20acute\x20reactions.\x20Tachypnea,\x20hypotension,\x20or\x20respiratory\x20stridor\x20may\x20be\x20also\x20seen.\x20Meperidine\x20is\x20used\x20to\x20shorten\x20the\x20reaction.</p>\x0a<p><strong>Hypochromic\x20normocytic\x20anemia</strong>\x20may\x20be\x20seen\x20due\x20to\x20decreased\x20erythropoietin.</p>\x0a<p>Headache,\x20nausea,\x20malaise,\x20vomiting,\x20and\x20phlebitis\x20at\x20the\x20site\x20of\x20injection\x20is\x20also\x20seen.</p>\x0a<p>Arachnoiditis\x20may\x20be\x20seen\x20with\x20intrathecal\x20injections.</p>\x0a<p>Formulations\x20of\x20amphotericin\x20B:</p>\x0a<p><strong>C-AMB(Conventional&nbsp;amphotericin\x20B)</strong>:\x20It\x20is\x20formulated\x20with\x20bile\x20salt\x20deoxycholate\x20and\x20is\x20given\x20as\x20an\x20intravenous\x20infusion.</p>\x0a<p><strong>ABCD(Amphotericin\x20B\x20colloidal\x20dispersion)</strong>:\x20It\x20is\x20formed\x20by\x20equimolar\x20concentrations\x20of\x20amphotericin\x20B\x20and\x20cholesteryl\x20sulfate.</p>\x0a<p><strong>L-AMB(Liposomal&nbsp;amphotericin\x20B)</strong>:\x20Here\x20amphotericin\x20B\x20is\x20incorporated\x20within\x20a\x20small\x20liposomal\x20vesicle.</p>\x0a<p><strong>ABLC(Amphotericin\x20B\x20lipid\x20complex)</strong>:\x20It\x20is\x20a\x20complex\x20of\x20amphotericin\x20B\x20with\x20two\x20phospholipids.</p>','gCzUk','PbsIb','<p>The\x20above\x20image\x20depicts\x20the<strong>\x20life\x20cycle\x20of\x20Onchocerca\x20volvulus,\u00a0</strong>which\x20is\x20transmitted\x20by\x20the<strong>\x20vector,\x20black\x20fly.\x20Ivermectin</strong>\x20is\x20the<strong>\x20drug\x20of\x20choice</strong>\x20for\x20<strong>onchocerciasis</strong>\x20caused\x20by\x20Oncocerca\x20volvulus\x20in\x20adults\x20and\x20children\x20aged\x20more\x20than\x205\x20years.\u00a0</p>\x0a<p>Onchocerciasis\x20may\x20present\x20with\x20subcutaneous\x20nodules\x20or\u00a0<strong>onchocercoma</strong>.\u00a0It\x20is\x20a\x20firm\u00a0<strong>non-tender\x20nodule</strong>\u00a0arising\x20from\u00a0bony\x20sites\x20like\x20the\u00a0coccyx\x20and\x20sacrum.\x20It\x20is\x20commonly\x20associated\x20with\u00a0<strong>pruritus</strong>\u00a0and\u00a0<strong>rashes</strong>.\x20Patients\x20may\x20also\x20have\x20loose\x20skin\x20with\x20hypo\x20or\x20hyperpigmentation\x20and\x20a\x20leopard\x20skin\x20appearance.</p>\x0a<p>Ivermectin\x20is\x20also\x20a\x20<strong>drug\x20of\x20choice</strong>\x20for\x20<strong>human\x20strongyloidiasis</strong>.\x20It<strong>\u00a0</strong>is\x20used\x20for<strong>\x20chemoprophylaxis\x20</strong>of\x20<strong>lymphatic\x20filariasis\x20</strong>caused\x20by\x20<strong><em>W.\x20bancrofti\x20</em>and\x20<em>B.\x20malayi.</em></strong>\x20It\x20is\x20as\x20effective\x20as\x20diethylcarbamazine\x20in\x20treating\x20lymphatic\x20filariasis.\x20It\x20can\x20also\x20be\x20used\x20in\x20strongyloidiasis,\x20ascariasis\x20and\x20enterobiasis.</p>\x0a<p>Ivermectin\x20activates\x20glutamate-gated\x20Cl\x20channels\x20and\x20GABA-gated\x20channels,\x20which\x20causes\x20muscular\x20paralysis\x20in\x20nematodes.\x20Cestodes\x20and\x20trematodes\x20are\x20not\x20sensitive\x20to\x20ivermectin\x20as\x20they\x20lack\x20receptors\x20for\x20binding.</p>\x0a<p>It\x20is\x20associated\x20with<strong>\u00a0Mazzotti\x20reaction</strong>\x20(fever,\x20pruritic\x20rash,\x20lymphadenopathy)\x20as\x20a\x20side\x20effect\u00a0when\x20given\x20for\x20filariasis\x20due\x20to\x20immune\x20system\x20activation\x20by\x20the\x20deadly\x20parasite.\x20This\x20reaction\x20is\x20also\x20seen\x20with\x20the\x20use\x20of\x20<strong>diethylcarbamazine</strong>.</p>','Nystatin','IuXlm','HuRDJ','questionNav','WRAqi','question_audio','8224yqdvCX','IpYXQ','1-C,\x202-B,\x203-A,\x204-D','gKHrN','0.5\x20-\x200.8\x20mEq/L','Subtotal\x20thyroidectomy','yseSp','Clopidogrel','explanation_audio_hin','1,\x202,\x203,\x204,\x20and\x205','A\x20patient\x20with\x20a\x20complex\x20psychiatric\x20history\x20is\x20on\x20a\x20monoamine\x20oxidase\x20(MAO)\x20inhibitor.\x20She\x20visits\x20her\x20primary\x20care\x20physician\x20with\x20increasing\x20depression.\x20The\x20physician\x20adds\x20a\x20selective\x20serotonin\x20reuptake\x20inhibitor\x20(SSRI).\x20Which\x20of\x20the\x20following\x20is\x20she\x20most\x20likely\x20to\x20develop?','jFQHE','application/vnd.apple.mpegurl','AZejq','\x22\x20controls\x20class=\x22w-full\x20rounded-lg\x22></video></div>','<p>The\x20given\x20image\x20is\x20suggestive\x20of\x20<strong>iris\x20pigmentation,&nbsp;</strong>which\x20is\x20seen\x20as\x20a\x20side-effect\x20of\x20topical&nbsp;<strong>prostaglandin\x20analogs</strong>\x20such\x20as<strong>\x20latanoprost\x20</strong>and<strong>\x20bimatoprost.&nbsp;</strong>The\x20mechanism\x20of\x20action\x20of\x20these\x20drugs\x20is&nbsp;<strong>increased\x20uveoscleral\x20outflow</strong><strong>.</strong></p>\x0a<p>Other\x20side\x20effects\x20of\x20topical\x20prostaglandins:</p>\x0a<ul>\x0a<li>Brown\x20pigmentation\x20of\x20iris\x20and\x20eyelash</li>\x0a<li>Dry\x20eyes</li>\x0a<li\x20style=\x22font-weight:\x20400;\x22\x20aria-level=\x221\x22>Macular\x20edema</li>\x0a<li\x20style=\x22font-weight:\x20400;\x22\x20aria-level=\x221\x22>Blurred\x20vision</li>\x0a<li\x20style=\x22font-weight:\x20400;\x22\x20aria-level=\x221\x22>Thickening\x20and\x20darkening\x20of\x20eyelashes(Hypertrichosis)</li>\x0a</ul>\x0a<p>The\x20main\x20classes\x20of\x20drugs\x20used\x20in\x20glaucoma\x20and\x20their\x20respective\x20mechanism\x20of\x20action\x20are\x20illustrated\x20below:</p>','NQSxF','LWHyY','UUGoK','CAnbi','totalTime','https://cdn1.dailyrounds.org/uploads/21168bb11bea4a9e9e9a38278b618a9f.JPEG','\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20','GzWuT','nav-btn-correct','oefvX','1-C,\x202-A,\x203-B,\x204-D','none','log','Biologicals\x20and\x20special\x20products\x20like\x20insulin,\x20toxin\x20and\x20antitoxins','azXLZ','Topiramate','FOovd','https://dhmbxeygs57ff.cloudfront.net/uploads/0d669e35bc1e4139bd255e4387c48c61x1280x1476.JPEG','1|4|0|5|3|2','PkcJF','https://cdn1.dailyrounds.org/uploads/0fbf15ad7b5548069875658a7e2cb57c.JPEG','correctAnswers','Oaceq','getAttribute','console','1,\x203,\x205','To\x20decrease\x20the\x20plasma\x20half\x20life\x20of\x20levodopa','keydown','Quinine\x20plus\x20doxycycline','WkMtm','strokeDasharray','A\x2040-year-old\x20male\x20patient\x20has\x20been\x20prescribed\x20a\x20drug\x20that\x20catalyzes\x20the\x20enzymatic\x20oxidation\x20of\x20uric\x20acid\x20into\x20allantoin\x20for\x20the\x20treatment\x20of\x20his\x20chronic\x20gout.\x20What\x20is\x20this\x20drug?','Omeprazole','1,\x202,\x204','<p><strong>Gastric\x20bezoar</strong>\x20can\x20be\x20seen\x20in\x20a\x20patient\x20taking\x20sucralfate.\x20Sucralfate\x20produces\x20a\x20<strong>viscous\x20gel\x20that\x20has\x20a\x20sticky\x20nature</strong>.\x20The\x20sticky\x20nature\x20may\x20be\x20responsible\x20for\x20gastric\x20bezoars,\x20particularly\x20in\x20those\x20with\x20gastroparesis.</p>\x0a<div\x20class=\x22page\x22\x20title=\x22Page\x20919\x22>\x0a<div\x20class=\x22section\x22>\x0a<div\x20class=\x22layoutArea\x22>\x0a<div\x20class=\x22column\x22>\x0a<p>Sucralfate\x20is\x20composed\x20of\x20a\x20sulfate\x20of\x20sucrose\x20with\x20Al(OH)<sub>3.\u00a0</sub>It\u00a0undergoes\x20cross-linking\x20to\x20produce\x20a\x20viscous\x20polymer\x20that\x20sticks\x20to\x20epithelial\x20cells\x20and\x20ulcers\x20in\x20acidic\x20environments.\x20It\x20inhibits\x20hydrolysis\x20of\x20the\x20mucosal\x20proteins\x20by\x20pepsin.</p>\x0a<p>It\x20is\x20used\x20in\x20the\x20prophylaxis\x20of\x20stress\x20ulcers,\x20and\x20in\x20conditions\x20where\x20mucosal\x20ulceration\x20is\x20not\x20responding\x20to\x20acid\x20suppression.</p>\x0a<p>Adverse\x20effects\x20of\x20sucralfate\x20include\x20constipation\x20and\x20bezoar\x20formation.\x20It\x20may\x20inhibit\x20absorption\x20of\x20other\x20drugs\x20like\x20digoxin,\x20cimetidine,\x20ketoconazole,\x20and\x20fluoroquinolone\x20antibiotics\x20due\x20to\x20the\x20viscous\x20layer\x20formed\x20in\x20the\x20stomach.\x20Hence\x20it\x20should\x20be\x20taken\x20at\x20least\x202\x20hours\x20after\x20administration\x20if\x20these\x20drugs.</p>\x0a</div>\x0a</div>\x0a</div>\x0a</div>\x0a<p>The\x20other\x20options:</p>\x0a<p><strong>Vitamin\x20B12\x20deficiency\x20</strong>and<strong>\x20increased\x20risk\x20of\x20bone\x20fractures\x20</strong>are\x20side\x20effects\x20of<strong>\u00a0proton\x20pump\x20inhibitors\x20</strong>(PPIs).\x20However,\x20their\x20clinical\x20significance\x20has\x20not\x20been\x20proven\x20yet.\u00a0<strong>Hypergastrinemia</strong>\x20is\x20more\x20commonly\x20seen\x20with<strong>\x20PPIs\x20</strong>than\x20H2\x20receptor\x20antagonists.</p>','add','taBhs','1-b,\x202-a,\x203-d,\x204-c','A\x20patient\x20who\x20was\x20being\x20treated\x20for\x20an\x20arrhythmia\x20presented\x20with\x20palpitations\x20and\x20chest\x20discomfort.\x20His\x20ECG\x20has\x20been\x20given\x20below.\x20Which\x20of\x20the\x20following\x20drugs\x20would\x20be\x20least\x20likely\x20to\x20cause\x20this\x20condition?','push','No\x20question\x20text\x20available','bookmarkedQuestions','parse','RuCzQ','Amoxicillin','frzMx','border-green-500','Betamethasone','<p><strong>Disulfiram</strong>\x20will\x20not\x20be\x20useful\x20for\x20the\x20treatment\x20of\x20opioid\x20detoxification.\x20It\x20is\x20used\x20in\x20cases\x20of\x20<strong>chronic\x20alcoholism</strong>.</p>\x0a<p>Two\x20years\x20back\x20when\x20the\x20patient\x20tried\x20to\x20cut\x20down\x20his\x20opioid\x20intake,\x20he\x20experienced\x20<strong>opioid\x20withdrawal</strong>\x20symptoms.\x20Symptoms\x20begin\x208-10\x20hours\x20after\x20the\x20last\x20consumed\x20dose.\x20Initially,\x20symptoms\x20include</p>\x0a<ul>\x0a<li>Lacrimation</li>\x0a<li>Rhinorrhea</li>\x0a<li>Yawning</li>\x0a<li>Sweating&nbsp;</li>\x0a</ul>\x0a<p>Later,\x20the\x20patient\x20develops</p>\x0a<ul>\x0a<li>Restless\x20sleep</li>\x0a<li>Weakness,\x20chills,\x20gooseflesh\x20(&ldquo;cold\x20turkey&rdquo;)</li>\x0a<li>Nausea\x20and\x20vomiting</li>\x0a<li>Muscle\x20aches\x20and\x20involuntary\x20movements\x20(&ldquo;kicking\x20the\x20habit&rdquo;)</li>\x0a<li>Hyperpnea</li>\x0a<li>Hyperthermia</li>\x0a<li>Hypertension</li>\x0a</ul>\x0a<p>The\x20treatment\x20for\x20the\x20opioid\x20withdrawal\x20includes:</p>\x0a<p><strong>Opioid\x20agonists\x20(methadone)\x20or\x20partial\x20agonists\x20(buprenorphine</strong>)\x20administered\x20<strong>orally\x20or\x20sublingually</strong>\x20may\x20be\x20substituted\x20for\x20injectable\x20narcotics.&nbsp;</p>\x0a<p><strong>Lofexidine</strong>&nbsp;and\x20clonidine\x20are\x20alpha\x202\x20agonists\x20which\x20can&nbsp;<strong>ameliorate\x20symptoms\x20of\x20opioid\x20withdrawal</strong>.\x20Lofexidine\x20is\x20the\x20first\x20<strong>non-opioid</strong>\x20treatment\x20for\x20managing\x20opioid\x20withdrawal\x20symptoms\x20in\x20adults\x20approved\x20by\x20the\x20FDA\x20in\x202018.</p>\x0a<p><strong>Naltrexone,</strong>\x20a\x20<strong>long-acting\x20opioid\x20antagonist</strong>,\x20is\x20used\x20as\x20an\x20<strong>adjunct</strong>\x20if\x20the\x20patient\x20is\x20already&nbsp;<strong>opioid-free.\x20</strong>Administration\x20of\x20naltrexone\x20to\x20patients\x20that\x20are\x20opioid-dependent\x20will\x20precipitate\x20acute\x20withdrawal\x20symptoms.</p>','wQsHN','IL-1\x20receptor\x20antagonist','YqlVl','(((.+)+)+)+$','fBJBg','prevBtn','A\x2032-year-old\x20female\x20patient\x20presented\x20with\x20right-sided\x20flank\x20pain\x20which\x20radiates\x20to\x20the\x20groin.\x20She\x20also\x20reports\x20nausea\x20and\x20one\x20episode\x20of\x20vomiting.\x20Her\x20X-Ray\x20abdomen\x20is\x20shown\x20below.\x20She\x20has\x20been\x20on\x20regular\x20medication\x20for\x20a\x20seizure\x20disorder.\x20Which\x20of\x20the\x20following\x20drugs\x20can\x20be\x20implicated\x20in\x20this\x20case?','1373246SCEONh','THvpJ','Beta\x202','xYgnG','safPo','Ogclm','An\x20infant\x20on\x20antibiotics\x20becomes\x20very\x20irritable.\x20Investigations\x20reveal\x20increased\x20intracranial\x20pressure.\x20However,\x20the\x20condition\x20resolves\x20on\x20discontinuation\x20of\x20the\x20drug.\x20Which\x20drug\x20had\x20the\x20baby\x20likely\x20been\x20on?','question_video','txyCM','xzgFk','yEQil','explanationVideoPlayer','__proto__','cKWnb','LFQaH','userHistory','Bookmark','split','yILyV','Triamcinolone','performanceModal','padStart','DsFRd','hQYQw','MGJlQ','1,\x202,\x203,\x204','You\x20are\x20an\x20intern\x20and\x20you\x20see\x20a\x2067-year-old\x20male\x20patient\x20with\x20a\x20history\x20of\x20liver\x20cirrhosis\x20present\x20to\x20the\x20emergency\x20department\x20with\x20massive\x20hematemesis.\x20He\x20is\x20hemodynamically\x20stable\x20now\x20after\x20the\x20first-line\x20management.\x20Which\x20of\x20the\x20following\x20agents\x20are\x20useful\x20in\x20the\x20medical\x20treatment\x20of\x20variceal\x20bleeding?','ahlWj','xtHYV','Macrolides','pCfKD','solutionContainer','24\x20hours','Cholestyramine','cEGQy','AgSct','In\x20which\x20of\x20the\x20following\x20conditions\x20can\x20rifampicin\x20be\x20used?','Switch\x20to\x20etoricoxib\x20instead\x20of\x20NSAIDs\x20and\x20use\x20pantoprazole\x20capsule\x20without\x20chewing','UMpDL','rTqwK','nhozM','nFGmZ','Octreotide','includes','<div\x20class=\x22mt-2\x22><p\x20class=\x22text-sm\x20text-white\x20text-opacity-70\x20mb-1\x22>English:</p><audio\x20src=\x22','border-gray-600','tPqQH','\x22><span\x20class=\x22font-bold\x20mr-3\x22>','A\x2054-year-old\x20woman\x20presented\x20to\x20the\x20clinic\x20with\x20difficulty\x20in\x20vision.\x20She\x20is\x20a\x20known\x20case\x20of\x20rheumatoid\x20arthritis\x20for\x20which\x20she\x20has\x20been\x20on\x20medication\x20for\x20many\x20years\x20along\x20with\x20drugs\x20for\x20the\x20management\x20of\x20her\x20diabetes\x20and\x20hypertension.\x20Fundus\x20examination\x20of\x20the\x20patient\x20shows\x20the\x20following\x20finding.\x20Which\x20of\x20the\x20following\x20drug\x20could\x20have\x20caused\x20this\x20finding?','Arrange\x20the\x20following\x20formulations\x20of\x20amphotericin\x20B\x20(AMB)\x20according\x20to\x20the\x20increasing\x20order\x20of\x20nephrotoxicity.','oRdYi','currentMode','LFfml','llnLj','innerHTML','Arrange\x20the\x20following\x20benzodiazepines\x20in\x20increasing\x20order\x20of\x20their\x20half-lives\x20(shortest\x20to\x20longest\x20acting).','VxdLT','avKZD','rReGi','yDMXn','UtHHf','questionReviewSection','SGOVs','textContent','cHFpl','data-option-index','notAttempted','GQnjt','getItem','appendChild','ZzOpN','A\x2065-year-old\x20male\x20patient\x20complains\x20of\x20intermittent\x20epigastric\x20pain\x20that\x20is\x20worse\x20with\x20food\x20intake\x20over\x20the\x20past\x203\x20months.\x20On\x20further\x20evaluation,\x20he\x20was\x20found\x20to\x20have\x20peptic\x20ulcer\x20disease\x20caused\x20by\x20H.\x20pylori.\x20Which\x20of\x20the\x20following\x20drugs\x20is\x20not\x20used\x20in\x20H.\x20pylori\x20eradication?','Mark\x20for\x20Review','ArrowLeft','sxval','Imiquimod','JbVYq','nlPXo','Increased\x20risk\x20of\x20bone\x20fractures','Year\x202022\x20-\x2023','</span></div>','markedForReview','NcaPN','tOXQG','2612968CIadwC','answered','yctYj','A\x2060-year-old\x20female\x20patient\x20presented\x20with\x20the\x20following\x20finding.\x20Her\x20medical\x20history\x20includes\x20hypertension\x20for\x20which\x20she\x20has\x20been\x20taking\x20regular\x20medications\x20for\x20the\x20past\x203\x20months.\x20Which\x20of\x20the\x20following\x20medication\x20is\x20most\x20likely\x20to\x20be\x20associated\x20with\x20this\x20finding?','round','accuracyScore','disabled','TEqYZ','1,\x202,\x203\x20and\x205','quizPerformanceData','solutionImages','Ezetimibe','totalQuestionsResult','LDsLU','https://dhmbxeygs57ff.cloudfront.net/uploads/c79334e432384464a4db8f878ca4023bx720x540.JPEG','sxQYV','QHdnC','optionsContainer','gzyet','jRbEJ','TNF-alpha\x20antagonist','VEmVL','bzBNw','50\x20mg','<p\x20style=\x22text-align:\x20left;\x22>The\x20device\x20in\x20image\x203\x20is\x20a\u00a0<strong>spacer\x20device\x20</strong>that\x20can\x20be\x20prescribed\x20to<strong>\u00a0</strong><strong>decrease\u00a0</strong>the\x20incidence\x20of\x20propellant-mediated\x20<strong>oropharyngeal\x20adverse\x20effects</strong>.</p>\x0a<p\x20style=\x22text-align:\x20left;\x22>Spacers\x20reduce\x20the\x20velocity\x20and\x20size\x20of\x20particles\x20entering\x20the\x20upper\x20airways.\u00a0This<strong>\u00a0</strong>reduces\x20the\x20amount\x20of\x20drug\x20depositing\x20in\x20the\x20oropharynx\x20and\x20increases\x20the\x20proportion\x20of\x20drugs\x20inhaled\x20into\x20the\x20lower\x20airways.\x20Thus,\x20a\x20less\x20amount\x20of\x20the\x20drug\x20gets\x20swallowed\x20and\x20absorbed\x20from\x20the\x20GI\x20tract\x20and\x20limits\x20local\x20side\x20effects.\u00a0</p>\x0a<p\x20style=\x22text-align:\x20left;\x22>Spacer\x20devices\x20are\x20<strong>useful</strong>\x20in\x20delivering\x20inhaled\x20drugs\x20to\x20<strong>children</strong>\u00a0who\x20are\x20not\x20able\x20to\x20use\x20a\x20pMDI\x20alone\x20but\x20can\x20also\x20be\x20used\x20by\x20<strong>adults</strong>\x20for\x20better\x20drug\x20delivery.\x20The\x20image\x20below\x20shows\x20the\x20use\x20of\x20a\x20spacer\x20device\x20with\x20a\x20face\x20mask\x20which\x20is\x20preferred\x20in\x20children\x20younger\x20than\x203\x20years\x20of\x20age.</p>','HZKex','uDGEY','BGcMC','XKCwV','Pioglitazone','dZIYW','5-Fluorouracil','AxNUC','MbNSt','incorrectAnswers','https://dhmbxeygs57ff.cloudfront.net/uploads/cf3ec9228e96415da2ec3c3932577099x596x600.JPEG','1.2\x20-\x201.6\x20mEq/L','progressBar','zgVVw','Liposomal\x20amphotericin\x20B\x20<\x20Conventional-AMB\x20<\x20Amphotericin\x20B\x20lipid\x20complex','Lorazepam\x20<\x20remimazolam\x20<\x20diazepam\x20<\x20midazolam','https://dhmbxeygs57ff.cloudfront.net/uploads/a16728452d0c4a8fb6ef7304909a6502x600x618.JPEG','index.html','megsr','VWshm','ufXDp','rAyOe','xeBtb','{}.constructor(\x22return\x20this\x22)(\x20)','Alpha\x202','</h4>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<span\x20class=\x22text-sm\x20px-3\x20py-1\x20rounded-full\x20bg-','explanation_video','pfast','completed','feoUA','resume','Vitamin\x20B12\x20deficiency','bookmarked','Which\x20of\x20the\x20following\x20are\x20mechanisms\x20of\x20action\x20of\x20dapsone?','selected','testModeReviewLegend','ZFevY','Are\x20you\x20sure\x20you\x20want\x20to\x20retake\x20the\x20quiz?\x20This\x20will\x20reset\x20all\x20your\x20answers.','\x22>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22option-letter\x22>','rgdpA','A\x2030-year-old\x20female\x20patient\x20with\x20early\x20morning\x20stiffness\x20and\x20chronic\x20pain\x20over\x20small\x20joints\x20was\x20diagnosed\x20with\x20rheumatoid\x20arthritis.\x20She\x20has\x20been\x20on\x20drugs\x20for\x20the\x20past\x20few\x20years,\x20without\x20any\x20improvement.\x20Now,\x20it\x20has\x20been\x20decided\x20to\x20start\x20her\x20on\x20biological\x20agents.\x20Which\x20of\x20the\x20following\x20will\x20not\x20be\x20used\x20in\x20this\x20patient?','<p><strong>Rimegepant</strong>\u00a0is\x20a\x20recently\x20approved\x20<strong>orally</strong>-administered\u00a0<strong>CGRP\x20(calcitonin\x20gene-related\x20peptide)\x20receptor\x20antagonist</strong>\u00a0used\x20in\x20the\x20treatment\x20of\x20an\x20<strong>acute\x20attack\x20of\x20migraine</strong>\x20with\x20or\x20without\x20aura.\x20It\x20is\x20not\x20effective\x20for\x20migraine\x20prophylaxis.</p>\x0a<p>The\x20major\x20side\x20effect\x20associated\x20with\x20the\x20drug\x20is\u00a0<strong>nausea</strong>.\x20Because\x20it\x20is\x20metabolized\x20by\x20CYP3A4,\x20concomitant\x20administration\x20with\x20CYP3A4\x20inducers/inhibitors\x20is\x20avoided.\x20It\x20is\x20also\x20avoided\x20in\x20Child-Pugh\x20C\x20cirrhosis\x20as\x20it\x20is\x20hepatically\x20metabolized.\u00a0</p>\x0a<p>CGRP\x20receptor\x20antagonists\x20are:</p>\x0a<ul>\x0a<li>Rimegepant</li>\x0a<li>Ubrogepant</li>\x0a<li>Erenumab</li>\x0a</ul>\x0a<p>Rimegepant\x20and\x20ubrogepant\x20are\x20used\x20only\x20for\x20the\x20treatment\x20of\x20an\x20acute\x20attack\x20of\x20migraine\x20while\u00a0<strong>erenumab</strong>\u00a0is\x20only\x20indicated\x20for\u00a0<strong>prophylaxis</strong>\u00a0of\x20migraine\x20in\x20adults.</p>','correct_choice_id','vgTzk','xGUIv','https://dhmbxeygs57ff.cloudfront.net/uploads/b2b1e13fe6134e12b1862511d5f653abx1280x1424.JPEG','Rivaroxaban','timed_study','avgTimeResult','A\x2055-year-old\x20female\x20patient\x20presented\x20with\x20a\x20complaint\x20of\x20lower\x20backache.\x20The\x20MRI\x20of\x20her\x20lumbosacral\x20spine\x20is\x20given\x20below.\x20Her\x20bone\x20mineral\x20density\x20is\x20measured,\x20and\x20her\x20T-score\x20is\x20-2.8.\x20She\x20is\x20given\x20oral\x20drugs,\x20but\x20she\x20develops\x20esophagitis.\x20Which\x20of\x20the\x20following\x20intravenous\x20treatment\x20plans\x20would\x20be\x20useful\x20in\x20this\x20scenario?','tDwEE','glass-light\x20px-6\x20py-3\x20text-white\x20hover:bg-purple-500\x20hover:bg-opacity-20\x20transition-all\x20duration-300\x20flex\x20items-center','VIjpA','MTDlB','<p>The\x20patient\x27s\x20complaints\x20of\u00a0breathing\x20difficulty,\x20facial\x20swelling,\x20and\x20palpitations\x20following\x20a\x20bee\x20sting\x20are\x20suggestive\x20of\x20anaphylactic\x20shock.\x20The\x20<strong>drug\u00a0of\x20choice</strong>\x20for\x20anaphylaxis\x20is\x20<strong>intramuscular\x20adrenaline</strong>\x20(<strong>0.5ml\x20in\x201:1000\x20dilution</strong>).\x20Activation\x20of\x20<strong>beta\x202</strong>\x20receptors\x20causes<strong>\x20bronchodilation</strong>.\x20Hence,\x20adrenaline\x20action\x20on\x20the\x20beta\x202\x20receptors\x20improves\x20the\x20breathing\x20difficulty\x20in\x20this\x20patient.\x20Apart\x20from\x20this,\x20beta\x202\x20receptors\x20also\x20inhibit\x20the\x20secretion\x20from\x20mast\x20cells.</p>\x0a<p><strong>Other\x20options:</strong></p>\x0a<table\x20style=\x22height:\x2099px;\x22\x20width=\x22456\x22>\x0a<tbody>\x0a<tr>\x0a<td\x20style=\x22width:\x2086.28125px;\x22><strong>Receptor</strong></td>\x0a<td\x20style=\x22width:\x20157.734375px;\x22><strong>Action</strong></td>\x0a<td\x20style=\x22width:\x20190.015625px;\x22><strong>Use\x20in\x20anaphylaxis\x20treatment\u00a0</strong></td>\x0a</tr>\x0a<tr>\x0a<td\x20style=\x22width:\x2086.28125px;\x22>Alpha\x201\x20and\x20Alpha\x202</td>\x0a<td\x20style=\x22width:\x20157.734375px;\x22>Vasoconstriction</td>\x0a<td\x20style=\x22width:\x20190.015625px;\x22>Increase\x20in\x20BP</td>\x0a</tr>\x0a<tr>\x0a<td\x20style=\x22width:\x2086.28125px;\x22>Beta\x201</td>\x0a<td\x20style=\x22width:\x20157.734375px;\x22>Cardiac\x20stimulation</td>\x0a<td\x20style=\x22width:\x20190.015625px;\x22>Increase\x20in\x20BP</td>\x0a</tr>\x0a<tr>\x0a<td\x20style=\x22width:\x2086.28125px;\x22>Beta\x202</td>\x0a<td\x20style=\x22width:\x20157.734375px;\x22>Bronchodilation</td>\x0a<td\x20style=\x22width:\x20190.015625px;\x22>Reverse\x20bronchoconstriction\u00a0</td>\x0a</tr>\x0a</tbody>\x0a</table>\x0a<p><br\x20/>The\x20net\x20effect\x20of\x20adrenaline\x20on\x20BP:\x20Adrenaline\x20rapidly\x20<strong>increases\x20blood\x20pressure</strong>\x20by\x20reversing\x20vasodilation\x20and\x20improving\x20cardiac\x20output.\x20This\x20is\x20critical\x20for\x20preventing\x20shock\x20and\x20ensuring\x20adequate\x20perfusion\x20to\x20vital\x20organs\x20during\x20anaphylaxis.</p>','markReviewBtn','modeModal','<table\x20style=\x22width:\x20372px;\x20height:\x20165px;\x22>\x0a<tbody>\x0a<tr\x20style=\x22height:\x2033px;\x22>\x0a<td\x20style=\x22width:\x2075.8359px;\x20height:\x2033px;\x22>Pindolol</td>\x0a<td\x20style=\x22width:\x20280.164px;\x20height:\x2033px;\x22>&nbsp;Non-selective,\x20intrinsic\x20agonist</td>\x0a</tr>\x0a<tr\x20style=\x22height:\x2028px;\x22>\x0a<td\x20style=\x22width:\x2075.8359px;\x20height:\x2028px;\x22>Carvedilol</td>\x0a<td\x20style=\x22width:\x20280.164px;\x20height:\x2028px;\x22>&nbsp;Non-selective,\x20antioxidant</td>\x0a</tr>\x0a<tr\x20style=\x22height:\x2030px;\x22>\x0a<td\x20style=\x22width:\x2075.8359px;\x20height:\x2030px;\x22>Betaxolol</td>\x0a<td\x20style=\x22width:\x20280.164px;\x20height:\x2030px;\x22>&nbsp;Beta\x201\x20selective,\x20membrane\x20stabilizing</td>\x0a</tr>\x0a<tr\x20style=\x22height:\x2031.5px;\x22>\x0a<td\x20style=\x22width:\x2075.8359px;\x20height:\x2031.5px;\x22>Acebutolol</td>\x0a<td\x20style=\x22width:\x20280.164px;\x20height:\x2031.5px;\x22>&nbsp;Beta\x201\x20selective,\x20intrinsic\x20agonist</td>\x0a</tr>\x0a</tbody>\x0a</table>\x0a<p><strong>Pindolol</strong>\x20is\x20a\x20non-selective\x20first-generation\x20&beta;-blocker\x20with\x20significant\x20intrinsic\x20agonist\x20activity,\x20which\x20may\x20result\x20in\x20a\x20<strong>smaller\x20reduction\x20in\x20heart\x20rate</strong>\x20and\x20blood\x20pressure.\x20This\x20is\x20useful\x20in\x20patients\x20with\x20diminished\x20cardiac\x20reserve\x20or\x20at\x20risk\x20of\x20bradycardia.</p>\x0a<p><strong>Carvedilol</strong>\x20is\x20a\x20non-selective\x20third-generation&nbsp;&beta;-blocker\x20with\x20<strong>antioxidant</strong>\x20and\x20anti-inflammatory\x20properties.\x20These\x20properties\x20make\x20it\x20useful\x20in\x20the\x20treatment\x20of\x20<strong>congestive\x20heart\x20failure</strong>.</p>\x0a<p><strong>Betaxolol\x20</strong>is\x20a\x20&beta;<sub>1</sub>&nbsp;selective\x20third-generation\x20&beta;-blocker\x20with\x20additional\x20<strong>calcium\x20entry\x20blockade</strong>\x20activity\x20and\x20a\x20slight\x20membrane-stabilizing\x20property.\x20It\x20does\x20not\x20have\x20agonist\x20activity.</p>\x0a<p><strong>Acebutolol</strong>\x20is\x20a&nbsp;&beta;<sub>1</sub>&nbsp;selective\x20second-generation&nbsp;&beta;\x20blocker\x20having\x20both\x20<strong>membrane-stabilizing</strong>\x20and\x20<strong>intrinsic\x20agonist</strong>\x20activity.\x20It\x20is\x20useful\x20in\x20the\x20treatment\x20of\x20atrial\x20and\x20ventricular\x20<strong>arrhythmias</strong>.</p>','fill','PwVkS','Match\x20the\x20following\x20pairs\x20of\x20drugs\x20with\x20their\x20antidotes.','Allopurinol','location','A\x20young\x20woman\x20presents\x20with\x20painless\x20warty\x20lesions\x20on\x20the\x20vulva\x20as\x20shown\x20in\x20the\x20image\x20below.\x20Which\x20of\x20the\x20following\x20is\x20a\x20topical\x20agent\x20that\x20can\x20be\x20prescribed\x20for\x20her\x20condition?','Neurokinin\x20receptor\x20antagonists','UqaCW','TrwuF','Remimazolam\x20<\x20midazolam\x20<\x20lorazepam\x20<\x20diazepam','A\x2035-year-old\x20female\x20patient\x20diagnosed\x20with\x20migraine\x20visited\x20her\x20doctor\x20and\x20noticed\x20a\x20new\x20drug,\x20rimegepant,\x20on\x20one\x20of\x20the\x20migraine\x20pamphlets.\x20Which\x20of\x20the\x20following\x20information\x20would\x20have\x20been\x20correctly\x20mentioned\x20in\x20the\x20pamphlet?','vozzB','red','now','contains','questionMedia','nUEdc','ZefwI','floor','A\x2030-year-old\x20male\x20patient\x20was\x20diagnosed\x20with\x20constipation\x20and\x20was\x20started\x20on\x20senna\x20laxatives.\x20After\x205\x20months,\x20the\x20patient\x20came\x20to\x20the\x20hospital\x20with\x20complaints\x20of\x20nausea,\x20vomiting,\x20and\x20abdominal\x20cramping.\x20The\x20colonoscopy\x20of\x20the\x20patient\x20is\x20shown.\x20The\x20diagnosis\x20of\x20this\x20patient\x20is\x20____________','ojqgy','5412PBDsqv','JkCKD','OTkBF','PVbaP','azZQS','Decreased\x20aqueous\x20production','iUKTk','FddWn','setItem','<div\x20class=\x22mt-4\x22><img\x20src=\x22','gZOVY','A\x20patient\x20with\x20Prinzmetal\x20angina\x20is\x20administered\x20isosorbide\x20mononitrate\x20and\x20is\x20noticed\x20to\x20have\x20symptomatic\x20relief.\x20What\x20is\x20the\x20mechanism\x20of\x20action\x20of\x20nitrate\x20in\x20this\x20case?','pqTpe','kkaep','usQeq','xzYpm','pathname','MnwPz','Hypergastrinemia','vLbnH','rsopf','MFzYz','IYIOX','xtXoc','gradient-yellow\x20px-6\x20py-3\x20text-white\x20transition-all\x20duration-300\x20flex\x20items-center','nav-btn-incorrect','WRIzg','KrYBW','2,\x203,\x20and\x204\x20only','Colchicine','not_attempted','lEaKb','https://dhmbxeygs57ff.cloudfront.net/uploads/93840ed926b44eb0b9c472744692f546x600x665.JPEG','A\x20patient\x20was\x20given\x20200\x20mg\x20of\x20a\x20drug\x20that\x20follows\x20first-order\x20kinetics.\x20If\x2075\x20mg\x20is\x20excreted\x20in\x2090\x20minutes,\x20how\x20much\x20drug\x20will\x20remain\x20at\x20the\x20end\x20of\x206\x20hours?','https://cdn1.dailyrounds.org/uploads/73e78df307ab449686e7e18b7b145007.JPEG','vehLb','nav-btn-not-attempted\x20hover:bg-white\x20hover:bg-opacity-20','</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20</button>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20','sjDwR','Zoledronate\x20\x205\x20mg\x20annually','eioZQ','isSupported','qkSEy','WVjJr','https://dhmbxeygs57ff.cloudfront.net/uploads/1da7704b5b1d483f8735fe14ced286d4x1280x1477.JPEG','JSqvj','mNABP','\x22\x20alt=\x22Explanation\x20Image\x22\x20class=\x22w-full\x20rounded-lg\x22></div>','XIgJO','quizHierarchy','Noncompetitive\x20antagonism','createElement','UdmLe','choices','not-attempted','BIQXA','755BowIBf','qRCbl','1,\x203\x20and\x205','getElementById','EEIGF','border-red-500','ndoHW','Vigabatrin','A\x2060-year-old\x20female\x20patient\x20was\x20diagnosed\x20with\x20parkinsonism.\x20She\x20was\x20commenced\x20on\x20combination\x20therapy\x20with\x20co-careldopa.\x20What\x20is\x20the\x20rationale\x20behind\x20this\x20combination\x20therapy?','incorrect','FDZBA','w-8\x20h-8\x20text-sm\x20font-medium\x20rounded\x20','GOoGT','<p>The\x20given\x20scenario\x20depicts\x20a\x20case\x20of\x20<strong>pseudotumor\x20cerebri</strong>\x20and\x20<strong>tetracyclines</strong>\x20are\x20associated\x20with\x20this\x20condition\x20in\x20infants,\x20even\x20when\x20given\x20in\x20normal\x20doses.\x20Only\x20<strong>elevated\x20intracranial\x20pressure</strong>\x20is\x20seen\x20without\x20any\x20abnormality\x20in\x20the\x20spinal\x20fluid.\x20Increased\x20pressure\x20returns\x20to\x20normal\x20after\x20therapy\x20is\x20discontinued.</p>\x0a<p>Other\x20<strong>side\x20effects</strong>\x20of\x20tetracyclines\x20are:</p>\x0a<ul>\x0a<li><strong>Teratogenic</strong></li>\x0a<li>Deposit\x20in\x20developing\x20teeth&nbsp;and\x20bones,\x20cause\x20brownish\x20discoloration\x20of\x20teeth\x20(chelating\x20property)</li>\x0a<li>Marked\x20suppression\x20of\x20normal\x20flora\x20of\x20intestine\x20causing\x20superinfection.<strong>&nbsp;Pseudomembranous\x20enterocolitis</strong>\x20is\x20a\x20rare\x20side\x20effect</li>\x0a</ul>','length','Nonsteroidal\x20anti-inflammatory\x20drugs','<p>The\x20rationale\x20behind\x20the\x20combination\x20therapy\x20of<strong>\x20levodopa</strong>\x20with\x20a\x20peripheral\x20DOPA\x20decarboxylase\x20inhibitor\x20like\x20<strong>carbidopa\x20(co-careldopa)</strong>\x20is\x20that\x20inhibition\x20of\x20the\x20metabolism&nbsp;of\x20levodopa\x20(i.e.\x20conversion\x20of\x20levodopa\x20into\x20dopamine)\x20in\x20the\x20peripheral\x20circulation\x20<strong>decreases\x20the\x20systemic\x20side\x20effects</strong>\x20of&nbsp;levodopa,\x20like\x20vomiting.</p>\x0a<p>Peripheral\x20dopa\x20decarboxylase\x20inhibitors\x20(carbidopa)\x20do\x20not\x20cross\x20the\x20blood-brain\x20barrier.\x20Therefore,\x20they\x20only\x20<strong>inhibit\x20</strong>the<strong>\x20conversion\x20of\x20levodopa</strong>\x20into\x20dopamine\x20in\x20the<strong>\x20periphery</strong>\x20and\x20<strong>not\x20in\x20the\x20brain</strong>.\x20This\x20leads\x20to\x20the\x20increased\x20plasma\x20half-life\x20of\x20levodopa,\x20and\x20therefore,\x20lower\x20doses\x20of\x20levodopa\x20can\x20be\x20prescribed.</p>\x0a<p>Benefits\x20of\x20combination\x20therapy:</p>\x0a<ul>\x0a<li>This\x20therapy\x20inhibits\x20the\x20metabolism\x20of\x20levodopa\x20in\x20the\x20periphery,\x20leading\x20to\x20<strong>increased\x20plasma\x20half-life</strong>\x20of\x20levodopa.</li>\x0a<li>Combination\x20therapy\x20reduces\x20adverse\x20effects\x20like\x20gastrointestinal\x20side\x20effects,\x20orthostatic\x20hypotension,\x20and\x20cardiac\x20arrhythmias.</li>\x0a<li>This\x20therapy\x20allows\x20for\x20increased\x20availability\x20of\x20levodopa\x20in\x20the\x20brain.</li>\x0a<li>Fluctuation\x20in\x20motor\x20control,\x20where\x20the\x20patient\x20is\x20alternately\x20well\x20and\x20disabled,\x20occurs\x20on\x20prolonged\x20therapy\x20with\x20levodopa.\x20This\x20type\x20of\x20\x22<strong>on-off</strong>\x22\x20effect\x20is\x20<strong>reduced</strong>\x20in\x20combination\x20therapy\x20because\x20of\x20sustained\x20dopamine\x20levels\x20in\x20the\x20brain.</li>\x0a<li><strong>Pyridoxine</strong>\x20enhances\x20the\x20peripheral\x20metabolism\x20of\x20levodopa.\x20Hence,\x20combination\x20therapy\x20with\x20carbidopa\x20nullifies\x20the\x20interaction\x20of\x20pyridoxine\x20with\x20levodopa\x20metabolism.</li>\x0a<li><strong>&nbsp;</strong>A<strong>\x20higher&nbsp;degree\x20of\x20improvement</strong>\x20is\x20seen&nbsp;in\x20combination\x20therapy\x20than\x20in\x20monotherapy\x20with\x20levodopa.</li>\x0a</ul>\x0a<p>Demerits\x20of\x20combination\x20therapy:</p>\x0a<p>This\x20therapy\x20decreases\x20the\x20concentration\x20of\x20levodopa\x20in\x20the\x20periphery,\x20but\x20increases\x20the\x20concentration\x20of\x20levodopa\x20reaching\x20the\x20brain.<strong>\x20Involuntary\x20movements\x20</strong>and\x20<strong>behavioral\x20adverse\x20effects</strong>\x20like\x20confusion,\x20hallucinations,&nbsp;nightmares,\x20and\x20delusions\x20are\x20<strong>not\x20reduced\x20</strong>after\x20the\x20addition\x20of\x20carbidopa<strong>.\x20</strong>In\x20fact,\x20they\x20are\x20<strong>increased</strong>&nbsp;in\x20patients\x20who\x20are\x20taking\x20levodopa\x20<strong>with\x20peripheral\x20carboxylase</strong>\x20inhibitors.<strong>&nbsp;</strong>This\x20is\x20because\x20<strong>higher</strong>\x20levels\x20of\x20<strong>dopamine</strong>\x20are\x20formed\x20in\x20CNS.</p>','A-4,\x20B-2,\x20C-3,\x20D-1','QGZmC','-600\x20text-white\x22>','replace','A\x20young\x20male\x20patient\x20presents\x20to\x20the\x20clinic\x20with\x20the\x20following\x20condition.\x20After\x20taking\x20a\x20detailed\x20past\x20medical\x20and\x20drug\x20history\x20of\x20this\x20patient,\x20your\x20senior\x20asks\x20you\x20about\x20the\x20drugs\x20implicated\x20in\x20this\x20condition.\x20Which\x20of\x20the\x20following\x20drugs\x20is\x20most\x20likely\x20to\x20be\x20your\x20answer?','timed_exam','ELkoh','<p>In\x20the\x20given\x20clinical\x20scenario,\x20the\x20patient\x20has\x20elevated\x20levels\x20of\x20triglycerides\x20with\x20low\x20levels\x20of\x20LDL\x20and\x20HDL\x20cholesterol.\x20This\x20pattern\x20is\x20also\x20seen\x20in\x20his\x20mother.\x20Therefore,\x20it\x20is\x20most\x20likely\x20to\x20be\x20<strong>familial\x20hypertriglyceridemia.</strong>&nbsp;Since\x20the\x20patient\x20does\x20not\x20have\x20risk\x20factors\x20for\x20coronary\x20heart\x20disease,\x20<strong>fenofibrate</strong>\x20will\x20be\x20beneficial\x20in\x20reducing\x20triglyceride\x20levels.</p>\x0a<p>Familial\x20hypertriglyceridemia\x20occurs\x20due\x20to\x20a\x20defect\x20in\x20the\x20lipolysis\x20of\x20the\x20triglyceride-rich\x20lipoproteins\x20(TRLs).\x20As\x20a\x20result\x20of\x20this,\x20the\x20levels\x20of\x20fasting\x20<strong>triglyceride\x20levels\x20are\x20elevated.</strong>\x20Plasma\x20LDL\x20levels\x20are\x20reduced\x20due\x20to\x20the\x20defective\x20conversion\x20of\x20triglyceride-rich\x20lipoproteins\x20to\x20LDL.\x20Identification\x20of\x20hypertriglyceridemia\x20in\x20first-degree\x20relatives\x20helps\x20in\x20the\x20diagnosis.</p>\x0a<p>Hypertriglyceridemia\x20can\x20also\x20be\x20secondary\x20due\x20to&nbsp;intake\x20of\x20simple\x20carbohydrates,\x20obesity,\x20insulin\x20resistance,\x20alcohol\x20use,\x20and\x20estrogen\x20treatment.</p>\x0a<p>Initial\x20management\x20involves\x20exercise\x20and\x20dietary\x20management\x20(restriction\x20of\x20fatty\x20food,\x20avoidance\x20of\x20alcohol,\x20estrogen-containing\x20medications,\x20etc)</p>\x0a<p>If\x20the\x20levels\x20of\x20the\x20triglycerides\x20are\x20<strong>&gt;500\x20mg/dL</strong>\x20despite\x20lifestyle\x20changes,\x20then\x20<strong>fibrates</strong>\x20and\x20<strong>fish\x20oil</strong>\x20can\x20be\x20used\x20to\x20reduce\x20the\x20levels\x20and\x20decrease\x20the\x20risk\x20of\x20pancreatitis.&nbsp;If\x20the\x20patient\x20has\x20risk\x20factors\x20for\x20coronary\x20heart\x20disease,\x20then\x20<strong>statin</strong>\x20therapy\x20will\x20be\x20beneficial.</p>\x0a<p>&nbsp;</p>\x0a<table\x20style=\x22height:\x20173px;\x20width:\x20933px;\x22>\x0a<tbody>\x0a<tr>\x0a<td\x20style=\x22width:\x20190px;\x22><strong>Class</strong></td>\x0a<td\x20style=\x22width:\x20190px;\x22><strong>HMG-\x20CoA\x20reductase\x20inhibitors\x20(statins)</strong></td>\x0a<td\x20style=\x22width:\x20162px;\x22><strong>Fibrates</strong></td>\x0a<td\x20style=\x22width:\x20220px;\x22><strong>Niacin</strong></td>\x0a<td\x20style=\x22width:\x20191px;\x22><strong>Bile\x20acid-binding\x20resins</strong></td>\x0a<td\x20style=\x22width:\x20334px;\x22><strong>Ezetimibe</strong></td>\x0a</tr>\x0a<tr>\x0a<td\x20style=\x22width:\x20190px;\x22><strong>Important\x20examples</strong></td>\x0a<td\x20style=\x22width:\x20190px;\x22>\x0a<p\x20class=\x22p1\x22>Lovastatin,\x20atorvastatin,\x20fluvastatin,\x20pravastatin,\x20simvastatin,\x20rosuvastatin,\x20pitavastatin</p>\x0a</td>\x0a<td\x20style=\x22width:\x20162px;\x22>\x0a<p\x20class=\x22p1\x22>Gemfibrozil\x20and\x20fenofibrate</p>\x0a</td>\x0a<td\x20style=\x22width:\x20220px;\x22>Niacin</td>\x0a<td\x20style=\x22width:\x20191px;\x22>&nbsp;\x0a<p\x20class=\x22p1\x22>Colestipol,\x20cholestyramine,\x20and\x20colesevelam</p>\x0a</td>\x0a<td\x20style=\x22width:\x20334px;\x22>Ezetimibe</td>\x0a</tr>\x0a<tr>\x0a<td\x20style=\x22width:\x20190px;\x22><strong>Mechanism\x20of\x20action</strong></td>\x0a<td\x20style=\x22width:\x20190px;\x22>\x0a<p\x20class=\x22p1\x22>Inhibits\x20HMG-CoA\x20reductase</p>\x0a</td>\x0a<td\x20style=\x22width:\x20162px;\x22>\x0a<p\x20class=\x22p1\x22>PPAR-<span\x20class=\x22s1\x22>&alpha;\x20mediated\x20increased\x20lipolysis</span></p>\x0a</td>\x0a<td\x20style=\x22width:\x20220px;\x22>Decreases\x20the\x20production\x20of\x20VLDLs\x20and\x20decreases\x20the\x20catabolism\x20of\x20HDLs</td>\x0a<td\x20style=\x22width:\x20191px;\x22>increase\x20the\x20excretion\x20of\x20bile\x20acids.\x20This\x20results\x20in\x20increased\x20conversion\x20of\x20cholesterol\x20mobile\x20acids\x20by\x20the\x20liver&nbsp;</td>\x0a<td\x20style=\x22width:\x20334px;\x22>inhibits\x20intestinal\x20sterol\x20absorption</td>\x0a</tr>\x0a<tr>\x0a<td\x20style=\x22width:\x20190px;\x22><strong>Major\x20effects\x20on\x20lipoprotein\x20levels</strong></td>\x0a<td\x20style=\x22width:\x20190px;\x22>\x0a<p>Reduces\x20LDL\x20levels</p>\x0a</td>\x0a<td\x20style=\x22width:\x20162px;\x22>\x0a<p>Reduces\x20triglyceride\x20levels</p>\x0a<p>A\x20moderate\x20increase\x20in\x20HDL\x20levels</p>\x0a</td>\x0a<td\x20style=\x22width:\x20220px;\x22>\x0a<p>Reduces\x20triglycerides,&nbsp;\x20LDL,\x20and\x20lipoprotein\x20a\x20levels</p>\x0a<p>Significant\x20increase\x20in\x20HDL\x20levels</p>\x0a</td>\x0a<td\x20style=\x22width:\x20191px;\x22>Reduces\x20LDL\x20levels&nbsp;</td>\x0a<td\x20style=\x22width:\x20334px;\x22>\x0a<p>Reduces\x20LDL\x20cholesterol</p>\x0a<p>Minimal\x20increase\x20in\x20HDL\x20level</p>\x0a<p>Also\x20decreases\x20the\x20absorption\x20of\x20phytosterols</p>\x0a</td>\x0a</tr>\x0a<tr>\x0a<td\x20style=\x22width:\x20190px;\x22><strong>Important\x20side\x20effects</strong></td>\x0a<td\x20style=\x22width:\x20190px;\x22>&nbsp;\x0a<p\x20class=\x22p1\x22>Elevations\x20of\x20serum\x20aminotransferase\x20activity</p>\x0a<p\x20class=\x22p1\x22>Elevation\x20of\x20creatine\x20kinase\x20activity</p>\x0a<p\x20class=\x22p1\x22>Myopathy</p>\x0a</td>\x0a<td\x20style=\x22width:\x20162px;\x22>\x0a<p\x20class=\x22p1\x22>rashes,\x20gastrointestinal\x20symptoms,\x20myopathy,\x20arrhythmias,\x20hypokalemia,\x20elevated\x20aminotransferases\x20or\x20alkaline\x20phosphatase</p>\x0a&nbsp;</td>\x0a<td\x20style=\x22width:\x20220px;\x22>\x0a<p>Cutaneous\x20vasodilation</p>\x0a<p>Elevations\x20in\x20aminotransferases\x20levels&nbsp;</p>\x0a</td>\x0a<td\x20style=\x22width:\x20191px;\x22>\x0a<p>Constipation</p>\x0a<p>Bloating&nbsp;</p>\x0a</td>\x0a<td\x20style=\x22width:\x20334px;\x22>\x0a<p>reversible\x20hepatic\x20function\x20impairment</p>\x0a<p>Rarely\x20myositis</p>\x0a</td>\x0a</tr>\x0a</tbody>\x0a</table>','Conventional-AMB\x20<\x20Liposomal\x20amphotericin\x20B\x20<\x20Amphotericin\x20B\x20lipid\x20complex','Abciximab','cMVvO','vHyUn','jAVMt','Which\x20of\x20the\x20following\x20is\x20the\x20mechanism\x20of\x20action\x20of\x20desmopressin\x20that\x20is\x20used\x20in\x20the\x20treatment\x20of\x20central\x20diabetes\x20insipidus?','weiJI','AusJq','IWTVm','YeSym','ykNTd','aweyA','Piqxz','\x22\x20data-src=\x22','1,\x202,\x203,\x204,\x205,\x206','style','hzaae','HOveL','1,\x202,\x203,\x204,\x205','correctCount','zNVST','gNsQZ','markReviewText','JYpki','ubDhb','To\x20reduce\x20the\x20systemic\x20side\x20effects\x20of\x20levodopa','https://cdn1.dailyrounds.org/uploads/60ce1391af7143039b785245db659574.PNG','<p><strong>Octreotide</strong>\x20is\x20a\x20useful\x20agent\x20in\x20treating\x20<strong>variceal\x20bleeding</strong>.</p>\x0a<p>Octreotide\x20is\x20a\x20<strong>somatostatin\x20analog</strong>\x20and\x20controls\x20variceal\x20bleeding\x20by</p>\x0a<ul>\x0a<li>Reducing\x20hepatic\x20and\x20azygous\x20blood\x20flow</li>\x0a<li>Reducing\x20hepatic\x20venous\x20wedge\x20pressure</li>\x0a<li>Constricting\x20splanchnic\x20arterioles:\x20direct\x20action\x20on\x20vascular\x20smooth\x20muscle.</li>\x0a<li>Decreasing\x20hyperdynamic\x20circulatory\x20syndrome\x20of\x20portal\x20hypertension\x20by\x20inhibiting\x20the\x20release\x20of\x20contributing\x20peptides.</li>\x0a</ul>\x0a<p>Initial\x20management\x20of\x20variceal\x20bleeding\x20involves\x20the\x20following:&nbsp;</p>\x0a<ul>\x0a<li>Admission\x20to\x20the\x20intensive\x20care\x20unit</li>\x0a<li>Placement\x20of&nbsp;<strong>two\x20large-bore\x20peripheral\x20cannulae</strong></li>\x0a<li>Blood\x20transfusion</li>\x0a<li><strong>Correction\x20of\x20coagulopathy</strong>&nbsp;with\x20Vitamin\x20K\x20and\x20tranexamic\x20acid</li>\x0a<li><strong>Octreotide</strong>,\x20a\x20somatostatin\x20analog\x20or&nbsp;<strong>terlipressin</strong>,\x20a\x20splanchnic\x20vasoconstrictor</li>\x0a<li>Prophylactic\x20antibiotic</li>\x0a<li>Endotracheal\x20intubation\x20for\x20airway\x20protection\x20if\x20bleeding\x20is\x20uncontrolled</li>\x0a<li>Upper\x20gastrointestinal\x20endoscopy</li>\x0a</ul>\x0a<p>Ultimately,\x20liver\x20transplantation\x20is\x20the\x20only\x20way\x20to\x20definitively\x20treat\x20portal\x20hypertension\x20and\x20variceal\x20bleeding.&nbsp;</p>','GRQGJ','</span><span>','Correct','mmqRe','ZwMeX','PVOLD','https://dhmbxeygs57ff.cloudfront.net/uploads/c699ca5e02ed49288892c025fec28dcfx500x333.PNG','4|0|5|2|1|3','Lidocaine','Lofexidine','Activates\x20Na+-Cl\x20symporter','bFCiq','GOGqV','A-1,\x20B-2,\x20C-3,\x20D-4','reload','facEz','toString','bookmarkBtn','HrgJr','pwxQm','HNWqK','CcMTG','Fever,\x20normotonia,\x20dilated\x20pupils\x20and\x20normal\x20reflexes','classList','TzQPK','<p><span\x20data-preserver-spaces=\x22true\x22>The\x20given\x20image\x20shows\x20a\x20depressed\x20nasal\x20bridge\x20(saddle\x20nose).\x20This\x20image\x20along\x20with\x20the\x20stippling\x20of\x20bone\x20epiphyses\x20points\x20to\x20<strong>fetal\x20warfarin\x20syndrome\x20</strong>or<strong>\x20warfarin\x20embryopathy</strong>.\u00a0</span></p>\x0a<p><strong><span\x20data-preserver-spaces=\x22true\x22>Features:</span></strong></p>\x0a<ul>\x0a<li><span\x20data-preserver-spaces=\x22true\x22>Repeated\x20abortions</span></li>\x0a<li><span\x20data-preserver-spaces=\x22true\x22>CNS\x20abnormalities</span></li>\x0a<li><span\x20data-preserver-spaces=\x22true\x22>Depressed\x20nasal\x20bridge/absent\x20nasal\x20bone/saddle\x20nose\x20at\x20birth</span></li>\x0a<li><span\x20data-preserver-spaces=\x22true\x22>Bleeding\x20diathesis\x20at\x20birth</span></li>\x0a<li><span\x20data-preserver-spaces=\x22true\x22>Growth\x20retardation\x20-\x20hypoplasia\x20of\x20nose,\x20eye\x20sockets,\x20and\x20long\x20bones\x20with\x20stippling\x20of\x20epiphyses\u00a0</span></li>\x0a</ul>\x0a<p><span\x20data-preserver-spaces=\x22true\x22><strong>Anticoagulation\x20in\x20pregnancy:</strong></span></p>\x0a<ul>\x0a<li><span\x20data-preserver-spaces=\x22true\x22>Warfarin:\x20Although\x20safe\x20for\x20the\x20mother,\x20it\x20can\x20lead\x20to\u00a0</span><strong><span\x20data-preserver-spaces=\x22true\x22>warfarin\x20embryopathy</span></strong><span\x20data-preserver-spaces=\x22true\x22>,\x20miscarriage,\x20IUGR,\x20and\x20stillbirths.</span></li>\x0a<li><span\x20data-preserver-spaces=\x22true\x22>Heparin:\x20It\x20is\x20safe\x20for\x20the\x20fetus</span><span\x20data-preserver-spaces=\x22true\x22>\u00a0but\x20is\x20less\x20effective\x20than\x20warfarin.</span></li>\x0a<li><span\x20data-preserver-spaces=\x22true\x22>LMWH:\x20It\x20is\x20inadequate,\x20and\x20ACOG\x20does\x20not\x20recommend\x20its\x20use\x20in\x20pregnant\x20women\x20with\x20prosthetic\x20heart\x20valves.</span></li>\x0a</ul>\x0a<table\x20class=\x22t1\x22\x20cellspacing=\x220\x22\x20cellpadding=\x220\x22>\x0a<tbody>\x0a<tr>\x0a<td\x20class=\x22td1\x22\x20valign=\x22top\x22>\x0a<p\x20class=\x22p1\x22><strong>Period\x20of\x20gestation</strong></p>\x0a</td>\x0a<td\x20class=\x22td1\x22\x20valign=\x22top\x22>\x0a<p\x20class=\x22p1\x22><strong>Anticoagulant</strong></p>\x0a</td>\x0a</tr>\x0a<tr>\x0a<td\x20class=\x22td1\x22\x20valign=\x22top\x22>\x0a<p\x20class=\x22p1\x22>Till\x2012\x20completed\x20weeks</p>\x0a</td>\x0a<td\x20class=\x22td1\x22\x20valign=\x22top\x22>\x0a<p\x20class=\x22p1\x22>LMWH\x20or\x20UFH</p>\x0a</td>\x0a</tr>\x0a<tr>\x0a<td\x20class=\x22td1\x22\x20valign=\x22top\x22>\x0a<p\x20class=\x22p1\x22>13\x20to\x2036\x20weeks</p>\x0a</td>\x0a<td\x20class=\x22td1\x22\x20valign=\x22top\x22>\x0a<p\x20class=\x22p1\x22>Warfarin</p>\x0a</td>\x0a</tr>\x0a<tr>\x0a<td\x20class=\x22td1\x22\x20valign=\x22top\x22>\x0a<p\x20class=\x22p1\x22>36\x20weeks\x20to\x206\x20hours\x20before\x20delivery</p>\x0a</td>\x0a<td\x20class=\x22td1\x22\x20valign=\x22top\x22>\x0a<p\x20class=\x22p1\x22>LMWH\x20or\x20UFH</p>\x0a</td>\x0a</tr>\x0a<tr>\x0a<td\x20class=\x22td1\x22\x20valign=\x22top\x22>\x0a<p\x20class=\x22p1\x22>6\x20hours\x20after\x20vaginal\x20and\x2024\x20hours\x20after\x20cesarian\x20section</p>\x0a</td>\x0a<td\x20class=\x22td1\x22\x20valign=\x22top\x22>\x0a<p\x20class=\x22p1\x22>LMWH\x20or\x20UFH\x20(ACOG\x20recommendation)</p>\x0a</td>\x0a</tr>\x0a</tbody>\x0a</table>\x0a<p><span\x20data-preserver-spaces=\x22true\x22>If\x20delivery\x20occurs\x20while\x20the\x20anticoagulant\x20is\x20still\x20effective,\x20and\x20excessive\x20bleeding\x20happens,\x20then\x20<strong>protamine\x20sulfate</strong>\x20is\x20given\x20intravenously.\u00a0</span></p>\x0a<p><span\x20data-preserver-spaces=\x22true\x22>Anticoagulation\x20of\x20pregnant\x20women:</span></p>\x0a<ul>\x0a<li><span\x20data-preserver-spaces=\x22true\x22>The\x20patient\x20taking\x20warfarin\x20should\x20discontinue\x20it\x20as\x20soon\x20as\x20pregnancy\x20is\x20diagnosed\x20and\x20replace\x20it\x20with\u00a0</span><strong><span\x20data-preserver-spaces=\x22true\x22>heparin\x205,000\x20units\x20twice\x20daily\x20subcutaneously\x20up\x20to\x20the\x2012th\x20week\x20of\x20gestation</span></strong><span\x20data-preserver-spaces=\x22true\x22>.\u00a0</span></li>\x0a<li><span\x20data-preserver-spaces=\x22true\x22>Heparin\x20is\x20then\x20replaced\x20by\u00a0</span><strong><span\x20data-preserver-spaces=\x22true\x22>a\x20warfarin\x20tablet\x20of\x203\x20mg\x20daily</span></strong><span\x20data-preserver-spaces=\x22true\x22>\u00a0to\x20be\x20taken\x20at\x20the\x20same\x20time\x20each\x20day\x20and\x20continued\u00a0</span><strong><span\x20data-preserver-spaces=\x22true\x22>up\x20to\x2036\x20weeks\x20</span></strong>in\x20patients\x20with\x20a\x20high\x20risk\x20of\x20thrombosis.</li>\x0a<li><span\x20data-preserver-spaces=\x22true\x22>Thereafter,\x20warfarin\x20is\x20replaced\x20by\u00a0</span><strong><span\x20data-preserver-spaces=\x22true\x22>heparin,\x20which\x20is\x20discontinued\x206\x20hours</span></strong><span\x20data-preserver-spaces=\x22true\x22>\u00a0just\x20before\x20delivery.</span></li>\x0a<li><span\x20data-preserver-spaces=\x22true\x22>Heparin\x20(unfractionated\x20or\x20LMWH)\x20is\x20restarted\x206\x20hours\x20after\x20vaginal\x20delivery\x20and\x2024\x20hours\x20after\x20the\x20cesarean\x20section.</span></li>\x0a<li><span\x20data-preserver-spaces=\x22true\x22>Unfractionated\x20heparin\x20(UFH),\x20LMWH,\x20and\x20warfarin\x20therapy\x20are\u00a0</span><strong><span\x20data-preserver-spaces=\x22true\x22>not\x20contraindicated</span></strong><span\x20data-preserver-spaces=\x22true\x22>\u00a0in\x20breastfeeding.</span></li>\x0a</ul>','timerContainer','Sulfonylurea','className','WGRtU','1,\x203,\x204\x20and\x205','YvwNx','TTMap','<p>The\x20drug\x20that\x20catalyzes\x20the\x20enzymatic\x20oxidation\x20of\x20uric\x20acid\x20into\x20allantoin\x20for\x20the\x20treatment\x20of\x20chronic\x20gout\x20is<strong>\x20pegloticase.\x20</strong></p>\x0a<p>Pegloticase\x20is\x20a\x20<strong>pegylated\x20uricase</strong>\x20(urate\x20oxidase)\x20that\x20catalyzes\x20the\x20enzymatic\x20oxidation\x20of\x20<strong>uric\x20acid\x20into\x20allantoin</strong>,\x20which\x20is\x20a\x20more\x20soluble\x20and\x20inactive\x20metabolite.\u00a0It\x20is\x20used\x20in\x20the\x20treatment\x20of\x20<strong>severe</strong>,\u00a0<strong>refractory\x20chronic\x20gout</strong>\x20or\x20in\x20cases\x20where\x20other\x20urate-lowering\x20therapies\x20are\x20contraindicated.\x20The\x20efficacy\x20of\x20this\x20drug\x20gets\x20lowered\x20if\x20antibodies\x20are\x20produced\x20against\x20the\x20drug,\x20which\x20occurs\x20in\x20many\x20patients.\x20This\x20also\x20increases\x20the\x20risk\x20of\x20infusion\x20reactions.\u00a0</p>\x0a<div\x20class=\x22page\x22\x20title=\x22Page\x20711\x22>\x0a<div\x20class=\x22section\x22>\x0a<div\x20class=\x22layoutArea\x22>\x0a<div\x20class=\x22column\x22>\x0a<div\x20class=\x22page\x22\x20title=\x22Page\x20711\x22>\x0a<div\x20class=\x22section\x22>\x0a<div\x20class=\x22layoutArea\x22>\x0a<div\x20class=\x22column\x22>\x0a<p><strong>Rasburicase</strong>\x20is\x20a\x20<strong>recombinant\x20uricase</strong>.\x20It\x20is\x20indicated\x20for\x20the\x20initial\x20management\x20of\x20elevated\x20plasma\x20uric\x20acid\x20levels\x20in\x20patients\x20with\x20malignancies\x20who\x20are\x20on\x20chemotherapy.\x20The\x20efficacy\x20is\x20limited\x20by\x20the\x20production\x20of\x20antibodies\x20to\x20the\x20drug.</p>\x0a</div>\x0a</div>\x0a</div>\x0a</div>\x0a</div>\x0a</div>\x0a</div>\x0a</div>\x0a<p><strong>Gout</strong>\x20occurs\x20due\x20to\x20the\x20precipitation\x20of\x20urate\x20crystals\x20in\x20the\x20tissues\x20with\x20a\x20subsequent\x20inflammatory\x20response.\x20In\x20an\x20acute\x20episode\x20of\x20gout,\x20there\x20is\x20painful\x20distal\x20monoarthritis\x20which\x20can\x20lead\x20to\x20joint\x20destruction,\x20subcutaneous\x20tophi,\x20and\x20renal\x20calculi.\x20Management\x20of\x20gout\x20includes:</p>\x0a<div\x20class=\x22page\x22\x20title=\x22Page\x20708\x22>\x0a<div\x20class=\x22section\x22>\x0a<div\x20class=\x22layoutArea\x22>\x0a<div\x20class=\x22column\x22>\x0a<ul>\x0a<li>Reduction\x20of\x20pain\x20and\x20inflammation:\x20NSAIDs,\x20colchicine,\x20glucocorticoids</li>\x0a<li>Inhibition\x20of\x20the\x20formation\x20of\x20urate:\x20Allopurinol,\x20febuxostat</li>\x0a<li>Promotion\x20of\x20urate\x20excretion:\x20Probenecid,\x20lesinurad</li>\x0a</ul>\x0a</div>\x0a</div>\x0a</div>\x0a</div>\x0a<p>Other\x20options:\u00a0</p>\x0a<p>Option\x20A:\x20<strong>Colchicine</strong>\x20acts\x20by\x20<strong>preventing\x20the\x20polymerization\x20of\x20microtubules\x20by\x20tubulin</strong>,\x20this\x20<strong>reduces\x20neutrophil\x20recruitment</strong>\x20to\x20inflamed\x20tissue\x20and\x20also\x20<strong>decreases\x20the\x20secretion\x20of\x20chemotactic\x20factors</strong>\x20by\x20activated\x20neutrophils.\x20Overall\x20reducing\x20the\x20inflammatory\x20response.</p>\x0a<p>Option\x20B:\u00a0<strong>Febuxostat</strong>\x20is\x20a\u00a0<strong>xanthine\x20oxidase\x20inhibitor</strong>\x20approved\x20for\x20the\x20<strong>treatment\x20of\x20hyperuricemia</strong>\x20in\x20patients\x20with\x20gout.</p>\x0a<p>Option\x20D:\x20<strong>Allopurinol</strong>\x20by\x20<strong>inhibiting\x20the\x20xanthine\x20oxidase</strong>\x20enzyme\x20prevents\x20the\x20conversion\x20of\x20xanthine\x20to\x20uric\x20acid.</p>','timeSpent','6.25\x20mg','incomplete','Teriparatide\x2020\x20g\x20annually','YYzrV','Drugs\x20with\x20a\x20warning\x20label\x20\x20Caution:\x20it\x20is\x20dangerous\x20to\x20take\x20this\x20preparation\x20except\x20under\x20medical\x20supervision','izjmb','\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<button\x20type=\x22button\x22\x20class=\x22option-button\x20','2,\x204,\x205','src','tIhxV','Pharmacology\x20Test','https://cdn1.dailyrounds.org/uploads/bbeb488b27f94db38b5aa6185ae9f5ea.PNG','solution','dataset','kMJKe','TAlJb','ZcNne','zweNT','V2\x20receptor\x20antagonist\x20of\x20vasopressin','constructor','The\x20dose-response\x20curve\x20is\x20plotted\x20for\x20drug\x20A\x20both\x20in\x20the\x20presence\x20and\x20absence\x20of\x20drug\x20B.\x20\x20What\x20type\x20of\x20effect\x20does\x20drug\x20B\x20have\x20on\x20drug\x20A?','true','oEalv','<p>The\x20clinical\x20features\x20are\x20suggestive\x20of\x20<strong>organophosphate\x20poisoning</strong>\x20and\x20<strong>IV\x20atropine</strong>\x20is\x20the\x20treatment\x20of\x20choice.</p>\x0a<p>The\x20organophosphates\x20commonly\x20used\x20as\x20pesticides\x20are\x20anticholinesterases.&nbsp;Toxicity\x20occurs\x20by\x20excessive\x20inhalation\x20of\x20vapors,\x20ingestion,\x20or\x20percutaneous\x20absorption.\x20It\x20inhibits\x20the\x20cholinesterase\x20activity\x20which\x20results\x20in\x20an\x20increase\x20of\x20acetylcholine,\x20leading\x20to\x20cholinergic\x20symptoms.</p>\x0a<p>The\x20predominant\x20initial\x20signs\x20are\x20of\x20muscarinic\x20excess\x20which\x20includes:&nbsp;<strong>(DUMBBELSS)</strong></p>\x0a<ul>\x0a<li><strong>D</strong>iarrhea</li>\x0a<li><strong>U</strong>rination</li>\x0a<li><strong>M</strong>iosis</li>\x0a<li><strong>B</strong>ronchospasm</li>\x0a<li><strong>B</strong>radycardia</li>\x0a<li><strong>E</strong>mesis</li>\x0a<li><strong>L</strong>acrimation</li>\x0a<li><strong>S</strong>alivation</li>\x0a<li><strong>S</strong>weating</li>\x0a</ul>\x0a<p>This\x20may\x20be\x20followed\x20by\x20cognitive\x20disturbances,\x20convulsions,\x20and\x20neuromuscular\x20blockade.</p>\x0a<p>Treatment:</p>\x0a<ul>\x0a<li>Maintenance\x20of\x20vital\x20signs\x20particularly\x20respiration</li>\x0a<li>Removal\x20of\x20clothing\x20and\x20washing\x20of\x20the\x20skin</li>\x0a<li><strong>IV\x20atropine\x202-\x205\x20mg.\x20</strong>If&nbsp;IV\x20administration\x20is&nbsp;not\x20possible,\x20then\x20<strong>2\x20mg\x20IM</strong>&nbsp;every\x205-10\x20minutes\x20(till\x20muscarinic\x20symptoms\x20disappear)</li>\x0a<li><strong>Pralidoxime,</strong>\x20a\x20cholinesterase\x20reactivator\x20can\x20also\x20be\x20used\x20for\x20treatment</li>\x0a</ul>','A\x20patient\x20has\x20been\x20taking\x20ramipril\x20to\x20control\x20his\x20hypertension\x20for\x20the\x20past\x2010\x20years.\x20On\x20a\x20recent\x20follow-up\x20visit,\x20the\x20doctor\x20advised\x20the\x20addition\x20of\x20one\x20more\x20antihypertensive\x20drug\x20to\x20his\x20regimen.\x20Which\x20of\x20the\x20following\x20drugs\x20cannot\x20be\x20prescribed\x20to\x20this\x20patient?','nav-btn-current','3,\x205','Teriparatide\x2020\x20g\x20monthly','YjItz','https://cdn1.dailyrounds.org/uploads/c8066293e7f1477da782821d1de724de.PNG','remove','gfYkF'];_0x5efc=function(){return _0x4963d2;};return _0x5efc();}</script>

</body></html>